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Abstract 
The three-dimensional structure of chromatin is essential for context-dependent 
regulation of gene expression in post-mitotic neurons. Chromosomal rearrangements have 
been observed in the aging brain, and proteins involved in chromatin organization have 
altered expression and/or localization in Alzheimer’s disease (AD). A human- and primate-
specific transcript of choline acetyltransferase produces an 82-kDa protein (82-kDa ChAT) 
that is localized to the nucleus of cholinergic neurons, but is found in the cytoplasm in 
individuals with mild cognitive impairment (MCI) and AD. The function of the 82-kDa 
ChAT protein is unknown, though recent evidence suggests it has a role in gene expression 
changes in response to cellular perturbations.  
In the present study, we explore whether 82-kDa ChAT is involved in global 
chromatin organization and an epigenetic response to cytotoxic amyloid-β (Aβ) exposure. We 
show that 82-kDa ChAT associates with chromatin in human SH-SY5Y neural cells using 
chromatin immunoprecipitation with next-generation sequencing (ChIP-seq), finding that 
acute exposure of cells to oligomeric Aβ1–42 increases 82-kDa ChAT associations with gene 
promoters and introns. Following Aβ1–42-exposure, 82-kDa ChAT co-localizes in nuclear 
aggregates with special AT-rich binding protein 1 (SATB1), which anchors DNA to 
scaffolding/matrix attachment regions (S/MARs). SATB1 has similar increases in genic 
associations following Aβ1–42-exposure, and both SATB1 and 82-kDa ChAT associate with 
synapse-related genes. The 82-kDa ChAT and SATB1 proteins have patterned genomic 
associations at regions enriched with S/MAR binding motifs, preventing an Aβ1–42-induced 
increase in an isoform-specific APP mRNA transcript. Finally, we show that 82-kDa ChAT 
expression during cholinergic differentiation of SH-SY5Y cells increases the steady-state 
levels of proteins related to synapse formation, resulting in increased neurite complexity. 
These results demonstrate that 82-kDa ChAT and SATB1 regulate chromatin 
organization at S/MARs, resulting in context-dependent gene expression changes in 
cholinergic cells and increased expression of synapse formation-related proteins during 
cholinergic differentiation. Cholinergic synapse dysfunction and degeneration is observed 
early in AD progression and 82-kDa ChAT is mislocalized in AD, therefore the loss of both 
the epigenetic response to Aβ and gene expression changes related to synapse formation and 
maintenance may have implications for the etiology or progression of MCI and AD. 
Keywords 
Choline acetyltransferase / Chromatin immunoprecipitation / Chromatin organization / 
Epigenetics / Scaffolding/matrix attachment regions / Super-resolution microscopy   
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Forward  
Non-dividing post-mitotic cells present a unique challenge in biology – how can cells 
survive, in some cases for the entire lifespan of an organism, while dealing with 
environmental challenges such as oxidative or endoplasmic reticulum stress, DNA damage, 
or changes in metabolic state? Many cellular homeostatic changes require a DNA response to 
either activate or repress transcription of response genes, which implies state-dependent 
dynamic regulation of gene access. It is thus critical for the cell to have tools dedicated to 
facilitating these responses.  
 This concept has led the idea of the “epigenome”, a set of specific DNA 
modifications that can dynamically alter transcriptional access to DNA depending on cell 
state. These modifications can be to the DNA itself, or to the core histones which together 
with the DNA make up the chromatin fiber (together called the nucleosome). Examples of 
well-known histone modifications include methylation and acetylation, but can also include 
phosphorylation, ubiquitination and sumolyation. Non-histone changes to chromatin are also 
possible; directly modifying nucleosome position can change what portion of DNA is 
accessible between nucleosomes, and methylation of DNA can restrict access of 
transcriptional activators.  
Together, chromatin modifications represent an incredible amount of dynamic 
regulation of chromatin access - but this system does not confer much specificity. Global 
changes to chromatin access with one or more modifications is likely counter-productive; 
state-dependent cellular responses often need varying levels of both chromatin access and 
restriction. Thus, it is advantageous for cells to be able to target specific genes for specific 
modifications in specific contexts. This is partially accomplished by transcription factors 
(TFs), which usually recruit transcriptional activators such as RNA Polymerase II, and can 
recruit chromatin modifiers as part of a TF complex. However, this does not account for all 
of the possible context-dependent chromatin modifications, nor does it account for 
transcriptional repression. Importantly, this also does not account for single gene changes – 
in fact, in order to target a single gene in each scenario the cell would need a TF for each 
modification, which would require an exponential number of proteins above the ~25,000 
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known human protein-coding genes. Thus, another level of chromatin regulation must be 
present in the cell. Cells organize genes into functional regions that can be accessed when 
needed, and there must exist context-dependent cell signaling events and/or chaperones to 
bring the correct modifications to genes. It is now becoming evident that gene expression 
depends on the three-dimensional folding of chromatin, where active and inactive segments 
of the genome tend to segregate in the same co-regulated space. 
This reasoning led me to explore how post-mitotic cells (i.e. neurons) respond to 
contextual environmental challenges through the regulation of chromatin organization. I 
placed emphasis on the special case of human cholinergic neurons, which are critical for 
cognition, memory, attention and sleep, but are lost early in dementia-related neurological 
disorders such as mild cognitive impairment and Alzheimer’s disease (AD). This case is 
especially interesting from a chromatin organization perspective; genetic background only 
accounts for ~1-5% of AD cases, while environment and lifestyle have been shown to be of 
etiological significance. There is now mounting evidence that there are epigenetic and 
chromatin organization related changes in both aging and AD. Therefore, elucidating how 
chromatin is organized in these cells, and how this is altered in stress and disease, is critical 
for understanding the pathogenesis of AD. 
The following story explores how a human and primate specific protein variant 
interacts with chromatin and is critical for chromatin organization in cholinergic neurons. 82-
kDa choline acetyltransferase (ChAT) is stably expressed in cholinergic nuclei but is reduced 
in aging individuals and redistributed to the cytoplasm in AD patients. The work presented 
here will show a novel role for 82-kDa ChAT in gene expression changes and chromatin 
organization during cholinergic differentiation and following cellular stress. These gene 
expression changes promote the healthy function of synaptic connections, an important point 
given that synaptic destabilization and degeneration are seen early in AD. Thus the work 
presented here is important for understanding healthy neuron function and disease etiology, 
and may help identify targets for AD prevention or treatment. 
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Chapter 1  
1 Introduction 
 
Proper chromatin organization is imperative for promoting accurate context-
dependent epigenetic modifications - changes in gene expression due to alterations 
directly to DNA or to the core histones that DNA wraps around in the nucleosome 
complex. Chromatin organization is essential for neuronal development and function, and 
defects in chromatin-associated processes has been implicated in many neurological 
disorders such as schizophrenia, intellectual disorder and autism spectrum disorder (Gong 
et al. 2008; Gregor et al. 2013; McCarthy et al. 2014). More recently, chromatin 
organization changes have been observed in neurodegenerative diseases such as 
Alzheimer’s disease (AD) and Parkinson’s disease (reviewed in Marques and Outeiro 
2013; Walker et al. 2013). Therefore, understanding how chromatin is organized in 
neurons and can become disrupted in disease is essential for identifying biomarkers for 
early disease detection, and for the development of novel therapeutics. 
This review will address how epigenetic modifications regulate gene expression, 
the relationship between these modifications and chromatin organization, and the 
disruptions in chromatin organization observed in aging and neurodegenerative disease. 
Several proteins related to epigenetic processes and chromatin organization are 
mislocalized to the cytoplasm in aging and AD, including DNA methyltransferase 
(DNMT) and repressor element 1-silencing transcription (REST) (Mastroeni et al. 2013; 
Lu et al. 2014). A human and primate-specific 82-kDa variant of choline 
acetyltransferase (ChAT) also has altered localization in AD and may be related to 
changes in gene expression (Gill et al. 2007; Albers et al. 2014); therefore this review 
will also explore the known literature for 82-kDa ChAT. It is beyond the scope of this 
review to present all the known literature on epigenetic processes and chromatin 
organization comprehensively, though there are several excellent reviews (Politz et al. 
2013; Alexander and Lomvardas 2014; Luperchio et al. 2014) that address these topics 
have had influence on the authors’ research.  
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1.1 Histone modifications and the regulation of transcriptional activation 
 
Epigenetic changes can result in the formation of euchromatin - DNA that is 
available for transcription and loosely packed; or heterochromatin - highly compacted 
DNA that is often transcriptionally repressed (Croft et al. 1999; Zink et al. 2004; 
Harnicarová et al. 2006). Heterochromatin can be further divided into facultative 
repression - DNA that is transiently repressed and easily reversed; and constitutive 
repression - a more permanent repressive state (Li and Zhou 2013; Saksouk et al. 2015; 
Stunnenberg et al. 2015; Jamieson et al. 2016). The sum of epigenetic alterations to both 
the DNA and 4 core histones (H3, H4, H2A and H2B) will determine this state, but in the 
case of activation still require recruitment of transcription factors (TFs) and 
transcriptional activators for transcription to occur. Together these alterations are known 
as the “histone code” and are a result of post-translational histone modifications, direct 
methylation of DNA, nucleosome positioning or microRNA (miRNA)-mediated gene 
repression. 
The most widely studied epigenetic alterations are to the core histones that make 
up the nucleosome complex. A well-known example of post-translational histone 
modifications is acetylation, where an acetyl group is reversibly added to lysine, 
removing its positive charge (Reviewed in Sterner and Berger 2000; Bannister and 
Kouzarides 2011). Histone acetylation by histone acetyltransferases (HATs) mainly 
occurs on histone H3 or H4, with the net negative charge causing the histones to repel 
each other, increasing access to the DNA strand between nucleosomes and allowing TFs 
and RNA polymerase II (Pol II) to bind DNA (Zhang et al. 2012; Vamos and Boros 
2012; Henry et al. 2013; Zhu et al. 2014). Deacetylation is accomplished by histone 
deacetylases (HDACs) which remove the acetyl groups and increases the positive charge 
on the histone that restricts DNA access by positioning nucleosomes closer together 
(Nagl et al. 2007; Choe et al. 2009; Reviewed in Li and Kumar 2010; Bannister and 
Kouzarides 2011). 
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While histone acetylation can directly alter access to DNA, histone methylation 
results in recruitment of transcriptional modifiers and either HATs or HDACs to DNA. 
Histones are methylated on lysine or arginine residues by replacing 1, 2 or 3 hydrogens in 
the NH3 (amino) group, resulting in mono-, di- or tri-methylation, respectively (Reviewed 
in Lachner et al. 2003; Sharma et al. 2010). Similar to acetylation, histones are 
methylated on lysine by histone methyltransferases (HMTs) and demethylated by histone 
demethylases (HMDs) (Lachner et al. 2003). Arginine methylation is accomplished by 
protein arginine methyltransferases (PRMTs) (Pal et al. 2004).  Some examples of 
methylation that leads to transcriptional activation include histone H3 lysine 4 (H3K4) 
tri-methylation (H3K4me3) and histone H3 lysine 79 tri-methylation (H3K79me3) 
(Liang et al. 2004; Kim et al. 2012). H3K4me3 is enriched at gene promoter regions that 
have active markers of transcription such as acetyl groups added by HATs and Pol II 
recruitment (Liang et al. 2004). In addition, H3K4me3 can lead to Histone 2A (H2A) 
replacement by the variant H2A.Z at transcription initiation sites, important for 
destabilizing the histone complex and allowing access to the nucleosome-related DNA 
(Fig. 1-1A) (Bártfai et al. 2010; Brunelle et al. 2015).  
Histone methylation by polycomb repressive complexes (PRCs) leads to the 
transient, facultative repression of transcription often found at the borders of 
heterochromatic regions (Fig. 1-1B) (Cheutin and Cavalli 2012; Dixon et al. 2012; 
Abraham and Kulesza 2013; Boros et al. 2014). Histone H3 lysine 27 tri-methylation 
(H3K27me3) is methylated by PRC2, recruited by HDACs and other chromatin 
organizers (Cheutin and Cavalli 2012; Abraham and Kulesza 2013; Kim et al. 2015). 
Importantly, PRC1 is also recruited to this region, which then adds the small molecule 
ubiquitin to H2A.Z (Cao et al. 2005; Sarcinella et al. 2007). Both the recruitment of 
HDACs and ubiquitination of H2A.Z facilitate the attenuation of transcription in these 
regions, but do not cause chromatin compaction (Sarcinella et al. 2007). Therefore, these 
regions are still accessible for chromatin modifiers and can be transcriptionally activated 
if needed.  
Finally, heterochromatin that is constitutively repressed is often enriched with 
histone H3 lysine 9 tri-methylation (H3K9me3), methylated by K9-HMT (Fig. 1-1C)  
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Figure 1-1. Regulation of histone modifications. 
(A) Histone acetyltransferases (HATs) acetylate histones, histone 3 lysine 4 (H3K4) 
methyltransferase (K4-HMT) tri-methylates histone H3K4 and histone H2A is replaced 
by H2A.Z. These modifications produce an ‘open’ histone state that allows RNA 
polymerase II (RNA Pol II) to bind to promoter regions and initiate transcription. (B) To 
promote facultative repression, polycomb repressive complex 1 (PRC1) ubiquitinates 
H2A.Z while PRC2 di-/tri-methylates H3K27. Histone deacetylases (HDACs) are 
responsible for the removal of acetyl groups resulting in a ‘closed’, but reversible, 
repressive state. (C) In the constitutively repressed state, H3K9 HMTs (K9-HMT) tri-
methylates H3K9, DNMTs methylate DNA and HDACs remove acetyl groups from the 
histones. In addition, heterochromatin protein 1 (HP1) is recruited to promoters to repress 
transcription further. Adapted from Sharma et al. 2010.
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(Nakayama et al. 2001; Barski et al. 2007; Vaquero et al. 2007). As with facultative 
repression, HDACs are also recruited to H3K9me3 regions to reduce histone acetylation 
(Nakayama et al. 2001). In addition, H2A.Z is replaced by H2A, and DNMTs are 
recruited to promoter regions to methylate the DNA which, in most cases, prevents the 
binding of TFs and Pol II (Nakayama et al. 2001; Barski et al. 2007). H3K9me3 rich 
regions are often bound with heterochromatin protein 1 (HP1) at gene promoters, which 
further promotes gene silencing and chromatin compaction (Nakayama et al. 2001). 
These modifications together lead to a repressive model of DNA compaction that is 
difficult, but not impossible to access. Constitutively repressed regions rich in H3K9me3 
tend to be found within heterochromatin regions, flanked by facultative repressive 
regions or activated regions (Barski et al. 2007). H3K9me3 is also enriched in the 
inactivated X chromosome (Brinkman et al. 2006).  
Both telomeres and centromeres are often enriched with H3K9me3 (Schotta et al. 
2002; Guenatri et al. 2004; Mikkelsen et al. 2007; Nakano et al. 2008). Telomeres have 
tandem repeats which are important for mitosis in dividing cells and often shorten with 
age, increasing the risk of cancer and an impaired DNA damage response (Allsopp et al. 
1992; Jurk et al. 2002; Zhang et al. 2007). Telomeric length is important for post-mitotic 
cells, as neurons respond to DNA damage through proteins that stabilize telomeres 
(Zhang et al. 2007; Jurk et al. 2012). Changes to telomeric length in post-mitotic neurons 
has been linked to neurological disorders such as Alzheimer’s disease (AD) and 
amyotrophic lateral sclerosis (Jurk et al. 2012; Linkus et al. 2016). Centromere silencing 
is especially important for post-mitotic neurons, as centromeres are key mediators of cell 
division (reviewed in Herrup and Yang 2007; Frade and Ovejero-Benito 2015). Neurons 
in AD can re-enter the cell cycle, with recent evidence showing that these cells may 
undergo abnormal centromere division on the X chromosome (Spremo-Potparević et al. 
2008), though it is unclear if this precedes or is a consequence of cell cycle re-entry.   
Interestingly, the resulting changes to transcriptional activation can depend on 
how many methyl groups are added to a specific lysine. For example, H3K9 can be 
mono- di- or tri- methylated (H3K9me/me2/me3) by the K9-HMT, which results in 
increased transcription, facultative repression, and constitutive repression, respectively 
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(Peters et al. 2003; Rougeulle et al. 2004; Barski et al. 2007). Another example is H3K20 
methylation; H3K20me is associated with constitutive repression (Oda et al. 2007), 
H3K20me2 is involved in recruitment of DNA damage repair proteins (Fradet-Turcotte et 
al. 2013), and H3K20me3 has been found in heterochromatic regions and thus 
hypothesized to play a role in repression as well (Wongtawan et al. 2011). Arginine 
methylation is associated with both transcriptional activation and repression depending 
on the residues methylated (Reviewed by Di Lorenzo and Bedford 2011). The 
mechanisms that lead to arginine methylation related changes in gene expression are 
largely unknown, though there is evidence to suggest that these modifications may 
promote or prevent docking of transcriptional modifiers (Di Lorenzo and Bedford 2011). 
Other histone modifiers have been studied to a lesser extent, but are also essential 
for chromatin regulation. These include the aforementioned H2A.Z ubiquitination – 
important for transient facultative repression, as well as phosphorylation and 
sumolyation. Histone phosphorylation is essential for demarcation of regions with DNA 
damage and recruitment of acetyltransferases essential to begin the repair process (Burma 
et al. 2009). In addition, phosphorylation of H3 serine 10 (H3S10ph), threonine 11 
(H3T11ph) or H3S28ph has been shown to increase H3 acetylation and transcriptional 
activation (Duan et al. 2008; Metzger et al. 2008; Sawicka et al. 2014), and 
phosphorylation of histone H2B serine 14 (H2BS14ph) is critical for the initiation of 
chromatin condensation during apoptosis (Cheung et al. 2003; Fernandez-Capetillo et al. 
2004). Finally, the addition of small ubiquitin-related modifier (SUMO) by sumolyation 
to histone H4 (H4-SUMO) is important for the attenuation of histone acetylation, and an 
important intermediary for the transition from transcriptional activation to constitutive 
repression (Yang et al. 2002; Girdwood et al. 2003; Shiio and Eisenmann 2003).   
Though not explored in this review, it is important to note that post-translational 
histone modifications work together with other epigenetic related changes to dynamically 
regulate access to DNA.  Other epigenetic mechanisms which are important for the short 
and long-term regulation of transcription include DNA methylation by DNMTs, gene 
repression by miRNAs and the regulation of nucleosome positioning. All of these 
mechanisms work together to support the normal regulation of transcription, but are also 
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important for the response to environmental challenges, such as changes in metabolic 
state, DNA damage, oxidative and nitrosative stress, or cell-cell communication events 
(e.g. neurotransmission) (see Zawia et al. 2009; Shahani and Sawa 2011; Brochier and 
Langley 2013; Vogel-Ciernia and Wood 2014 for reviews). In order to respond with 
specificity, chromatin must be organized in a manner that allows access to the correct 
genomic sequences at the correct time. How cells organize chromatin, with emphasis on 
neurons, will be explored in the following section. 
 
1.2 Chromatin organization in post-mitotic cells 
 
During interphase and in non-dividing cells, chromatin is generally organized into 
both heterochromatic and euchromatic compartments. Heterochromatin is found largely 
at the nuclear periphery, associated with nuclear lamina proteins, lamin A or B, or in peri-
nucleolar regions (Peric-Hupkes et al. 2010; Shah et al. 2013; Reviewed in Luperchio et 
al. 2014). Euchromatic regions of activated chromatin are mainly found in the nuclear 
interior, with very little nuclear membrane or lamina association (see Kalverda et al. 
2008; Luperchio et al. 2014 for reviews). In the absence of outside input, post-mitotic 
cells must maintain this organization for their entire lifespan. In contrast, a mitotic cell 
does change its chromatin organization during cell division, as chromosomes must 
become compacted during prophase and remain in this state until cell division is 
complete (Hinde et al. 2012). 
One advantage to having this type of localization-dependent organization is that 
cells can change the state of gene activation and response time to environmental input by 
altering the localization of individual genes. One example of this function in neurons is 
the BDNF gene. BDNF encodes brain-derived neurotropic factor (BDNF), a protein 
important for neuron development, survival and synaptic development (Bamji et al. 2006; 
Chen et al. 2013). BDNF also has an important role in synaptic plasticity; changes in 
synapse number and strength based on repeated stimulation (Montalbano et al. 2013). In 
adult non-dividing neurons, BDNF is localized to the nuclear periphery. However, after 
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repeated activation of hippocampal neurons by kinate-induced seizures, the gene is 
rapidly internalized and activated (Walczak et al. 2013). BDNF mRNA levels peak by 2 h 
after stimulation, with this fully attenuated by 7 d. Though the mRNA levels are no 
longer elevated, an interesting observation is that the gene remains localized in the 
nuclear interior for at least 28 d following stimulation (Walczak et al. 2013). This 
localization change is important for sensitivity to the next stimulation. When Walczak et 
al. (2013) stimulated these cells 28 d following the initial stimulation, Pol II recruitment 
to the BDNF gene was significantly increased compared to naïve animals, suggesting that 
gene localization is important for magnitude of response.  
Recently, mounting evidence has shown that chromatin organization is more 
complex than simple heterochromatin/euchromatin regions. Active and inactive segments 
of the genome tend to segregate in space, while co-regulated regions group within the 
same Topologically Associating Domain (TAD) which are thought to contribute to their 
coordinated expression or silencing (Dixon et al. 2012; Heidari et al. 2014; reviewed in 
Luperchio et al. 2014) (Fig. 1-2). Centrally localized TADs tend to be rich in H3K27me3 
and are flanked by boundary elements (BoEs); DNA/protein complexes (also termed 
insulators) that can organize chromatin into looped structures (Lin et al. 2011; Dixon et 
al. 2012; Heidari et al. 2014). BoEs allow DNA to be accessed by chromatin remodeling 
proteins, TFs, and Pol II, and are enriched with H3K27me3 or H3K4me3 depending on 
the state of transcriptional activation (Dixon et al. 2012; Narendra et al. 2015). TAD 
architecture has been described as a domain within domain system: Inter-TAD contact 
results in coordinated regulation of inter-TAD regions into megabase pair (Mb) large 
‘meta-TADs’  (Heidari et al. 2014; Fraser et al. 2015), and BoEs can also be found 
within 50-100 kb ‘sub-TAD’ regions (Dixon et al. 2012; Heidari et al. 2014). Meta-TAD 
and sub-TAD interacting regions are often sites of transcriptional activation (Heidari et 
al. 2014; Fraser et al. 2015; Smith et al. 2016). TADs can also interact with and bind to 
the nuclear lamina at 0.1-10 Mb wide lamina-associated domains (LADs; Guelen et al. 
2008). This correlates well with the finding of heterochromatin at the nuclear periphery, 
as LADs are mainly enriched with H3K9me3 and highly compacted (Guelen et al. 2008; 
Meuleman et al. 2013). LADs are also flanked by BoEs that interact with chromatin that 
is enriched with H3K27me2/3 and accessible to chromatin organizers (Guelen et al.  
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Figure 1-2. Chromatin is organized into topology and lamina associated domains. 
Chromatin is organized into large 0.1-1 megabase pair wide topology-associated domains 
(TADs), flanked by boundary elements (BoEs) that organize chromatin and allow access 
for chromatin modifying proteins. BoEs are found at chromatin enriched with 
H3K27me2/3 or H3K4me3. In H3K4me3 boundary regions, transcription factors (TFs) 
and RNA Pol II are recruited for activation of transcription. TADs found at the nuclear 
periphery are associated with lamin A/B and termed lamina-associated domains (LADs). 
LADs are often constitutively repressed, enriched with H3K9me3 and flanked by BoEs 
and H3K27me2/3 regions. A notable exception is where euchromatic regions of LADs 
interact with nuclear pore complexes. Adapted from Luperchio et al. 2014.  
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2008). This type of organization is critical to maintain transcriptional repression, but still 
allow access to genes when environmental state-dependent changes occur. As an 
exception, genes within LADs that are localized near nuclear pores are often euchromatic 
to facilitate transcriptional activation and rapid mRNA transport out of the nucleus 
(Brickner et al. 2012). 
Chromatin looping by BoEs can help to regulate gene expression of differentially 
expressed alleles. One well-known example of this type of regulation is the imprinted 
H19/Igf2 locus. Chromatin organizers bring an enhancer close to the promoter of the H19 
gene on the maternal allele, while segregating it from the Igf2 promoter (Engel et al. 
2008). On the paternal allele the region that binds these organizers is hypermethylated, 
inhibiting H19 expression and allowing the enhancer to activate Igf2 transcription (Engel 
et al. 2008). H19 encodes H19, which is involved in the attenuation of cell proliferation 
(Gabory et al. 2009), while Igf2 encodes the insulin-like growth factor 2 (IGF-2), a 
critical protein for cell growth (reviewed in Pollak 2012). In this case, proper imprinting 
is critical for homeostatic balance of cell growth, and dysregulation of proper H19 
repression on the paternal allele has been shown to lead to tumor development and 
proliferation in cancer cells (Cui et al. 2002; Ulaner et al. 2003).  
There are a few exceptions to the peri-nucleolar and lamina-associated 
heterochromatin seen in neurons. Olfactory neurons, which each have a uniquely 
expressed olfactory receptor, have a large amount of heterochromatin in the center of the 
nucleus (Clowney et al. 2012). This heterochromatin ‘core’ contains the approximately 
~2800 olfactory receptor genes, which are enriched with H3K9me3 histone markers and 
tightly compacted, leading to constitutive repression (Clowney et al. 2011; Clowney et 
al. 2012). However, during development one of these genes is looped out of the core, 
associated with a distal transcription enhancer leading to gene activation (Lomvardas et 
al. 2006; Clowney et al. 2012). Only one gene is activated in a single olfactory sensory 
neuron, and each neuron has a unique gene that is activated (Clowney et al. 2012). Thus, 
chromatin organization is critical in olfactory sensory neurons for receptor specificity. 
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Another exception where heterochromatin is not associated with the nuclear 
lamina is in retinal rod cells of nocturnal animals. At birth, these animals display a 
normal pattern of chromatin organization, with heterochromatin associated with the 
lamina at the nuclear periphery (Solovei et al. 2013; Reviewed in Alexander and 
Lomvardas 2014). However, by post-natal day 14 (P14) nuclear lamina proteins are 
downregulated leading to the internalization of the heterochromatin (Solovei et al. 2013). 
By adulthood, and throughout the entire lifespan of these animals, the heterochromatin is 
found exclusively in the center of the nucleus with the euchromatin surrounding it 
(Solovei et al. 2009; Solovei et al. 2013). This inside out configuration allows for the rod 
cells to diffract light more efficiently at night, when these cells are more active (Solovei 
et al. 2009). 
As these examples highlight, chromatin organization is important for neuron 
specialization and normal function. Chromatin organization in post-mitotic cells is also 
critical for neuronal development and synaptic plasticity. For example, Ctcf encodes 
CTCF (CCCTC-binding factor), a BoE critical for chromatin topology and organization 
(Dixon et al. 2012). Children born with mutations in Ctcf display intellectual disability, 
microcephaly and often show autistic features (Gregor et al. 2013). Ctcf was also 
identified recently as a schizophrenia susceptibility gene (Juraeva et al. 2014). 
Dysregulation of Alpha Thalassemia/Mental Retardation Syndrome X-Linked (ATRX), a 
protein involved in chromatin remodeling and downregulation of gene expression, has 
also been linked to intellectual disorder and autism-spectrum disorder (Gong et al. 2008; 
Martínez et al. 2014).  
In terms of normal neural development and synaptic plasticity, Vogel-Ciernia et 
al. (2013) showed that the Brg1-associated factor subunit BAF53b (part of the SWI/SNF 
chromatin remodeling complex) is important for long-term memory consolidation, 
dendritic arborization and hippocampal synaptic plasticity. Mutations in BAF53b leads to 
impairments in synaptic plasticity, driven by abnormal gene expression of postsynaptic 
genes (Vogel-Ciernia et al. 2013). Thus, chromatin organization is important for proper 
neuron function and development, but may also be important for environmental and 
context-based gene regulation.  
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1.3 Chromatin organization and scaffolding/matrix attachment regions 
 
A large advantage of having a high level of organization of chromatin is the 
ability to have state-dependent dynamic regulation of chromatin access. This is 
accomplished by accessing the chromatin loops created by chromatin organizers and 
results in locus-specific regulation. One method to produce this type of looping involves 
anchoring either local or distant genes to nuclear matrix proteins at scaffolding/matrix 
attachment regions (S/MARs) (Heng et al. 2004; Reviewed in Politz et al. 2013). DNA is 
anchored to S/MARs by organizers such as special AT-rich binding protein 1 (SATB1; 
Cai et al. 2003; reviewed by Kohwi-Shigematsu et al. 2013) and S/MAR-binding protein 
1 (SMAR1; Sinha et al. 2010). These organizers recruit chromatin modifying enzymes to 
the region to either activate or repress transcription, depending on what is recruited (Fig. 
1.3). For example, SATB1 can recruit HDAC1 to repressed regions and the HAT p300 to 
activated regions (reviewed by Kohwi-Shigematsu et al. 2013). SATB1 has previously 
been shown to be important for anchoring chromatin loops on the beta-globin locus, in 
order to bring the gene encoding the activated beta-globin subunit close to hypersensitive 
sites but segregate other genes away from this region (Wen et al. 2005; Wang et al. 
2009). SATB1-mediated chromatin looping is also involved in cytokine activation 
through the TH2-cytokine (IL4/5/13) locus in T-cells (Cai et al. 2006), regulation of the 
switch from the pro-apoptotic BCL2 gene to the anti-apoptotic NOXA gene (Yang et al. 
2015), X-chromosome inactivation (Agrelo et al. 2009), as well as in regulating gene 
expression of the major histocompatibility complex (MHC) class I locus (Kumar et al. 
2007). 
There is now emerging evidence that S/MARs may also be involved in context-
dependent regulatory events. In HCT116 p53+/+ cells exposed to UV radiation to induce 
DNA double strand breaks, SMAR1 recruits HDAC1 to the BAX and PUMA promoters 
(Sinha et al. 2010). This results in deacetylation and repression of these pro-apoptotic 
genes. However, if DNA damage is extensive, SMAR1 releases HDAC1, allowing 
acetylation of the BAX and PUMA promoters and the initiation of apoptosis (Sinha et al.  
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Figure 1-3. SATB1 recruitment to scaffolding/matrix attachment regions. 
SATB1 binds to DNA at regions that interact with the nuclear matrix, known as 
scaffolding/matrix attachment regions (S/MARs). This results in locus specific chromatin 
looping of local or distant genes that can be accessed by chromatin organizers. (A) 
SATB1-mediated looping at S/MARs can recruit histone H3K4 methyltransferase (K4-
HMT) for H3K4 tri-methylation (H3K4me3) and histone acetyltransferases such as p300 
for acetylation, resulting in RNA Pol II recruitment and transcriptional activation. (B) 
SATB1 can also recruit histone deacetylases (HDACs) and either polycomb repressive 
complex 2 (PRC2) or K9-HMT for H3K27me2/3 or H3K9me3, respectively. Recruitment 
of these chromatin modifiers results in facultative or constitutive repression. Adapted 
from Kohwi-Shigematsu et al. 2013. 
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2010). While this is a good example of how cells can respond to environmental 
challenges, we are just beginning to unravel how these mechanisms work and under 
which conditions cells utilize these processes. There are only a few studies assessing how 
organizers such as SATB1 or SMAR1 function in neural cells, and these studies only 
focus on neural development (Balamotis et al. 2012; Close et al. 2012; Wang et al. 
2015). Understanding how these processes may contribute to cell-state changes is critical, 
as chromatin organization is disrupted in aging cells and in neurodegenerative diseases 
such as AD. 
 
1.4 Chromatin organization in aging and Alzheimer’s disease  
 
There is now an immense amount of data showing that there are large scale 
epigenetic and organizational changes in disease conditions. For example, there is a large 
amount of evidence showing that dysregulation of chromatin organization may be an 
etiological factor in many types of cancer (reviewed in Sharma et al. 2010). Recently, 
researchers have become interested in chromatin organization related changes during 
aging and senescence. Shah et al. (2013) showed that LADs predominantly enriched with 
H3K9me3 start to lose this histone marker during aging, replaced by H3K27me2/3 
‘canyons’ and H3K4me3 ‘mesas’ in senescent human IMR90 cells. Along with decreased 
lamin A and B, the increase in H3K4me3 results in abnormal activation of genes and 
destabilization of peripheral-associated heterochromatin leading to internalization of 
these genes (Shah et al. 2013). It has been proposed that this may be a model for the 
increases in inappropriate gene activation seen in many cell types during both aging and 
senescence (reviewed in Luperchio et al. 2014), and we can speculate that regions 
enriched with H3K27me2/3 would be more easily activated compared to H3K9me3 
enrichment. 
In post-mitotic neurons, aging related changes in epigenetic regulation are less 
clearly defined. Studies have reported increases in H3K27me2/3, H3K9me3 and DNA 
methylation, leading to inappropriate repression of gene expression (Wang et al. 2010; 
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Hernandez et al. 2011; Walker et al. 2013). In addition, Cheung et al. (2010) found that 
in aging human prefrontal cortex neurons there are approximately 100 genes abnormally 
enriched in H3K4me3, all related to cell cycle regulation. In a separate study from Tang 
et al. (2011), neurons from human prefrontal cortex of older subjects had reductions in 
histone acetylation of H3K9/K14 on genes related to inhibitory neurotransmission and 
mitochondrial function.  
There is also increasing evidence that neurons in aging-related diseases, such as 
AD and related dementias, have complex changes in epigenetic related regulation. AD is 
characterized by the progressive dysfunction and loss of cholinergic neurons, resulting in 
impairments in memory, cognition, attention, mood and motor control (see Sheridan and 
Hausdorff 2007; McCade et al. 2011; Arshavsky 2014; Stella et al. 2014 for reviews). 
While AD is the most common form of dementia worldwide, only ~1-5% of cases can be 
explained completely by genetic origin (reviewed in Piaceri et al. 2013); this is most 
commonly related to mutations in amyloid precursor protein (APP) or presenilin 1/2 
(PS1/PS2) that result in the overproduction of toxic β-amyloid (Aβ) and an early-onset of 
disease symptoms (see Tanzi 2012; Wu et al. 2012 for reviews). Accumulation of Aβ 
together with hyperphosphorylation of the microtubule-associated protein tau are thought 
to underlie cholinergic dysfunction and neurodegeneration in AD (Alonso et al. 1996; 
reviewed in Hardy and Selkoe 2002; Zussy et al. 2013), though the etiology of the ~95% 
of ‘sporadic’ late-onset cases is not well understood. Recently, Miller et al. (2008) 
provided evidence that individuals with moderate to severe AD have large changes in 
transcription for functional groups of genes related to ion transport, synaptic transmission 
and RNA processing among others. Despite these transcriptional changes, efforts to 
identify susceptibility genes have been largely unsuccessful; only a few genes have been 
identified that have single-nucleotide polymorphisms or alleles related to AD 
susceptibility (Bertram 2011; Piaceri et al. 2013). These data suggest that both genetic 
and environmental factors may underlie the observed transcriptional changes in AD, 
providing rationale for a recent focus on identifying whether epigenetic changes also 
occur in AD and related dementias.  
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Initial studies exploring epigenetic changes in AD have shown complex and 
mixed results. For example, in CK-p25 AD model mice which have increased Aβ-peptide 
production and severe cognitive impairment, there is abnormal enrichment of H3K4me3 
and H3K27 acetylation (H3K27ac) on promoters of immune response genes (Gjoneska et 
al. 2015), whereas in the same mice neuroplasticity-related genes show hypoacetylation 
(Gräff et al. 2012). Primary cortical cultures treated with Aβ also have increased 
H3K4me3 on somatostatin and cortistatin genes (Rubio et al. 2012), and in 3xTg AD 
model mice H3 and H4 acetylation is elevated (Walker et al. 2013). 3xTg AD mice have 
APP, PS1 and tau transgenes, resulting in a severe AD phenotype (Sterniczuk et al. 
2010a; 2010b). However, aged AD model mice and human AD patients have increased 
HDAC2-related deacetylation of synaptic plasticity related genes (Guan et al. 2009; Gräff 
et al. 2012), and inhibition of HDACs in AD mouse models improves learning and 
memory deficits (Guan et al. 2009). Findings from human post-mortem brain samples are 
also variable, with some studies reporting increases and others decreases in global 
acetylation levels (Gräff et al. 2012; Zhang et al. 2012b; Narayan et al. 2015). Finally, 
3xTg AD model mice show increases in H3K9me2 levels and related chromatin 
compaction (Walker et al. 2013), further adding to the complexity of the epigenetic 
changes seen in AD pathology. It is clear that more studies are needed to help define the 
complex epigenetic landscape in aging and AD, but evidence suggests that these changes 
are gene specific and therefore are likely due to changes in chromatin organization.  
In support of this hypothesis, shRNA depletion of chromodomain helicase DNA 
binding protein 5 (CDH5, a paralog to the mi-2/Nurd remodeling complex) in primary rat 
cortical cultures causes both activation and repression of aging and AD-related genes 
(Potts et al. 2011). Aging-related downregulation of lamin B in neurons results in 
centrally located senescence-associated heterochromatic foci (Jurk et al. 2012). 
Interestingly, Zhang et al. (2009) showed that inhibiting SATB1 orthologs in C. elegans 
reduces lifespan. Zhang et al. (2009) further showed that changes in SATB1 expression 
levels and activation may also be related to AD pathology; knockdown of CREB-binding 
protein, a binding partner for SATB1, accelerates Aβ-induced paralysis in a transgenic C. 
elegans AD model. In PS19 AD model mice, there are observed reductions in sirtuin 1 
(SIRT1), a histone and protein deacetylase that activates SATB1 (Xue et al. 2012; Cho et 
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al. 2015). SIRT1 expression increases activation of a disintegrin and metalloproteinase 
domain-containing protein 10 (ADAM10) in human glioma cells and N2a cells 
(Theendakara et al. 2013; Lee et al. 2014). Aβ is produced by cleavage of APP; 
ADAM10 promotes non-amyloidogenic processing APP and is thought to be 
neuroprotective (APP processing will be discussed in further detail in the next section) 
(Reviewed by Endres and Fahrenholz 2012). Given that SIRT1 can deacetylate and 
activate SATB1 (Xue et al. 2012), reductions in SIRT1 could further affect global 
chromatin organization, but this remains to be elucidated. It is evident that, while there is 
some evidence that chromatin organization may be altered in AD, more studies are 
needed to clarify these changes and elucidate how this may relate to disease etiology and 
progression. 
An interesting observation in AD neurons is that proteins involved in epigenetic 
regulation and gene expression are mislocalized in AD patients. Recently, Mastroeni et 
al. (2013) showed that DNMT1 and Pol II were abnormally sequestered in the cytoplasm 
of CA1 hippocampal neurons from AD patients. They were able to recapitulate this effect 
after 36 h of exposure to toxic Aβ-oligomers in human SK-N-Be(2) neuroblastoma cells. 
As another example, REST, a neuronal gene repressor that is activated in aging and is 
involved in the cell stress response, is abnormally localized to autophagosomes in 
prefrontal cortex neurons of AD patients (Lu et al. 2014). In addition, there is observed 
cytoplasmic accumulation of H3K4me3 in early stage AD patients (Mastroeni et al. 
2015). 
Mastroeni et al. (2013) showed that the cytosolic sequestering of DNMT and Pol 
II was due to reduced nuclear import caused by decreased Ran-GTP mRNA and protein 
expression in both AD patients and in SK-N-Be(2) cells. In addition, Lee et al. (2006) 
have shown that importin-α is abnormally localized to Hirano bodies (intracellular 
aggregates of actin) in hippocampal neurons from AD patients. Both of these proteins are 
part of critical nuclear import/export mechanisms that regulate the import a large number 
of nuclear proteins (Reviewed in Chook and Blobel 2001). 
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Recently, a human and primate specific 82-kDa variant of choline 
acetyltransferase (82-kDa ChAT) was also found to have altered localization in 
cholinergic neurons of AD and frontotemporal dementia patients. 82-kDa ChAT is 
localized to the nucleus of cholinergic neurons of healthy adults, but is mislocalized to 
the cytoplasm in patients with AD and MCI (Gill et al., 2007). Though the function of 
82-kDa ChAT is currently unknown, there are a few clues that this protein may also be 
involved in gene expression changes.   
 
1.5 82-kDa ChAT nuclear expression and gene regulation 
 
Cholinergic neurons are critical for functions such as motor control, cognition, 
attention, sleep, learning and memory (see Hasselmo 2006; Woolf and Butcher 2011; 
Brown et al. 2012 for reviews). Understanding cholinergic neuron function and 
communication is important as AD and MCI are characterized by changes in the function 
of cholinergic neurons. Following a period of enhanced activity that may be due to 
changes in synaptic plasticity, cholinergic neuron function is eventually lost due to the 
effects of Aβ (Walsh et al. 2002; Townsend et al. 2006; Shankar et al. 2008). Aβ can 
oligomerize and form aggregates, which can lead to cellular toxicity, synapse 
degeneration, inhibition of synaptic plasticity, oxidative stress and apoptosis (Lambert et 
al. 1998; Nunomura et al. 2001; Shankar et al. 2008; Dewachter et al. 2009; Zussy et al. 
2013).  Aβ toxicity in basal forebrain cholinergic neurons results in reduced choline 
uptake and ChAT activity, leading to reduced acetylcholine (ACh) release (Bao et al. 
2012; Nunes-Tavares et al. 2012). 
Canonical ChAT enzyme function includes the production of the neurotransmitter 
ACh, catalyzed from choline and acetyl Coenzyme A (Traiffort et al. 2005). ChAT is 
encoded at the cholinergic gene locus, which also encodes the vesicular acetylcholine 
transporter (Misawa et al. 1997; Traiffort et al. 2005). There are at least 8 known splice 
variants of ChAT mRNA, all of which produce a 69-kDa protein (Misawa et al. 1997; 
Traiffort et al. 2005). In humans and non-human primates, the M-transcript is transcribed 
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by an additional in-frame transcription initiation site that results in the production of 82-
kDa ChAT (Misawa et al. 1997; Traiffort et al. 2005). While both 69 and 82-kDa-ChAT 
can enter the cell nucleus, in healthy cells 82-kDa ChAT is localized predominantly in 
the nucleus, while 69-kDa ChAT is a nucleo-cytoplasmic shuttling protein that is 
primarily localized within the cytoplasm (Resendes et al., 1999). 
The 82-kDa ChAT protein has a unique nuclear import signal (Gill et al., 2003) 
which may be responsible for an absence of nuclear export in healthy cells. 82-kDa 
ChAT is not the only nuclear localized neurotransmitter synthesizing enzyme; Olalla et 
al. (2002) reported that glutaminase, which synthesizes the excitatory neurotransmitter 
glutamate, is found in both the mitochondria and nuclei of glutamatergic neurons. 
Interestingly, in human brain tissue obtained from the basal forebrain of aged patients 
with MCI or AD, the nuclear localization of 82-kDa ChAT is redistributed mainly to the 
cytoplasm (Gill et al., 2007). The regulation of nuclear import/export mechanisms for 
these enzymes is currently unknown. Additionally, the mechanisms that contribute to the 
redistribution of 82-kDa ChAT, and the consequences of this altered localization have yet 
to be elucidated. 
Recently, our lab has published data providing evidence for a role of 82-kDa 
ChAT in gene expression changes. Primary neuronal cultures prepared from brain of 
APP/presenilin 1 (PS1) double transgenic mice that transiently express 82-kDa ChAT 
have increased gene expression of GGA3, which encodes golgi-associated, gamma-
adaptin ear-containing, ARF binding protein 3 (GGA3) (Albers et al. 2014). GGA3 is 
involved in endosomal vesicle trafficking of β-secretase 1 (BACE1) for lysosomal 
degradation and recycling (Tesco et al. 2007; Kang et al. 2010), and in this model 82-
kDa ChAT expression resulted in reductions in the protein expression and activity of 
BACE1 (Albers et al. 2014). APP can be cleaved by either α- (e.g. ADAM10) or β-
secretases prior to cleavage by γ-secretase (Fig. 1.4) (reviewed in Chow et al. 2010). If 
APP is cleaved by an α-secretase, it results in the generation of a soluble APP-α fragment 
(sAPPα) and a membrane bound fragment that when cleaved by γ-secretase produces β-
amyloid peptide Aβ17–40/42 (p3) and the APP intracellular C-terminal domain (AICD) 
(Chow et al. 2010). Conversely, if cleaved by β-secretase, APP produces a soluble APP-β  
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Figure 1-4. APP metabolism. 
APP is a membrane bound protein that can be cleaved by either α- or β-secretases. 
Cleavage by α-secretases produces a soluble APP α fragment (sAPPα) and a membrane-
bound fragment that is cleaved by γ-secretase to produce amyloid β- peptide Aβ17–40/42 
(p3) and the APP intracellular c-terminal domain (AICD). The p3 peptide promotes 
synapse formation and maintenance. Cleavage of APP by β-secretases produces a shorter 
sAPPβ fragment and longer membrane-bound fragment. When this fragment is cleaved 
by γ-secretase it produces AICD and Aβ1-40/42. The production of Aβ1-42 has been linked 
to cellular toxicity, protein misfolding, synapse degeneration, inhibition of synaptic 
plasticity, oxidative stress, and apoptosis. Adapted from Chow et al. 2010.  
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fragment (sAPPβ) and a membrane bound fragment that produces a longer Aβ1–40/42 
peptide and AICD when cleaved by γ-secretase (Chow et al. 2010). Though it is likely 
that cholinergic neurons require a balance between both α- and β-secretase mediated 
cleavage, the production of p3 is thought to be neuroprotective and promote synapse 
formation and maintenance (Furukawa et al. 1996; Furukawa et al. 1996b; Kojro et al. 
2001; Stein et al. 2004). Oligomeric Aβ1–42 is thought to be the more toxic form of the 
peptide (Shankar et al. 2008; Zussy et al. 2013; Jin and Selkoe 2015). It is unclear how 
exposure of cells to Aβ may mediate this toxicity, though it is known that Aβ binds to 
cell surface receptors that mediate cell-signaling events (Young et al. 2009; Beraldo et al. 
2016). It is also possible that Aβ may enter the cell through endocytosis, and promote 
toxicity through oxidative or nitrosative stress (reviewed by Rowan et al. 2007; Lana et 
al. 2016; Singh et al. 2016). Therefore, limiting Aβ1–42 production in cholinergic neurons 
is likely a protective mechanism. Consequently, as a result of the observed reduction in 
BACE1 levels in 82-kDa ChAT-expressing APP/PS1 neurons, Albers et al. (2014) 
showed that these cells also decreased production and secretion of Aβ1–42. 
In addition to the indirect protein expression changes of BACE1, 82-kDa ChAT 
may have a direct role in changing gene expression related to APP processing.  In human 
IMR32 neuroblastoma cells expressing 82-kDa ChAT, there are several genes altered 
related to APP metabolism and binding, as measured by microarray (Albers et al. 2014). 
One of these genes included ADAM10, which encodes ADAM10. Other genes included 
the α-secretase ADAM17, and genes that encode proteins related to APP binding, such as 
APBA2 (which encodes X11-like [X11L]), APPBP2 (which encodes protein interacting 
with APP tail 1 [PAT1]), and RTN1 (which encodes reticulon 1 [RTN1]) (He et al. 2004; 
Sakuma et al. 2009; Dilsizoglu Senol et al. 2015). Finally, related to cholinergic neuron 
function, Matsuo et al. (2011) reported that 82-kDa ChAT expression in SH-SY5Y cells 
enhances transcription of the cholinergic-specific sodium-coupled choline transporter 
(CHT). 
In the same microarray evaluating gene expression changes in IMR32 cells 
expressing 82-kDa ChAT, we also observed gene expression changes related to histone 
acetylation and chromatin organization. Some of these genes included upregulation of 
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CBFA2T1, which can bind to and facilitate the activity of HDACs (Baby et al. 2014); 
KPNB1, which can control nuclear import of the PER/CRY repressor complex (Lee et al. 
2005); CHD3, a component of the Mi-2/NuRD histone remodeling complex (reviewed by 
Kunert and Brehm 2009); ACTL6, which is part of a neuron-specific chromatin 
remodeling complex (Yoo et al., 2009); and SATB1, involved in chromatin organization 
as discussed above. There were also changes in genes related to the cell stress response, 
cell cycle, and inflammation/immune response. Taken together, these results clearly 
indicate that 82-kDa ChAT has a role in gene expression changes for multiple pathways. 
Elucidating how 82-kDa ChAT expression leads to these changes is essential to 
understanding the gene expression changes that may occur when 82-kDa ChAT 
expression is reduced in aging individuals, or when the localization is altered in AD and 
MCI patients (Gill et al. 2007). 
Based on the above observations, one hypothesis is that 82-kDa ChAT changes 
gene expression, either by direct interactions with DNA or by recruiting chromatin 
modifying proteins or transcription factors (Fig. 1.5). Another possible role for 82-kDa 
ChAT may be recruiting or acting as a non-canonical HAT. We previously solved the 
crystal structure of 69-kDa ChAT, an O-acetyltransferase that has the small molecule 
choline as its normal substrate (Kim et al. 2005). There is no evidence to indicate that 
ChAT is able to mediate the N-acetylation required for histone acetylation (Grant and 
Berger 1999; Sterner and Berger 2000), and the structural features of its catalytic domain 
may not be accessible to accommodate a protein-based amino acid residue such as lysine 
(Kim et al. 2005). Interestingly, Britton et al. (2013) showed that histone H3 can be 
acetylated by O-acetylation at several serine and threonine residues. This recent finding 
provides an intriguing hypothesis for the recruitment of 82-kDa ChAT to DNA for the O-
acetylation of histones. Finally, 82-kDa ChAT could be modulating the available acetyl-
CoA pool via its canonical production of ACh to “fine-tune” the local amount of histone 
acetylation. Our laboratory demonstrated previously that 82-kDa ChAT in isolated nuclei 
is catalytically active and can mediate ACh synthesis (Gill et al. 2003).  The work 
presented in this thesis will test the first hypothesis; that 82-kDa ChAT interacts directly 
with DNA to modulate context-dependent gene expression. 
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Figure 1-5. Possible roles for nuclear 82-kDa ChAT in gene expression changes. 
 
82-kDa ChAT expression in neural cells has previously been shown to alter gene 
expression. These changes could be mediated through (1) recruitment of chromatin 
modifying enzymes such as histone methyltransferases (HMTs), histone 
acetyltransferases (HATs) or deacetylases (HDACs), transcription factor (TF) complexes 
and/or RNA polymerase II (RNA Pol II). Whether this results in transcriptional activation 
or repression depends on the state of histone acetylation and methylation (H3KXme3). 
(2) As an acetyltransferase, 82-kDa ChAT may be acting as a HAT and directly altering 
histone acetylation; or (3) could be modifying the available local pool of acetyl-CoA by 
canonical acetylcholine production. 
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1.6 Hypothesis and objectives 
 
The following work was designed to test the specific hypothesis that: 
The nuclear localization of 82-kDa ChAT  mediates gene expression and 
chromatin organizational changes. 
To test this hypothesis, we will: 
(1) Explore the relationship between 82-kDa ChAT and chromatin, and determine 
whether this relationship changes following cellular perturbations, such as 
exposure to oligomeric Aβ.  
(2) Explore the relationship between 82-kDa ChAT and SATB1 at chromatin, and 
show that the interaction with chromatin is dependent on both proteins. We will 
also explore whether 82-kDa ChAT and SATB1 may be involved in S/MAR 
formation and chromatin organization, and show a functional result of this 
interaction on the APP gene. 
(3) Show that 82-kDa ChAT regulates the gene expression of synapse formation and 
maintenance-related genes, leading to developmental changes in synapse 
formation.   
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Chapter 2  
2 Objective I- 82-kDa ChAT interacts with chromatin  
 
 
 
Portions of this chapter have been reproduced with permission from: 
 
Winick-Ng W, Caetano FA, Winick-Ng J, Morey TM, Heit B, Rylett RJ (2016) 82-kDa 
choline acetyltransferase and SATB1 localize to β-amyloid induced matrix attachment 
regions. Sci Rep, 6: 23914. 
 
 
 
Figure 2-4 (A) was produced in collaboration with Mrs. Jennifer Winick-Ng, using the 
statistical programming software SAS. 
Figures 2-12 and 2-13 were produced in collaboration with Mr. Trevor Morey, who made 
the recombinant 82-kDa choline acetyltransferase protein. 
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2.1 Introduction and Rationale 
 
We have shown previously that 82-kDa choline acetyltransferase (82-kDa ChAT) 
expression in neural cells alters the expression of genes related to amyloid precursor 
protein (APP) processing (Albers et al. 2014). In addition, the expression of 82-kDa 
ChAT in cortical neurons cultured from brains of transgenic mice expressing mutant 
APP/Presenilin-1 leads to changes in the amount of β-amyloid (Aβ) produced and 
secreted, as well as the expression and activity of the β-secretase BACE1 which cleaves 
APP in the amyloidogenic pathway (Albers et al. 2014). These changes were mediated by 
gene expression increases in the golgi-lysosome trafficking protein GGA3, which 
resulted in lysosomal degradation of BACE1 (Albers et al. 2014). Collectively, these data 
demonstrate that the expression of 82-kDa ChAT in neural cells can lead to gene 
expression changes, therefore we predict that 82-kDa ChAT could interact with 
chromatin, either directly or in combination with other DNA-interacting proteins.  
When modelled using the DNA-binding prediction software BindN+ (Wang and 
Brown 2006) and DNABindR (Yan et al. 2006), the 118 amino acid N-terminal extension 
found on 82-kDa ChAT contains several potential DNA-binding motifs (Fig. 2-1A). 
These included a basic residue region with high DNA-binding prediction and several 
tandem (S/T)PXX or XPRK motifs. These latter motifs bind AT-rich DNA at the minor 
groove and each have a 50% probability to bind DNA based upon both surface 
accessibility and orientation (Suzuki 1989, Yang et al. 2003). It is noteworthy that the 
crystal structure of 69-kDa ChAT has been solved by our lab previously and shows 
several surface-accessible regions of basic residues that could facilitate the association 
with DNA (Kim et al. 2005). To test whether these 82-kDa ChAT N-terminal DNA-
binding motifs were surface exposed, we used the Iterative Threading ASSEmbly 
Refinement (I-TASSER) server to perform predictive modelling of 82-kDa ChAT using 
the 69-kDa ChAT crystal structure as a backbone (Zhang 2008; Roy et al. 2010; Roy et 
al. 2012) (Fig. 2-1B). These models show that the N-terminal region of 82-kDa ChAT is 
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also predicted to be surface exposed and could interact with DNA. Thus we hypothesized 
that 82-kDa ChAT interacts with chromatin. The data presented in this chapter 
demonstrates that 82-kDa ChAT interacts with chromatin, and that this interaction is 
altered by cellular perturbations such as oligomeric Aβ1-42, Hoechst dye (a DNA-binding 
competitor), or the histone deacetylase inhibitor trichostatin A (TSA). 
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Figure 2-1. DNA binding prediction for 82-kDa ChAT. 
(A) The 118 amino acid residue amino-terminus of 82-kDa ChAT is flanked by two in-
frame methionine initiation sites, and contains a unique nuclear localization sequence. 
Several DNA binding prediction software databases predicted high DNA binding 
probability at 2 basic residue regions, as well as 5 SPXX/XPRK DNA binding motifs. 
There was an additional SPXX motif in the 69-kDa ChAT region near the amino 
terminus with high DNA binding prediction. (B) (i) and (ii) show protein prediction 
modelling for 82-kDa ChAT with surface exposed DNA-binding motifs and NLS. (iii) is 
the same view as (ii), but with a surface mesh to visualize the surface-exposed amino acid 
residues. 
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2.2 Methods 
 
Cell Culture and transfection  
SH-SY5Y cells obtained from American Type Culture Collection (Manassus, 
VA) were grown on 35 mm glass-bottom plates (0.14 mm thick; MatTek Corp., Ashland, 
MD, USA) for live cell imaging. In other experiments, SH-SY5Y cells stably expressing 
heterologous 82-kDa ChAT (Albers et al. 2014) were plated on coverslips for 
immunostaining. Cells were differentiated using 10 μM all-trans-retinoic acid for 3 days, 
which produces substantial morphological and biochemical cholinergic differentiation of 
cells (Hashemi et al. 2003). Experiments from stably transfected cells were derived from 
a single clone. This clone was selected from multiple clones that were screened for low 
levels of expression. For live imaging, cells were transfected with a plasmid encoding an 
82-kDa ChAT-eGFP fusion protein or the peGFP vector (Clontech Laboratories Inc., 
Mountain View, CA, USA) using Lipofectamine 2000 (Invitrogen, Burlington, ON, 
Canada). Aβ oligomers were prepared as described (Stine et al. 2003) from lyophilized 
Aβ1-42 or the reverse peptide purchased from rPeptide (Bogart, GA, USA). Cells were 
treated with 100 nM oligomeric Aβ1-42, 10 nM trichostatin a (TSA), or F12 media 
(vehicle) for the indicated times.  
 
Antibodies  
The 82-kDa ChAT protein was detected with a custom rabbit polyclonal antibody 
CTab (Dobransky et al. 2000). Other antibodies used were: anti-β -tubulin (2146S; Cell 
Signaling, Danvers, MA, USA); anti-Matrin3 (BL2526; Bethyl Laboratories Inc., 
Montgomery, Tx, USA); and anti-histone H2A (H2A) (PA1–41004; Thermo Fisher 
Scientific, Waltham, MA, USA). The pan-anti-Tau antibody was a generous gift from the 
laboratory of Dr. Michael Strong. AlexaFluor 647-conjugated secondary antibody 
(Invitrogen) was used for immunostaining visualization. 
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Nuclear sub-fractionation and immunoblotting  
Total, cytosolic and nuclear subcellular fractions were isolated from cells treated 
with either vehicle or Aβ1-42 as described previously (Ye and de Lange 2004). SH-SY5Y 
cells were plated on 60 mm dishes at a density of 1x106 cells/plate, then treated for 4 h 
with either vehicle or Aβ1-42. Cells were then lysed in Buffer A (containing 10 mM 
HEPES pH 7.9, 10% glycerol, 0.5% (v/v) Triton X-100, 5 mM MgCl2, 1 mM 
dithiothreitol (DTT), 10 mM KCl, protease inhibitor cocktail [Sigma Aldrich; final 
concentration: 1.04 mM 4-(2-Aminoethyl) benzenesulfonyl fluoride hydrochloride 
(AEBSF), 0.8 µM aprotinin, 40 µM bestatin, 14 µM N-[N-(L-3-trans-carboxyirane-2-
carbonyl)-L-leucyl]-agmatine; 1-[N-[(L-3-trans-carboxyoxirane-2-carbonyl)-L-
leucyl]amino]-4-guanidinobutane (E-64), 20 µM leupeptin and 15 µM pepstatin], and 
phosphatase inhibitors [final concentration: 10 mM sodium fluoride, 1 mM sodium 
vanadate, 20 mM sodium phosphate, 3 mM β-glycerolphosphate, 5 mM sodium 
pyrophosphate]). After incubation for 15 min on ice, lysates were viewed under a light 
microscope to confirm that cells had been lysed and nuclei were intact. Lysates were then 
spun at 0.3 x g for 10 min at 4°C. The supernatant containing soluble cytosolic proteins 
was transferred to a new tube and the pellet was washed with cold PBS (containing 
inhibitors, as above). The pellet was then lysed in Buffer B (20 mM HEPES pH 7.9, 25% 
Glycerol, 0.2% Nonidet P-40, 5 mM MgCl2, 1 mM DTT, 150 mM KCl and inhibitors as 
described above) to lyse the nuclei and release soluble proteins. After incubation on ice 
for 15 min, lysates were spun at 0.9 x g for 5 min at 4°C. The supernatant was transferred 
to a new tube, and the pellet was washed in PBS. The pellet was then lysed in Buffer C 
(same as Buffer B, but containing 420 mM KCl and 700 U/mL DNase I) to release 
euchromatic chromatin associated proteins. After incubation for 15 min on ice, the lysate 
was spun at 18,800 x g for 15 min at 4°C and the supernatant was transferred to a new 
tube. The resulting pellet containing insoluble and nuclear matrix associated proteins was 
lysed using 2x Laemmli buffer (2% (w/v) sodium dodecyl sulfate (SDS), 10% glycerol, 
62.5 mM Tris-HCl, pH 6.8, 2.5% b-mercaptoethanol, and 0.001% bromophenol blue), 
then incubated at 100°C for 10 min with intermittent vortex mixing.  Cells were also 
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lysed in duplicate with radioimmunoprecipitation (RIPA) buffer (50 mM Tris-HCl, pH 
8.0, 150 mM NaCl, 1% (v/v) Triton-X 100), 0.5% (w/v) sodium deoxycholate, 0.1% 
(w/v) SDS, 700 U/mL DNAse I, and inhibitors as described above), sonicated for 3 x 10s, 
and spun at 18,800 x g for 15 min at 4°C to obtain whole cell extract. 
Ten μg of protein from each of the whole cell extract, cytosolic (10 mM KCl) and 
soluble nuclear fractions, and half of the chromatin and insoluble protein fractions were 
separated on SDS–polyacrylamide gel electrophoresis (SDS-PAGE) gels. The density of 
protein bands was visualized using Image Lab (Version 5.0, BioRad). 
 
Live cell imaging and immunostaining  
For live imaging, cells were exposed to 625 ng/mL Hoechst 33342 DNA stain 
(Sigma-Aldrich) for 20 min prior to imaging in growth medium containing phenol-red 
free FluroBrite DMEM (Invitrogen) and 20 mM 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES). For immunostaining, cells were stained with 
primary antibody CTab (1:1,000) followed by AlexaFluor 647 (for 82-kDa ChAT) 
secondary antibodies. Cells were either treated with 625 ng/mL Hoechst prior to fixation 
or counterstained with 2.5 μg/mL Hoechst after immunostaining. 
For confocal microscopy, digital images were acquired with a Zeiss LSM510-
Meta laser-scanning confocal microscope (Carl Zeiss Canada Ltd., Toronto, ON, Canada) 
using a 63X oil-immersion objective (NA = 1.4). For live cell imaging, images were 
acquired using 405 nm excitation and 420–480 emission for Hoechst; and 488-nm 
excitation and 505-nm emission using a long-pass filter for 82-kDa ChAT-EGFP at 1024 
× 1024 resolution. For immunostaining, images were acquired for Hoechst as above; and 
647-nm excitation and 650-nm long-pass emission filter for 82-kDa ChAT. In some 
experiments, 1 µm slices through the z-plane were taken in series. Images were processed 
in ImageJ (Schneider et al. 2012) where manipulations included filtering, thresholding, 
digital magnification, and deconvolution, then formatted in Adobe Illustrator (Adobe 
Systems Inc, San Jose, CA, USA). For z-stack images, the images were rendered in 3D 
55 
 
by Imaris (version 7.0.0; Bitplane Scientific Software, Connecticut, USA) before creating 
a 3D surface for 82-kDa ChAT and Hoechst. 
 
Chromatin immunoprecipitation with next-generation sequencing (ChIP-seq)  
ChIP samples were obtained from 82-kDa ChAT-expressing cells treated for 4 h 
with vehicle (F-12 media) or 100 nM Aβ1–42. SH-SY5Y cells were plated on 10 cm 
dishes at a density of 4.0x106 cells per plate (10x106 cells final), with 3 plates per 
treatment. Following differentiation and treatment, cells were exposed to 0.5% methanol-
free ultra-pure paraformaldehyde for 20 min at room temperature to cross-link proteins 
and DNA. Cross-linking was halted with 5 min of 125 mM glycine added to the media, 
and then cells were lysed in 1% SDS (containing 50 mM Tris-HCl, 10 mM EDTA with 
the addition of protease and phosphatase inhibitors). Lysates were then sonicated in a 
cold room for 10 s followed by 1 min on ice, repeated 5 times. Lysates were centrifuged 
and then diluted in buffer containing Tris-HCl and EDTA (Tris-EDTA) to 0.1% SDS. 
Each sample was divided into 4 equal parts, and 3 of these aliquots were incubated in 2.5 
µg of anti-ChAT antibody overnight at 4°C on a rocker. For each sample, one aliquot did 
not have anti-ChAT antibody added prior to the incubation to serve as a negative control; 
this also allowed us to determine if the sonication step was successful (Appendix 1). 
Following incubation with antibody, lysates were added to 25 µl magnetic Dynabeads 
(Invitrogen, Ontario, Canada) and incubated for 2 h at 4°C on a rocker. Dynabeads with 
antibody-protein-DNA complexes were recovered then washed in a cold room once in a 
0.1% SDS low-salt buffer (150mM NaCl), once in a high-salt buffer (500mM NaCl), then 
in a 0.5 M LiCl buffer before two final washes in Tris-EDTA buffer at room temperature. 
Protein-DNA complexes were then eluted from the beads by a Tris-EDTA buffer 
containing 1% SDS for 2 h at 55°C with 20 µg Proteinase K to digest proteins. Samples 
were then incubated overnight at 65°C to reverse the cross-linking. DNA was extracted 
by phenol:chloroform, then precipitated by adding 100% ethanol containing 150 mM 
sodium acetate overnight at -20°C. DNA pellets were washed twice in 70% ethanol, and 
then the pellets was resuspended in ultrapure water.  
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A single ChIP sample for 82-kDa ChAT and input after cell exposure to either 4 h 
of vehicle (F-12 media) or 100 nM Aβ1–42was analyzed at the Donnelly Sequencing 
Centre (Toronto, ON). ChIP-seq samples were individually barcoded with Illumina 
TruSeq® adapter sequences (Illumina, San Diego, CA, USA) for library construction, 
then run on 2 single read 1:51bp lanes using a HiSeq2500. 
ChIP-seq samples generated ten to twenty million 50 base pair, paired-end reads 
for each sample. Each ChIP-seq FASTQ file was loaded onto the Galaxy server 
(http://usegalaxy.org) (Giardine et al. 2005) for analysis. The general ChIP-seq analysis 
workflow can be found in Figure 2-2. First, each sample was tested for quality control 
(QC) statistics, including quality scores, GC content and over-represented sequences. All 
the sequences were of sufficient quality, the GC content approximated the GC content of 
the human genome (~41%) (Antonarakis 2010) and the only overrepresented sequences 
that were found corresponded to the adapter sequences used in the library construction 
and were at ~1% of the total reads. Reads were then mapped to the human genome (hg38, 
updated December 2013) using the Burrows-Wheeler Aligner (Li and Durbin 2009), with 
repeat-masking and default parameters. Unique peaks were identified for each sample 
using the model-based analysis of ChIP-seq (MACS) (Zhang et al. 2008) tool with p-
value < 0.00001, and filtered out significant peaks found in the corresponding input 
sample. 
Peaks found by the MACS procedure were compared to genomic features 
obtained from the UCSC genome table browser (Kent et al. 2002) using in-house SAS 
programs (version 9.4, Cary, NC, USA). SAS was used to compute average peak lengths 
for each sample and to annotate peaks found within a known gene. ChIP-seq tracks were 
visualized using the Intergrative Genomics Viewer (Broad Institute, Cambridge, MA, 
USA; version 2.3.59) (Robinson et al. 2011). These gene lists were uploaded to the 
Database for Annotation, Visualization and Integrated Discovery (DAVID) server 
(http://david.abcc.ncifcrf.gov/) (Huang da et al. 2009; 2009a) for GO analysis. Finally, 
FASTA formatted peaks were uploaded to the discriminative DNA motif discovery 
(DREME) tool (http://meme.nbcr.net/meme/cgi-bin/dreme.cgi) (Bailey 2011) for motif  
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Figure 2-2. ChIP-sequencing workflow. 
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discovery. SAS was also used in several downstream analyses to compute additional 
features of the ChIP-seq data. 
 
Data deposition 
The ChIP-seq data were deposited in the NCBI Geo Database, accession number: 
GSE73576. 
 
Recombinant 82-kDa ChAT preparation  
Recombinant 82-kDa ChAT protein was prepared as described previously for 69-
kDa ChAT protein (Kim et al. 2005a).  Briefly, cDNA encoding for wild-type 82-kDa 
ChAT was inserted into a pProEX HTa plasmid containing a 6X His6 tag and a TEV 
cleavage site and transformed and expressed in competent BL-21 cells. Recombinant 82-
kDa ChAT protein was purified and verified for antibody specificity (using both a C- and 
N-terminal anti-ChAT antibodies) and enzymatic activity using a radioenzymatic assay 
(unpublished data). 
 
Electrophoretic mobility shift assay  
Purified recombinant 82-kDa ChAT protein was used for an electrophoretic 
mobility shift assay (EMSA) using biotinylated DNA oligomers annealed to their reverse 
complement (Table 2.1). Samples were prepared using the LightShift Chemiluminescent 
EMSA kit (Themo Scientific) according to manufacturer’s instructions. Recombinant 
protein (0-500 ng) was combined with reaction buffer (final concentration: 1X Binding 
Buffer, 1-2 µg Poly (dI•dC), 2.5% glycerol, 5mM MgCl2, 0-100 mM KCl, 0-20 mM 
EDTA, 0.05% NP-40, and 0-3 µg BSA) prior to incubation with 20 - 200 fmol biotin-
labelled DNA. In some experiments, a 200-fold molar excess of non-biotinylated DNA 
was added as a competitor. As a positive control reaction, Epstein-Barr nuclear antigen 
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(EBNA) extract was incubated with reaction buffer and biotin-labelled DNA (Table 2-1). 
Samples were incubated for 20-60 min at room temperature prior to the addition of 1X 
Loading Buffer. Some samples had 2.5 µg anti-ChAT antibody added to the reaction at 
15 min prior to completion. Samples were then separated on a 6% Tris-Borate EDTA 
electrophoresis gel and transferred to an Amersham Hybond-XL nylon membrane (GE 
Healthcare, Mississauga, ON). Membranes were then cross-linked for 10 min at 254 nm 
prior to incubation in stabilized streptavidin-horseradish peroxidase conjugate and 
detection by chemiluminescence. 
 
Data Analysis  
The data are presented as mean ± SEM, with n values indicating the number of 
independent experiments performed with separate cell populations. Each n value 
represented the average of multiple sample replicates for each experiment. GraphPad 
Prism 5 (GraphPad Software, San Diego, CA, USA) was used for data analysis. Data 
were assessed for normality using Bartlett’s test and statistically significant differences 
were tested by unpaired Student’s t-test, or between groups using one or two-way 
ANOVA with Dunnett’s, Tukey’s or Bonferroni’s post hoc multiple comparison test as 
appropriate, with statistical significance defined as p ≤ 0.05. For cell counting, an 
independent and blinded observer determined the number of cells with nuclear 
aggregations on 63x magnification images. Each image had at least 20 cells, and 5 
images were counted for each replicate of each treatment. The total number of cells in all 
5 images was pooled to determine the percentage of cells with nuclear aggregations. 
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Table 2-1. DNA oligomer pairs used for EMSA. 
 
 
  
Name Details Oligomer 5’ - 3’ Reverse Compliment 3’ - 5’ 
EBNA 
target  
Provided in 
EMSA kit 
…TAGCATATGCTA… ...TAGCATATGCTA… 
DREME TCCAT (from 
DREME analysis 
in ChIP-seq) 
GCAGTCCATCGTCCATG
CTCCATCTCCATCTCCAT
TCCATTCCATTAGAC 
GTCTAATGGAATGGAATGG
AGATGGAGATGGAGCATG
GACGATGGACTGC 
AT-Rich Random A/T  GCAGAAAAAAAAAAAA
AAAAAAAAAAAAAAAA
AAAAAAAAAAAAAAGG
AC 
GTCCTTTTTTTTTTTTTTTTT
TTTTTTTTTTTTTTTTTTTTT
TTTTCTGC 
ATC-Rich 1 (A/T)3-nC(A/T)3-6 GCGCATTCTTACTTTACT
ATGGATTCTATATATCTT
TGATACTATTTTTCATTG
GAC 
GTCCAATGAAAAATAGTAT
CAAAGATATATAGAATCCA
TAGTAAAGTAAGAATGCGC 
ATC-Rich 2 ATACATA GCAGATACATAGATACA
TAATACATAGATACATA
ATACATAATACATAGGA
C 
GTCCTATGTATTATGTATTA
TGTATCTATGTATTATGTAT
CTATGTATCTGC 
APP peak Found from 
ChIP-Seq 
GCAGTATTTTGGTATTTT
GTTATGGCAGCCCTAGC
AGACTAATGCATTTAGG
AC 
GTCCTAAATGCATTAGTCT
GCTAGGGCTGCCATAACAA
AATACCAAAATACTGC 
Random 
motif 
ATGC random 
order (50% GC) 
GCAGACCGCAGAGTGCG
CAATACGAGGTAAAGCC
AGTCACCCAGTGAGAC 
GTCTCACTGGGTGACTGGC
TTTACCTCGTATTGCGCACT
CTGCGGTCTGC 
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2.3 Results 
 
82-kDa ChAT associates with chromatin at synapse and cell stress genes 
The 82-kDa ChAT protein structure contains predicted DNA-binding motifs, and 
has been demonstrated to alter gene expression in neural cells. Therefore, we inquired if 
82-kDa ChAT could be associated with chromatin. An additional objective was to 
determine the impact of Aβ-exposure on the ability of 82-kDa ChAT to interact with 
chromatin. We chose 100 nM Aβ1-42, as this treatment has previously been shown to be 
rapidly internalized in SH-SY5Y cells (Lana et al. 2016), and to activate the ERK/MAPK 
signaling pathway in SH-SY5Y cells within 10 min of treatment (Young et al. 2009). 
Further, signaling events leading to immediate early gene activation alter gene expression 
of target genes several hours after stimulation (Li et al. 1996; Yaniv et al. 2010). Thus, 
we used cell fractionation analysis in retinoic acid-differentiated SH-SY5Y cells that 
stably express heterologous 82-kDa ChAT, to identify subcellular compartments whereby 
82-kDa ChAT was localized after 4 h of cell treatment with either vehicle (F-12 media) 
or 100 nM Aβ1-42. (Fig. 2-3). A large proportion of the 82-kDa ChAT protein was found 
in the fraction containing soluble nuclear proteins (150 mM KCl). In control cells, a small 
immuno-positive band for 82-kDa ChAT protein was found in the euchromatic chromatin 
(420 mM KCl) fraction, but no immuno-positive band was observed in the insoluble 
pellet fraction containing heterochromatic associated, nuclear matrix associated and 
insoluble proteins. Interestingly, after 4 h exposure of cells to 100 nM Aβ1-42, there was a 
strong 82-kDa ChAT protein immuno-positive band in the 420 mM KCl fraction and a 
small band detected in the insoluble pellet fraction. As a control, β-tubulin was found 
mainly in the 10 mM KCl (cytosolic) fraction, while histone H2A was found only in the 
insoluble pellet fraction.  
Given that the 82-kDa ChAT protein was found in sub-cellular fractions 
containing euchromatic- and heterochromatic-associated proteins after exposure to Aβ1-
42, we next employed chromatin immunoprecipitation followed by next-generation 
sequencing (ChIP-seq) for 82-kDa ChAT in cells treated for 4 h with either vehicle or 
100 nM Aβ1-42 (Fig. 2-4). We found 7460 peaks for 82-kDa ChAT after vehicle  
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Figure 2-3. 82-kDa ChAT associates with chromatin. 
Immunoblot showing cell fractionation of SH-SY5Y cells stably expressing 82-kDa 
ChAT treated with either vehicle or 100 nM oligomeric Aβ1–42 for 4 h. Aβ -treated cells 
showed an increase in 82-kDa ChAT protein levels present in the 420 mM KCl fraction, 
with a small amount of protein detected in the insoluble protein fraction. β -tubulin and 
histone H2A were used as controls for the 10 mM KCl and insoluble protein fractions, 
respectively, n = 8. 
  
63 
 
 
 
Figure 2-4. 82-kDa ChAT has altered genome association after exposure of cells to 
Aβ. 
(A) ChIP-seq was performed for SH-SY5Y cells stably expressing 82-kDa ChAT treated 
with either vehicle or 100 nM oligomeric Aβ1–42 for 4 h. Genomic features identified for 
82-kDa ChAT. Both treatment groups had over 50% of the peaks at intergenic regions, 
but Aβ1–42 treatment increased association with introns, promoters and exons. Average 
peak length for 82-kDa ChAT after either vehicle or Aβ1–42-exposure was also tested. 
Treatment with Aβ1–42 significantly decreased the 82-kDa ChAT peak length. ***p < 
0.001 (Student’s t-test). (B) Top DREME motif hits for 82-kDa ChAT after vehicle or 
Aβ1–42-exposure of cells. The top motifs for both treatments revealed a TC2-3AT motif. 
(C) Example ChIP-seq tracks for 82-kDa ChAT after vehicle or Aβ1–42-exposure of cells 
for regions of GAB2 and MAGI2 genes. Peaks are highlighted in blue for Aβ1–42 peaks 
and red for vehicle peaks. H3K27Ac is overlaid to show active transcription initiation 
sites.  
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treatment, and 6345 peaks after Aβ1-42 treatment, with 250 peaks overlapped and an 
additional 414 peaks within 200 nt of one another. We further observed that 57.4% of 
peaks were found in intergenic regions after vehicle-treatment, compared to 51.3% after 
Aβ1-42-exposure (Fig. 2-4A). The decrease in intergenic regions after exposure to Aβ1-42 
was explained by an increase in the percentage of the peaks found in introns (42.1%) 
compared to vehicle treatment (37.2%). In addition, the percentage of peaks found in 
promoters and exons was also increased after Aβ1-42-exposure (9.3% and 3.4%, 
respectively) compared to vehicle treatment (7.7% and 2.7%, respectively). We also 
observed that the average peak length was significantly reduced after Aβ1-42 treatment for 
82-kDa ChAT (132.6 ± 2.2 nucleotides (nt)) compared to vehicle treatment (192.6 ± 3.2 
nt). Smaller peak sizes suggest targeted genomic associations with sequence-specific 
DNA targets (Pepke et al. 2009).  Next, we used the DREME tool for motif discovery 
(Fig. 2-4B) and observed that the top DREME motifs contained the motif TC2-3AT in 
both conditions. DREME also revealed an additional ATC-rich motif only after exposure 
to Aβ1–42. This sequence was identical to a known binding motif ((A/T)3-6C(A/T)3-n; 
Yasui et al. 2002) for special AT-rich sequence binding protein 1 (SATB1), an 
organizing component of the nuclear matrix (Yasui et al. 2002; Cai et al. 2003; Galande 
et al. 2007). Examples of ChIP-seq tracks from random genomic targets for 82-kDa 
ChAT, treated with vehicle or Aβ1-42, are shown in Fig. 2-4C for GAB2 and MAGI2 
genes, with H3K27 acetylation (H3K27ac) overlaid to show one example of active 
transcription initiation sites. We identified no relationship between the peaks for 82-kDa 
ChAT and H3K27ac. Additional tracks can be found in Figure 2-5 for chromosomes 1, 7 
and 10, the full GAB2 and MAGI2 genes, as well as a region of the APP gene. 
Chromosomes 7 and 10 showed large peaks for 82-kDa ChAT flanking the centromeres 
(Fig. 2-5A).  
Next, we annotated 82-kDa ChAT ChIP-seq peaks found in intergenic regions for 
cells treated with either vehicle or 100 nM Aβ1-42. In agreement with the genomic 
features, we found 3700 non-duplicate genes that contained peaks for 82-kDa ChAT, 
with this increasing to 4507 genes after Aβ1-42-exposure. Of these genes, there were 820 
genes in common for both treatments. Using these annotations, we evaluated whether 
there were significant functional groups for annotated genes using the DAVID server  
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Figure 2-5. Examples of ChIP-seq tracks for 82-kDa ChAT. 
(A) ChIP-seq tracks for chromosomes 1, 7 and 10 for 82-kDa ChAT in cells treated with 
either vehicle or Aβ1-42. For chromosome 1, there was a portion of data not covered at the 
start of the q-arm. No other chromosome had a gap in data coverage. For chromosomes 7 
and 10, there was a large peak of coverage flanking the centromeres. (B) ChIP-seq tracks 
for GAB2 and MAGI2 whole genes, as well as for a region of APP, for 82-kDa ChAT in 
cells treated with either vehicle or Aβ1-42. Peaks are highlighted in blue for 82-kDa ChAT 
Aβ1-42 peaks and red for 82-kDa ChAT vehicle peaks. H3K27Ac is overlayed to show 
active transcription initiation sites. 
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(Appendices 2-4). DAVID is an integrated bioinformatics approach to gene ontology 
(GO) that combines multiple computational and statistical methods and has been cited in 
over 21,000 publications (Huang da et al. 2009; 2009a). For genes associated with 82-
kDa ChAT after vehicle or Aβ1-42-exposure, we found no significant GO terms (defined 
as p < 1.0E-05 and –log(FDR) > 1.5). However, for genes associated with 82-kDa ChAT 
in both treatment conditions, we found significant GO terms for cell adhesion (p = 1.2E-
08, - log(FDR) = 4.7), synapse (p = 1.3E-08, -log(FDR) = 4.8), membrane (p = 7.1E-08, -
log(FDR) = 4.0), and glycoprotein (p = 3.2E-06, -log(FDR) = 2.3). In addition to these 
GO terms we also identified several genes previously identified by a meta-analysis of 
genome wide association studies assessing AD risk, including BIN1, CR1, EFNA5, 
GAB2, MAGI2, MTHFD1L and PRUNE2 (Bertram 2011). We also found several APP 
binding and metabolism related genes in several conditions (Table 2-2). It is of interest 
that ADAM10, ADAM17, APBA2, APPBP2, and RTN1 were previously identified as 
upregulated by 82-kDa ChAT in a gene expression microarray. We also identified several 
additional APP related genes, such as ADAM12, APBB1, APBB2 and NAE1, as well as 
APP itself.  
 
82-kDa ChAT sub-nuclear distribution is altered after cell exposure to oligomeric Aβ1-42 
or trichostatin A 
As previously stated, we found that 82-kDa ChAT associated with chromatin after 
both vehicle and Aβ1-42-exposure, with increases in genic associations at introns, 
promoters and exons after 4 h of 100 nM Aβ1-42-exposure. Therefore, we imaged changes 
to the sub-nuclear localization of 82-kDa ChAT after 4 h of vehicle or Aβ1-42-exposure by 
confocal microscopy.  We observed diffuse, slightly punctate staining for 82-kDa ChAT 
in the nuclei of vehicle-treated cells, with a small amount of cytoplasmic staining (Fig. 2-
6A[a–c]). After exposure of cells to 100 nM oligomeric Aβ1-42 for 4 h, 
immunofluorescence staining of cells for 82-kDa ChAT reveals highly-fluorescent 
aggregates of the protein within the nuclei of many cells (Fig. 2-6A[d–f]). We  
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Table 2-2. Selected APP interacting genes with 82-kDa ChAT association by ChIP-
seq. 
 
 
 
Gene 
 
 
Function 
 
82-kDa ChAT 
(Vehicle) 
 
82-kDa ChAT 
(Aβ) 
Microarray fold 
change  
ADAM10 Alpha secretase proteolytic 
cleavage of APP 
 
Intron 1 
 
Intron 14 
 
2.4 
ADAM12 matrix metalloproteinase, 
multiple catalytic targets 
 
Intron 3 
 
Intron 2 
 
n/a 
ADAM17 MAP-kinase signalling, APP 
cleavage 
 
Intron 1 
 
-- 
 
1.2 
APBA2 
(x11β) 
signal transduction, APP 
binding  
 
-- 
 
Promoter 
 
2.2 
APBB1 APP binding, involved in APP 
signaling 
 
Promoter 
 
-- 
 
n/a 
APBB2 APP binding, involved in 
signaling 
 
Intron 1 
 
Intron 6 
 
n/a 
APP β-amyloid precursor, synapse 
maintenance 
 
-- 
 
Intron 13 
 
n/a 
APPBP2 Binds to APP intracellular 
domain 
 
Intron 4 
 
-- 
 
1.4 
NAE1 APP binding, can drive APP-
mediated apoptosis 
 
-- 
 
Intron 7 
 
n/a 
RTN1 Modulates β-secretase 
activity, APP binding near 
cleavage site 
 
 
-- 
 
 
Intron 1, 3 
 
 
14.8 
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Figure 2-6. 82-kDa ChAT forms nuclear aggregates after exposure to Aβ. 
(A) SH-SY5Y cells stably expressing 82-kDa ChAT were exposed to either vehicle (F12 
media; a–c) or 100 nM oligomeric Aβ1–42 for 4 h (d–f). Aβ-treated cells had nuclear 
aggregates of 82-kDa ChAT protein. The left panel shows 82-kDa ChAT staining, center 
panel shows staining with Hoechst dye to label DNA, and right panel is the overlay; n = 
5, with at least 6 cells imaged per treatment; scale bar 20 μm. (g) Quantification of the 
number of cells with nuclear aggregates of 82-kDa ChAT, n = 8 with at least 100 cells 
counted per treatment. ***p < 0.001 (Student’s t-test). (B) SH-SY5Y cells were 
transiently transfected with 82-kDa ChAT-eGFP and treated with either vehicle (a–c) or 
100 nM oligomeric Aβ1–42 (d–f) for 4 h, then live cells were exposure to Hoechst dye for 
20 min prior to imaging. Aβ-exposed cells had aggregates of 82-kDa ChAT-eGFP (inset 
on d) surrounding areas with little ChAT-eGFP and aggregates of Hoechst dye (inset on 
e,f). Scale bar 5 μm; n = 5.  
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determined that 58 ± 2% of Aβ -treated cells had at least 1 nuclear aggregate of 82-kDa 
ChAT, compared to 13 ± 1% of vehicle-treated cells (Fig. 2-6A[g]). 
Next, we determined whether these Aβ -induced aggregates are also formed in live cells 
that express 82-kDa ChAT as a fusion protein with enhanced green fluorescent protein 
(82-kDa ChAT-eGFP; Fig. 2-6B). Consistent with findings in the previous experiment, 
vehicle-treated cells had a diffuse distribution of 82-kDa ChAT-eGFP in nucleus (a–c), 
whereas cells treated for 4 h with 100 nM Aβ1–42 had nuclear aggregates of 82-kDa 
ChAT-eGFP (Fig. 2-6B[d–f]). As a DNA marker, we treated live cells with 625 ng/mL 
Hoechst 33342 for 20 min prior to imaging. When the Aβ -induced aggregates of 82-kDa 
ChAT-eGFP were imaged at higher magnification, it is apparent that there were areas 
within the aggregates that have lower levels of 82-kDa ChAT staining (Fig. 2-6B[inset 
d]) and that these were enriched with Hoechst dye (Fig. 2-6B[inset e–f]).  
The competitive minor groove binding compound Hoechst 33342 stains DNA at 
the minor groove in live cells or in cells that have been fixed with paraformaldehyde. 
When added to live cells or in vitro to purified protein-DNA complexes, Hoechst can 
compete with and displace proteins that bind DNA using S(T)PXX or XPRK motifs 
(Amirand et al. 1998; Deka et al. 1999). However, if protein-DNA complexes are 
crosslinked with paraformaldehyde then the DNA can no longer be accessed by Hoechst 
and binding at that specific region will not occur. Given that 82-kDa ChAT has S(T)PXX 
and XPRK motifs which can bind to AT-rich DNA motifs, we next determined whether 
treatment with Hoechst in SH-SY5Y cells stably expressing heterologous 82-kDa ChAT 
prior to fixation could alter the sub-nuclear distribution of 82-kDa ChAT by confocal 
microscopy. Cells were treated for 4 h with either vehicle or 100 nM Aβ1-42 followed by 
exposure to Hoechst stain, either following fixation (2500 ng/mL for 5 min) or prior to 
fixation (625 ng/mL for 20 min). As observed in previous experiments, vehicle-treated 
cells had a diffuse distribution of 82-kDa ChAT in the nucleus, both in cells treated with 
Hoechst following fixation (Fig. 2-7[A-C]) or prior to fixation [D-F]. After exposure to 
Aβ1-42, cells that were treated with Hoechst dye following fixation (Fig. 2-7[G-I]) had 
aggregates of 82-kDa ChAT that did not appear to have any relationship with the Hoechst   
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Figure 2-7. Effect of Aβ1-42 treatment on 82-kDa ChAT nuclear distribution in SH-
SY5Y cells. 
Retinoic acid differentiated SH-SY5Y cells stably expressing 82-kDa ChAT were treated 
for 4 h with either vehicle (A-F, P-U) or 100 nM Aβ1-42 (G-L, V-AA). For each 
treatment, cells were either treated with Hoechst stain following fixation or prior to 
fixation, and immunostained for 82-kDa ChAT prior to being imaged. For vehicle treated 
cells, 82-kDa ChAT appeared to be diffusely localized with a punctate-like appearance, 
and overlapped with the Hoechst stain when applied following (A-C) and prior to (D-F) 
imaging. For cells treated with Aβ1-42 and Hoechst stain following fixation (G-I), there 
were aggregations of 82-kDa ChAT in the nuclei. However for Aβ1-42 treated cells that 
had Hoechst applied prior to fixation (J-L), there were accumulations of 82-kDa ChAT 
surrounding regions with lower ChAT expression. For some cells, 3D images were 
acquired by taking 1 µm sections through the entire nucleus, and then compiled and 
rendered in Imaris before creating a 3D surface for each fluorophore. For vehicle treated 
cells, 82-kDa ChAT appeared to be localized mainly to the periphery of the nucleus, and 
overlapped with the Hoechst stain when applied following (P-R) and prior to (S-U) 
imaging. For cells treated with Aβ1-42 and Hoechst stain following fixation (V-X), there 
were regions of ChAT aggregation surrounded by regions of Hoechst accumulation. This 
pattern was reversed for Aβ1-42 treated cells that had Hoechst applied prior to fixation (Y-
AA). Un-rendered 3D vehicle samples are shown for Hoechst stain following (AA-CC) 
and prior to (DD-FF) fixation. The left panel shows Hoechst staining, the center panel 
shows 82-kDa ChAT and the right panel is the overlay of the first two panels. Scale bar 3 
µm; n = 4 with at least 3 cells images per treatment.  
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dye. However, in Aβ1-42-treated cells exposed to Hoechst dye prior to fixation, there were 
areas within the aggregates that have lower levels of 82-kDa ChAT staining (Fig. 2-7[J-
L, N,O]) and these areas were enriched with Hoechst dye (Fig. 2-7[J-L, M,O]). These 
latter results are similar to observations made in the previous experiment using live cells. 
In order to better visualize and identify patterns in the 3-dimensional structure of the 
nucleus, we next captured images at 1 µm intervals through the entire nucleus in the z-
plane. For vehicle-treated cells, 82-kDa ChAT appeared to be localized mainly to the 
periphery of the nucleus, and there appeared to be no difference in localization when the 
Hoechst stain was applied either following or prior to imaging (Fig. 2-7[P-U]). After 
exposure to Aβ1-42, cells that were treated with Hoechst dye following fixation had 
aggregates of 82-kDa ChAT that were surrounded by regions where Hoechst dye 
accumulated (Fig. 2-7[V-X]). This pattern was reversed for Aβ treated cells where 
Hoechst dye was applied prior to fixation ([Y-AA]). The vehicle-treated cell images prior 
to rendering are also shown as a comparison to the 3D images (Fig. 2-7[BB-GG]). 
In some experiments, we chose to pre-treat cells with trichostatin A (TSA), a 
histone deacetylase (HDAC) inhibitor (Hu and Colburn 2005), prior to exposure of the 
cells to either vehicle or 100 nM Aβ, because of evidence previously linking 82-kDa 
ChAT to changes in histone acetylation (Gill 2005) and linking increases in oxidative 
stress with increases in histone acetylation (Duclot et al. 2010; Gu et al. 2013). We chose 
a concentration of 10 nM TSA based on a previous study that showed TSA-induced 
increases in histone acetylation in SH-SY5Y cells with this concentration (De los Santos 
et al. 2007). In cells treated for 6 h with either TSA or 2 h with TSA followed by the 
addition of Aβ1-42 for an additional 4 h, when Hoechst dye was applied following fixation 
there was nearly complete separation of 82-kDa ChAT and Hoechst (Fig. 2-8[A-F]). 
However, when Hoechst dye was added to the live cells prior to fixation there appeared 
to be regions of Hoechst accumulation surrounded by 82-kDa ChAT (Fig. 2-8[G-L]). We 
next evaluated the effect of decreasing the Hoechst dye concentration when applied prior 
to fixation on the localization of 82-kDa ChAT in TSA-treated cells (Fig. 2-9). Compared 
to 625 ng/mL Hoechst-treatment prior to fixation (Fig. 2-8[J-L], Fig. 2-9[A-C]) cells 
treated with 125 ng/mL Hoechst prior to fixation had less Hoechst staining, but still had  
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Figure 2-8. Effect of trichostatin A treatment on 82-kDa ChAT nuclear distribution 
in SH-SY5Y cells. 
Retinoic acid differentiated SH-SY5Y cells stably expressing 82-kDa ChAT were treated 
for 6 h with either 10 nM trichostatin A (TSA) alone (A-C, G-I) or TSA and 4 h 100 nM 
Aβ1-42 (D-F, J-L). 3D images were produced by capturing 1 µm sections through the 
entire nucleus, with these then compiled and rendered in Imaris before creating a 3D 
surface for each fluorophore. In cells treated with either TSA or TSA plus Aβ1-42, when 
Hoechst dye was applied following fixation (A-C, D-F, respectively) there was nearly 
complete separation of 82-kDa ChAT and Hoechst. However,,when Hoechst dye was 
applied to these cells prior to their fixation (G-I, J-L) there appeared to be regions of 
Hoechst stain accumulation surrounded by 82-kDa ChAT. The left panel shows Hoechst 
staining, the center panel shows 82-kDa ChAT and the right panel is the overlay of the 
first two panels. Scale bar 3 µm; n = 3 with at least 3 cells images per treatment. 
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Figure 2-9. Titration of Hoechst stain in cells prior to fixation reverses TSA induced 
Hoechst accumulation. 
Retinoic acid differentiated SH-SY5Y cells stably expressing 82-ChAT were treated for 6 
h with 10 nM TSA and a range of concentrations of Hoechst dye prior to fixation, then 
fixed and immunostained for 82-kDa ChAT. Cells were imaged by taking 1 µm sections 
through the entire nucleus, and 3D images were compiled and rendered in Imaris before 
creating a 3D surface for each fluorophore. In cells treated with TSA, when Hoechst was 
applied prior to fixation at 625 ng/ml (A-C) or 125 ng/ml (D-F), there appeared to be 
regions of Hoechst stain accumulation surrounded by 82-kDa ChAT. For Hoechst dye at 
62.5 ng/ml (G-I), there appeared to be less accumulations of Hoechst, and at 32.5 ng/ml 
Hoechst dye (J-L) both ChAT and Hoechst appeared to overlap completely similar to 
vehicle treated cells (M-O). The top panels show Hoechst staining, the middle panels 
show 82-kDa ChAT and the bottom panels is the overlay of the first two panels. Scale bar 
3 µm; n = 2 with at least 3 cells images per treatment. 
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regions of Hoechst surrounded by 82-kDa ChAT (Fig. 2-9[D-F]). However, when cells 
were treated prior to fixation with 62.5 ng/mL (Fig. 2-9[G-I]) or 31.25 ng/mL (Fig. 2-
9[J-L]) Hoechst dye, there appeared to be no relationship between 82-kDa ChAT and the 
Hoechst, similar to observations made in vehicle-treated cells (Fig. 2-7[S-U], Fig. 2-
9[M-O]). These data suggest that treatment with TSA facilitates changes in 82-kDa 
ChAT localization in live unfixed cells incubated with Hoechst dye, dependent on the 
Hoechst dye concentration. 
To further provide evidence that 82-kDa ChAT may display Hoechst 
displacement, we repeated the 3D z-stack imaging experiments with endogenous tau, a 
protein that binds to DNA at the minor groove via S(T)PXX motifs (Fig. 2-10; Wei et al. 
2008). Although tau has not been shown previously to be displaced by Hoechst stain, it is 
displaced by the minor groove binder distamycin A in gel shift assays (Krylova et al. 
2005; Wei et al. 2008; Majumder and Dasgupta 2011). For our experiments, wild-type 
SH-SY5Y cells were differentiated for 3 days with retinoic acid, then treated for 6 h 
either with or without 10 nM TSA followed by exposure to Hoechst stain either prior to 
or after being fixed with paraformaldehyde. Cells were then immunostained for total tau 
protein, and imaged as described above. In vehicle-treated cells exposed to Hoechst dye 
following fixation, tau protein appeared to be localized mainly to the periphery of the 
nucleus, and overlapped with the Hoechst stain (Fig. 2-10[A-C]). However, when treated 
with Hoechst dye prior to fixation, there appeared to be accumulations of Hoechst dye 
surrounded by tau protein in the nuclei (Fig. 2-10[G-I]). Compared to vehicle treatment, 
we observed the same pattern in cells that were treated with TSA and Hoechst dye either 
following or prior to fixation (Fig. 2-10[D-F, J-L]). Single slice images were taken from 
the same 3D images for TSA treated cells with Hoechst dye following or prior to fixation 
(Fig. 2-10[M-W]). These images indicate that for cells treated with Hoechst dye prior to 
fixation, there appears to be the same pattern of expression as 82-kDa ChAT, with 
accumulations of tau surrounding accumulations of Hoechst dye. We also decided to 
perform 3D z-stack imaging for the endogenous expression of Matrin3, a major groove 
DNA binding protein that contains very few S(T)PXX regions, but does have two zinc 
finger domains that bind to the major groove of DNA (Fig. 2-11[A]; Salton et al. 2011). 
Therefore, we treated retinoic acid differentiated wild-type SH-SY5Y cells either with or   
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Figure 2-10. Effect of TSA on three-dimensional tau protein nuclear distribution in 
SH-SY5Y cells. 
(A) S(T)PXX DNA binding domains located in human tau isoform 1. There are several 
groupings of DNA binding regions found throughout the primary sequence of the protein. 
(B) Retinoic acid differentiated SH-SY5Y cells were treated with either vehicle or 10 nM 
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TSA for 6 h. For each treatment, cells were treated with Hoechst stain either following 
fixation (A-F) or prior to fixation (G-L), then immunostained for endogenous tau prior to 
being imaged. Cells were imaged by taking 1 µm sections through the entire nucleus, and 
3D images were compiled and rendered in Imaris before creating a 3D surface for each 
fluorophore. For control cells, tau appeared to be localized mainly to the periphery of the 
nucleus, and overlapped with the Hoechst stain when it was applied following fixation 
(A-C). For control cells treated with Hoechst prior to fixation (G-I), there appeared to be 
accumulations of Hoechst dye surrounded by tau. The same pattern as control was 
observed in cells treated with TSA and Hoechst dye either following (D-E) or prior to (J-
L) fixation. Single slice images were taken from the same 3D images for TSA treated 
cells treated with Hoechst dye either following (M-P) or prior to (Q-T) fixation. The 
inset on (S) shows a region of Hoechst dye accumulation (U) surrounded by tau (V), and 
the overlay of the two (W). In the top image (A-L), the left panel shows Hoechst 
staining, the center panel shows tau protein and the right panel is the overlay of the first 
two panels. In the bottom image (M-T), an additional right panel shows the differential 
contrast image for each slice. Scale bar 3 µm; n = 2 with at least 5 cells images per 
treatment. 
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Figure 2-11. Effect of TSA on three-dimensional Matrin3 protein nuclear 
distribution in SH-SY5Y cells. 
(A) DNA binding domains located in human Matrin3. There are two zinc finger domains 
located within the protein, but only a few S(T)PXX domains which are not grouped 
together. (B) Retinoic acid differentiated SH-SY5Y cells were treated with either vehicle 
or 10 nM TSA for 6 h. For each treatment, cells were treated with Hoechst stain either 
following fixation (A-F) or prior to fixation (G-L), then immunostained for endogenous 
matrin 3 prior to being imaged. Cells were imaged by taking 1 µm sections through the 
entire nucleus, and 3D images were compiled and rendered in Imaris before creating a 3D 
surface for each fluorophore. For control and TSA treated cells, Matrin3 appeared to be 
localized mainly to the periphery of the nucleus, and overlapped with the Hoechst stain 
when applied following fixation (A-C, D-F; respectively). For control and TSA treated 
cells with Hoechst dye applied prior to fixation (G-I, J-L; respectively), both Hoechst 
and Matrin3 expression appeared similar to Hoechst following fixation. Scale bar 3 µm; n 
= 2 with at least 5 cells images per treatment. 
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without TSA for 6 h, then stained with Hoechst dye either following or prior to fixation 
and immunostained for endogenous Matrin3 protein (Fig. 2-11[B]). In each treatment 
condition, Matrin3 was completely overlapped with Hoechst, and there did not appear to 
be any aggregates of Hoechst or Matrin3. 
 
Assessment of the in vitro DNA-binding potential for 82-kDa ChAT protein 
Based on the observations that 82-kDa ChAT protein associates with chromatin 
and has altered localization following live exposure to Hoechst dye, we assessed whether 
purified recombinant 82-kDa ChAT could bind directly to oligomeric DNA (Table 2-1). 
In our initial study, we performed EMSA experiments according to the manufacturer’s 
recommendations for the EBNA extract with the objective of detecting the positive 
EBNA control and testing several of the DNA oligomers (at 200 fmol) for 82-kDa ChAT 
(Fig. 2-12). These results suggest that the EBNA positive control worked as intended. 
Moreover, both the AT-rich and SATB1 motif DNA oligomers potentially show DNA 
binding of 82-kDa ChAT, though a non-specific band appeared at the same height in 
samples that contained no protein. Therefore, we used these two sequences for further 
testing. Appendix 5 shows the results in the EMSA optimization using the ATC-rich 
motif (A/T)3-nC(A/T)3-6. Increasing the incubation time to either 45 or 60 min increased 
the intensity of the shifted band, but this did not differ from that of the non-specific band. 
Both mixing the samples by rotation during the incubation period and increasing the 
incubation temperature to 37°C increased the intensity of the bands for reaction samples 
either containing and not containing 82-kDa ChAT protein (125 fmol DNA oligomer 
concentration). Addition of an antibody recognizing 82-kDa ChAT to the samples for 15 
min prior to the end of the incubation period appeared to produce a small reduction in 
signal (100 fmol DNA oligomer concentration). Importantly, when we added the 
reducing agent tris(2-carboxyethyl)phosphine (TCEP) to block reactive cysteine residues 
and prevent oxidation of ChAT protein (Kim et al. 2005a), we were observed a stronger 
intensity band compared to samples incubated in the absence of TCEP (Fig. 2-13). These 
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data suggest that 82-kDa ChAT is sensitive to oxidation, which may interfere with its 
ability to bind DNA. 
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Figure 2-12. Initial EMSA testing for 82-kDa ChAT. 
Purified recombinant 82-kDa ChAT (50 ng) or control EBNA extract was incubated with 
annealed biotinylated DNA oligomers from Table 2.1 and then separated on TBE 
electrophoresis gels. DNA and proteins were transferred to nylon membranes and 
exposed to stabilized streptavidin-horseradish peroxidase conjugate. (A) The control 
EBNA extract shows a strong shift when incubated with its target DNA sequence (20 
fmol), with this shift not observed for samples containing 200-molar excess non-
biotinylated competitor DNA. The AT-Rich and (B) ATC-Rich 1 motif sequences (200 
fmol) showed a shifted band of stronger intensity after incubation with 82-kDa ChAT, 
though a non-specific background band at the same height was observed in samples that 
did not contain 82-kDa ChAT. Competition appeared to attenuate the AT-Rich shifted 
band, but not the ATC-Rich 1 shifted band. The ATC-Rich 2 sequence resulted in a 
strong non-specific shifted band that was present in all conditions, while the random, 
APP and DREME oligomers did not produce a shifted band. Increasing the 82-kDa 
ChAT protein incubated to 100 ng did not produce a shift for the DREME, AT-Rich or 
APP sequences. 
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Figure 2-13. 82-kDa ChAT DNA binding is sensitive to oxidation. 
Purified recombinant 82-kDa ChAT was incubated with annealed biotinylated DNA 
oligomers from Table 2.1 (only the ATC-Rich 1 motif was used for these experiments at 
100 fmol). Addition of the reducing agent TCEP to prevent oxidation of 82-kDa ChAT 
resulted in an increase in the intensity of shifted immunoreactive band. N = 2. 
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2.4 Discussion 
 
This chapter explored the novel finding that 82-kDa ChAT can associate with 
chromatin, and that this association is altered in neural cells treated with Aβ1-42. 
Specifically, we found that (1) 82-kDa ChAT associates with chromatin; (2) 82-kDa 
ChAT increases its association with gene introns and promoters at synapse and 
membrane associated genes after cells have been exposed to Aβ1–42; and (3) nuclear 
localized 82-kDa ChAT forms aggregates in Aβ1–42-treated cells.  These aggregates were 
enriched with DNA, and are dependent on whether Hoechst stain was applied prior to 
fixation of the cells and upon the concentration of Hoechst dye. Finally, while we 
observed DNA-protein shifts by EMSA when we incubated 82-kDa ChAT with DNA 
oligomers, more data and optimizations are required to determine whether 82-kDa ChAT 
is directly binding to DNA.  
When we assessed the cellular distribution of 82-kDa ChAT by nuclear 
subfractionation, we observed that there was an 82-kDa ChAT immuno-reactive band in 
the fraction containing proteins associated with euchromatic chromatin (150 mM KCl) in 
both vehicle and Aβ1–42-treated cells, though the Aβ1–42 treated cells had higher 82-kDa 
ChAT levels in this fraction compared to vehicle treated cells. It was interesting that we 
observed a stronger band in the Aβ1–42-exposed samples, as we found a similar number of 
ChIP-seq associations regardless of treatment. This could be explained partially by the 
increased genic associations observed after Aβ1–42 treatment, as regions such as exons 
and promoters are naturally more likely targets for transcriptional activation. In addition, 
the 82-kDa ChAT ChIP associations had smaller peak sizes in cells treated with Aβ1–42, 
indicative of more targeted gene associations at regulatory sites that could alter gene 
transcriptional states (Pepke et al. 2009). An important limitation for the cellular 
fractionation experiments is that while we observed a positive immuno-reactive band for 
the insoluble fraction after Aβ1–42 treatment, we could not distinguish whether the 
proteins in this fraction were associated with heterochromatin or the nuclear matrix, or 
whether these were insoluble proteins. For example, previous unpublished work from our 
laboratory has found by co-immunoprecipitation that 82-kDa ChAT may interact with 
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Matrin3, a nuclear matrix protein. Therefore, it will be important for future studies to 
explore whether or not 82-kDa ChAT has insoluble components or changes its interaction 
with the nuclear matrix after exposure to Aβ1–42. 
In addition to the Aβ1–42-induced increases in 82-kDa ChAT genic associations, 
we also observed multiple significant DREME motifs for both vehicle and Aβ1–42-
exposed cells. Multiple DREME motifs often indicate that proteins may be in a complex 
with other proteins or transcription factors (Bailey 2011), and small, targeted ChIP peaks 
usually indicate transcription factor binding (Pepke et al. 2009). It is interesting to note 
that the DREME motif sequences may support both these observations. For example, the 
TC2-3AT motif observed after both vehicle and Aβ1–42-treatment has partial sequence 
homology to the nuclear factor of activated T-cells (NFAT) transcription factor 
(Kheradpour and Kellis 2014; Fig. 2-14). NFAT is dephosphorylated by calcineurin after 
neuronal activation and cell exposure to oligomeric Aβ1–42, leading to transcriptional 
activation of calcium homeostasis, synapse maintenance and neuro-inflammation related 
genes (Schwartz et al. 2009; Abdul et al. 2010). Interestingly, we observed that 82-kDa 
ChAT associated with synapse and membrane related genes regardless of treatment, and 
a previous microarray in human neural cells expressing 82-kDa ChAT found gene 
expression changes in many membrane-associated genes related to APP processing 
(Albers et al. 2014). These data suggest that NFAT could be part of a complex with 82-
kDa ChAT, a relationship that is explored further in Chapter 4. In addition to the partial 
NFAT motifs, we also observed a DNA-binding motif for SATB1, which anchors 
chromatin loops to the nuclear matrix as part of scaffolding/matrix attachment regions 
(S/MARs), and can recruit HDACs or histone acetyltransferases (HATs) specifically to 
these regions (Yasui et al. 2002; Cai et al. 2003; Galande et al. 2007). S/MARs are 
anchored to the nuclear matrix by SATB1 binding to local and distant ATC-rich DNA 
sequences, forming chromatin loops that are accessible for chromatin modifying factors 
to repress or activate transcription (Yasui et al. 2002; Galande et al. 2007). The role of 
SATB1 in the association of 82-kDa ChAT with chromatin is explored further in Chapter 
3. 
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Figure 2-14. DREME motifs for nuclear factor of activated T-cells (NFAT). 
NFAT DNA-binding motifs with partial sequence homology to the TC2-3AT motif found 
by ChIP-seq for 82-kDa ChAT. 
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An important result from the ChIP-seq data is that 82-kDa ChAT is highly 
associated with centromeric regions of chromatin, a feature known to be important for 
heterochromatin organization and cell cycle regulation (DeBeauchamp et al. 2008; 
Fernius et al. 2013). As previously discussed in the Introduction, constitutive repression 
and chromatin compaction in the centromere is essential for proper regulation of cell 
cycle division (Spremo-Potparević et al. 2008); in the case of neurons, cells are 
maintained in Go. It is of interest that neurons in the brains of AD patients show evidence 
of cell cycle re-entry attempts and abnormal centromere division (Spremo-Potparević et 
al. 2008). This is especially interesting given that the nuclear localization of 82-kDa 
ChAT is lost in AD (Gill et al. 2007). Future studies will be important to determine if 
there is a role for 82-kDa ChAT in cell cycle regulation. 
Finally, an observation from the ChIP-seq data was that there was very little 
overlap in the genomic associations for 82-kDa ChAT after vehicle and Aβ1–42-exposure, 
with only 250 peaks in common out of a total of 13,805 peaks (1.8%). This observation, 
combined with the observed increases in intron, promoter and exon associations after 
Aβ1–42-exposure, led us to explore how 82-kDa ChAT was expressed in nuclei and 
whether there were any observable Aβ1–42-induced changes in 82-kDA ChAT sub-nuclear 
localization. When visualized by confocal microscopy, we observed that exposure to 
Aβ1–42 induced the formation of 82-kDa ChAT aggregates in the nuclei of SH-SY5Y 
cells. Importantly, when live cells were treated with Hoechst dye, we observed DNA 
staining within the aggregates. Hoechst binds to AT-rich DNA sequences and can 
displace other proteins that bind to DNA at AT-rich regions of the minor groove 
(Amirand et al. 1998; Deka et al. 1999). The 82-kDa ChAT protein is predicted to bind to 
DNA through S(T)PXX and XPRK motifs that bind AT-rich DNA (Suzuki 1989, Yang et 
al. 2003), therefore we determined whether Hoechst treatment in live cells could alter 82-
kDa ChAT nuclear localization. We noted that 82-kDa ChAT sub-nuclear localization 
was altered when Hoechst dye was added to cells prior to fixation with 
paraformaldehyde, but not after fixation in Aβ1–42-treated cells. We did not observe this 
effect in vehicle treated cells. When taken in combination with the data suggesting that 
there is increased association of 82-kDa ChAT DNA with euchromatic DNA after cells 
are exposed to Aβ1–42, these findings suggest that the Aβ1–42-induced 82-kDa ChAT 
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aggregates are associated with euchromatic AT-rich DNA. To test this possibility further, 
we also treated cells with the HDAC inhibitor TSA, which increases histone acetylation 
and availability of chromatin for transcription (Hu and Colburn 2005), observing that this 
treatment also facilitated the changes in 82-kDa ChAT localization in live unfixed cells 
incubated with Hoechst dye. These data support the hypothesis that 82-kDa ChAT may 
be binding to DNA at AT-rich sequences, however it is important to consider a few 
limitations of this study. While TSA is a class I and II HDAC inhibitor and increases 
histone acetylation, these changes may not be global as there are also class III and IV 
HDACs which would not be affected. Thus, it is possible that some regions may remain 
heterochromatic, and local chromatin regions will have non-uniform acetylation levels. 
Though we showed that the sub-nuclear distribution of Hoechst in 82-kDa ChAT 
expressing cells is altered by cellular perturbations, confirmation of Hoechst 
displacement should be confirmed by EMSA methods (Amirand et al. 1998; Deka et al. 
1999). Our preliminary EMSA results suggest that 82-kDa ChAT could bind to AT- and 
ATC-rich DNA sequences, however there were non-specific bands in the non-82-kDa 
ChAT containing samples, indicating that this assay requires further optimization.  
Despite these limitations, the ChIP-seq data also showed that 82-kDa ChAT associates 
with DNA at AT and ATC-rich sequences. Thus, the notion that 82-kDa ChAT associates 
with euchromatic chromatin at AT-rich sequences is promising and warrants further 
investigation. 
The data presented in this chapter shows that 82-kDa ChAT associates with 
chromatin, with increased genic associations after cells are exposed to oligomeric Aβ1–42. 
The results suggest that the chromatin associations of 82-kDa ChAT may be dynamically 
regulated after environmental challenges and cellular perturbations, with possible 
implications for genes related to synapse and membrane maintenance, AD risk, and APP 
processing. Given that the nuclear levels of 82-kDa ChAT decline with increasing age 
and the onset of cognitive impairment (Gill et al. 2007), and that synaptic dysfunction is 
seen early in the pathogenesis of AD, the loss of this epigenetic response may have 
implications for the onset or progression of MCI and AD. 
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Chapter 3  
3 Objective II- 82-kDa ChAT and SATB1 work together to regulate 
chromatin organization 
 
 
 
Portions of this chapter have been reproduced with permission from: 
 
Winick-Ng W, Caetano FA, Winick-Ng J, Morey TM, Heit B, Rylett RJ (2016) 82-kDa 
choline acetyltransferase and SATB1 localize to β-amyloid induced matrix attachment 
regions. Sci Rep, 6: 23914. 
 
 
 
Figure 3-6 (A) - data collection was done by Mr. Trevor Morey. 
Figures 3-8, 3-10, 3-13 and 3-14 and Tables 3-4 and 3-5 were produced in collaboration 
with Mrs. Jennifer Winick-Ng, using the statistical programming software SAS. 
Figures 3-3 and 3-15 were produced in collaboration with Dr. Fabiana A Caetano. 
Figure 3-15 [h] and [i] – analysis was performed by Dr. Bryan Heit. 
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3.1 Introduction and Rationale 
 
The 82-kDa choline acetyltransferase (82-kDa ChAT) protein interacts with 
chromatin, with increased genic association at promoters and introns after SH-SY5Y cells 
are exposed to oligomeric Aβ1-42. An important observation from these data included the 
identification of an Aβ-specific motif that had sequence similarity with special AT-rich 
sequence binding protein 1(SATB1). SATB1 anchors chromatin loops to the nuclear 
matrix as part of scaffolding/matrix attachment regions (S/MARs), and can recruit 
histone deacetylases (HDACs) or histone acetyltransferases (HATs) specifically to these 
regions (Yasui et al. 2002; Cai et al. 2003; Galande et al. 2007). S/MARs are anchored to 
the nuclear matrix by SATB1 binding to local and distant AT-rich DNA sequences, 
forming chromatin loops that are accessible for chromatin modifying factors to repress or 
activate transcription (Yasui et al. 2002; Galande et al. 2007). 
In the previous chapter, we demonstrated that Aβ1–42-exposure increases 82-kDa 
ChAT protein levels in heterochromatic/nuclear matrix associated nuclear fractions, 
suggesting that 82-kDa ChAT could interact with the nuclear matrix. Interestingly, co-
immunoprecipitation experiments performed in our laboratory suggest that 82-kDa ChAT 
could interact with the nuclear matrix protein matrin-3 (unpublished data). Moreover, 
from microarray data previously published by our laboratory (Albers et al. 2014), SATB1 
mRNA levels are increased 5.5 fold in IMR32 cells transiently expressing 82-kDa ChAT. 
Together, these data indicate that SATB1 could be a target for complex formation with 
82-kDa ChAT. In this chapter, we explore the relationship between 82-kDa ChAT and 
SATB1 in human SH-SY5Y neuroblastoma cells.  We test how SATB1 interacts with 
chromatin, and compare this interaction to the genomic distribution of 82-kDa ChAT 
after exposure to oligomeric Aβ1–42. Finally, we ask whether both 82-kDa ChAT and 
SATB1 are involved in chromatin organization, and whether this results in changes to 
gene expression.   
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3.2 Methods 
 
Cell Culture and transfection  
SH-SY5Y cells stably expressing heterologous 82-kDa ChAT (Albers et al. 2014) 
were differentiated as described in Chapter 2. Cells were treated with either 100 nM 
oligomeric Aβ1–42 (as described in Chapter 2), F12 media (vehicle), NAD+ (Sigma-
Aldrich, Oakville, ON, Canada) or resveratrol (Sigma-Aldrich) with or without pre-
treatment with EX527 (Sigma-Aldrich) at the times and concentrations indicated. Cells in 
some experiments were transfected with either scrambled control siRNA or specific 
siRNA duplexes targeted against human SATB1 (Santa-Cruz Biotechnology, Dallas, TX, 
USA) for 24 h with Lipofectamine RNAiMAX (Invitrogen) prior to treatment with Aβ or 
resveratrol. As an additional negative control, cells were mock transfected with 
Lipofectamine containing no siRNA. 
 
Antibodies  
The 82-kDa ChAT protein was detected as described in Chapter 2. Goat anti-
SATB1 (sc-5989) was from Santa Cruz Biotechnology; AlexaFluor 546 or 647-
conjugated secondary antibody (Invitrogen) was used for immunostaining visualization 
as appropriate. 
 
Nuclear isolation and Co-Immunoprecipitations 
To assess protein-protein interactions, we recovered proteins from cell lysates by 
Co-IP, then identified proteins by immunoblot and mass spectrometry. For nuclear 
isolation and subsequent immunoprecipitation, samples were prepared using the 
Universal Magnetic Co-IP kit (Active Motif, California, U.S.A.) according to the 
manufacturer’s directions. Briefly, cells were lysed in hypotonic buffer (provided by the 
Universal Magnetic Co-IP kit and containing deacetylase, protease and phosphatase 
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inhibitors), and centrifuged at 14,400 x g for 30 s at 4°C. The pellet containing cell nuclei 
was lysed in complete digestion buffer (provided by the Universal Magnetic Co-IP kit 
and containing deacetylase, protease and phosphatase inhibitors) and DNA was digested 
with DNAse I (800 units/mL) for 10 min at 37°C, followed by the addition of 10 mM 
EDTA to stop the reaction. Protein lysates were quantified using the Bradford method 
(Bradford 1976), and an aliquot containing 500 µg of lysate was diluted to a final volume 
of 500 µl in Co-IP/wash buffer (provided by the Universal Magnetic Co-IP kit and 
containing 50 mM NaCl and 0.1% NP-40) and incubated with 4 ug CTab for 4 h at 4°C, 
followed by immunocapture onto 25 µL protein G magnetic beads (provided by the 
Universal Magnetic Co-IP kit) for 1 h at 4°C. Samples were washed 4 times with Co-
IP/wash buffer and immune complexes were eluted into 20 µL 2x Reducing Loading 
Buffer (130 mM Tris; pH 6.8, 20% (v/v) glycerol, 4% (w/v) SDS, 0.02% (w/v) 
bromophenol blue, and 100 mM DTT) then heated for 5 min at 95°C prior to separation 
of proteins on SDS–polyacrylamide gel electrophoresis (SDS-PAGE) gels. Five µg of 
total nuclear lysate for each sample was also loaded onto each gel prior to separation on 
SDS-PAGE gels. Gels were stained with Imperial Protein Stain (Thermo Fisher 
Scientific, Waltham, MA, USA) for 20 min, then washed in water for 16 h at RT prior to 
mass spectrometry preparation (see below). 
For 82-kDa ChAT-SATB1 co-immunoprecipitations (Co-IPs), cells were lysed in 
Triton X-100 buffer (10 mM HEPES, pH 7.4, 5 mM MgCl2, 1 mM ethylene glycol 
tetraacetic acid, 5% glycerol (v/v), 0.5% Triton X-100 (v/v), protease inhibitor cocktail 
[Sigma Aldrich; final concentration: 1.04 mM 4-(2-aminoethyl) benzenesulfonyl fluoride 
hydrochloride (AEBSF), 0.8 µM Aprotinin, 40 µM Bestatin, 14 µM N-[N-(L-3-trans-
carboxyirane-2-carbonyl)-L-leucyl]-agmatine; 1-[N-[(L-3-trans-carboxyoxirane-2-
carbonyl)-L-leucyl]amino]-4-guanidinobutane (E-64), 20 µM Leupeptin and 15 µM 
Pepstatin], and phosphatase inhibitors [final concentration: 10 mM sodium fluoride, 1 
mM sodium vanadate, 20 mM sodium phosphate, 3 mM β-glycerolphosphate, 5 mM 
sodium pyrophosphate]) containing either 150 mM or 450 mM NaCl. Aliquots of cell 
lysate containing 4 mg of protein were diluted to a final volume of 1 ml in Triton X-100 
buffer. To immunoprecipitate 82-kDa ChAT and associated proteins (ChAT Co-IP), 
diluted lysates were incubated with 2.5 μg/mg lysate of anti-ChAT antibody (CTab) at 
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4°C for 24 h, followed by immunocapture onto 50 μL of protein-G Dynabeads 
(Invitrogen, Life Technologies, Burlington, ON, Canada) for 1 h at 4°C. Immunocaptured 
samples were washed 6x with Triton X-100 buffer, then immune complexes were eluted 
into 50 μL of 2x Laemmli sample buffer (126 mM Tris-HCl; pH 6.8, 20% (v/v) glycerol, 
4% (w/v) SDS, 0.01% (w/v) bromophenol blue, and 5% (v/v) 2-mercaptoethanol) by 
heating samples at 75°C for 15 min before separation of proteins on SDS-PAGE gels. 
Immunoreactive bands were analyzed by immunoblotting. 
To analyze SATB1 protein expression, cells were lysed in 
radioimmunoprecipitation (RIPA) buffer as described in Chapter 2. Cell lysates were 
centrifuged at 21,100 x g for 15 min at 4°C, then heated at 95°C for 5 min in 1x Laemmli 
sample buffer (63 mM Tris-HCl; pH 6.8, 10% (v/v) glycerol, 2% (w/v) SDS, 0.01% 
(w/v) bromophenol blue, and 2.5% (v/v) 2-mercaptoethanol). Aliquots of cell lysate 
containing 50 μg of protein were separated on SDS-PAGE gels, followed by transfer onto 
polyvinylidene difluoride (PVDF) membranes. Non-specific proteins were blocked in 5% 
horse serum in PBS containing 0.1% Triton-X 100 (PBS-T) for 1 h at room temperature, 
followed by incubation in 1:100 anti-SATB1 antibody in 3% bovine serum albumin in 
PBS-T overnight at 4°C. Following 1 h in 1:5000 HRP-conjugated anti-goat antibody, the 
density of immunoreactive bands were visualized using Image Lab (Version 5.0, 
BioRad). Immunoreactive band density for SATB1 was normalized to total density levels 
for each band, followed by normalization to β-actin. 
 
Mass Spectrometry  
Individual protein bands from Imperial Protein stained SDS-PAGE gels were 
isolated by an Ettan Spot Picker (GE Healthcare, Mississauga, Ontario, Canada) at the 
MALDI Mass Spectrometry Facility (London, Ontario, Canada). In-gel digestion was 
performed using a MassPREP automated digester station (PerkinElmer). Gel pieces were 
Coomassie destained using 50mM ammonium bicarbonate and 50% acetonitrile which 
was followed by protein reduction using 10 mM dithiotreitol (DTT), alkylation using 55 
mM iodoacetamide (IAA), and tryptic digestion. Peptides were extracted using a solution 
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of 1% formic acid and 2% acetonitrile and lyophilized. Prior to mass spectrometric 
analysis, dried peptide samples were re-dissolved in a 10% acetonitrile and 0.1 % TFA 
(trifluoroacetic acid) solution. MALDI matrix, α-cyano-4-hydroxycinnamic acid 
(CHCA), was prepared as 5 mg/mL in 6mM ammonium phosphate monobasic, 50% 
acetonitrile, 0.1 % trifluoroacetic acid and mixed with the sample at 1:1 ratio (v/v). 0.75 
uL of the samples/matrix mixture was deposited on the MALDI target and allowed to air 
dry. 
Mass Spectrometry data were obtained using a 4700 Proteomics Analyzer, 
MALDI TOF TOF (Applied Biosystems, Foster City, CA, USA).  Data acquisition and 
data processing were respectively done using 4000 Series Explorer and Data Explorer 
(both from Applied Biosystems).  The instrument is equipped with a 355 nm Nd:YAG 
laser; the laser rate is 200 Hz.  Reflectron and linear positive ion modes were used.  
Reflectron mode was calibrated at 50 ppm mass tolerance.  Each mass spectrum was 
collected as a sum of 1000 shots. MALDI-TOF results were entered into the Mascot 
server (http://www.matrixscience.com/; Matrix Science, Massachusetts, USA) to 
determine significant sequence similarity with known proteins. Mascot searches were 
performed with the following parameters: NCBI database, trypsin digest with 1 missed 
cleavage allowed, carbamidomethyl fixed modification, oxidation (M) variable 
modification, 50 ppm peptide mass tolerance. 
 
Immunofluorescence staining of cells and confocal imaging  
For immunofluorescence staining, cells were incubated with primary rabbit anti-
human CTab antibody (1:1000), either with or without goat anti-SATB1 antibody 
(1:100), followed by AlexaFluor 647 (for 82-kDa ChAT) or AlexaFluor 542 (for SATB1) 
secondary antibodies. Cells were then counterstained with 2.5 μg/mL Hoechst dye. 
Images were acquired and processed as described in Chapter 2, with 543-nm excitation 
and 560- to 615-nm band-pass emission filter for SATB1, and 647-nm excitation and 
650-nm long-pass emission filter for 82-kDa ChAT.  In some experiments, cells were 
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imaged with an Olympus Fluoview 1000 (Olympus Canada Inc., Richmond Hill, ON, 
Canada) using a 60X oil-immersion objective (NA = 1.35). 
 
Super-resolution ground-state depletion imaging 
For super-resolution ground-state depletion imaging (SR-GSDIM), digital images 
of fixed cells were acquired with a Leica super resolution ground-state depletion 
microscope (SR-GSD; Leica Microsystems Inc., Concord, ON, Canada) using a 160X 
oil-immersion objective, NA 1.47. Images were captured using the reversible saturable 
optical fluorescence transitions principle, as described (Heintzmann et al. 2002; Fölling 
et al. 2008). Images were captured using the Leica Application Suite Advanced 
Fluorescence software, then processed on Imaris (version 7.5.0, Bitplane USA, Concord, 
MA, USA). Identification of 82-kDa ChAT clusters and quantification of cluster size and 
spacing was performed in Matlab (Mathworks, Natick, MA, USA) using a custom-
written implementation of the Ordering Points To Identify Clusters algorithm (Ankerst et 
al. 1999; Caetano et al. 2015). Regular spacing of ChAT molecular clusters was detected 
by measuring the inter-cluster distance between each cluster and all other clusters in an 
image, and then performing a normalized Fast Fourier Transform to detect any regular 
cluster spacing. 
To quantify co-localization on SR-GSDIM images, Imaris was used to create 
surface dots representing each protein, based on the estimated size for each protein and 
resolution of the image. We defined the protein size with the addition of both primary and 
secondary antibodies as 60 nm. Using the XT co-localize spots module, we set the 
threshold distance for co-localized dots to be 2/3rds the size of the smallest protein and 
computed the distance between each pair of dots, and thus the threshold for co-
localization was set to 40 nm. 
 
Chromatin immunoprecipitation with next-generation sequencing (ChIP-seq)  
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ChIP and subsequent next-generation sequencing (ChIP-seq) was performed as 
described in Chapter 2, with the exception that the concentration of anti-SATB1 primary 
antibody used in these experiments was 5 ug. To visualize non-normal distribution of the 
distance between ChIP peaks, kernel density estimation was used, with a smoothing 
parameter of 0.5. We also included a published (Law et al. 2010) human ATRX dataset 
(NCBI accession: GSE22162) that was mapped to hg19 using Bowtie2. 
 
Data deposition 
ChIP-seq data was deposited in the NCBI Geo Database, accession number: 
GSE73576. 
 
Reverse transcription (RT) real-time PCR (qPCR) and ChIP-qPCR 
For ChIP-qPCR, primers (Table 3-1) were incubated with DNA from either the 
primary antibody sample or corresponding input sample. Duplicate samples were 
incubated without primary antibody (IgG control). For reverse transcription-qPCR (RT-
qPCR), total RNA was isolated from SH-SY5Y cells and reverse transcribed as described 
previously (Albers et al. 2014). 1x iQ SYBR Green Supermix (Bio-Rad) was added prior 
to PCR amplification and real-time detection using a Bio-Rad C1000™ Thermal Cycler 
and CFX95 Real-Time system. After each cycle, fluorescent activity was determined, and 
a final crossing point (threshold cycle, Ct) was calculated. Primer efficiency and 
amplifications of a single PCR product was confirmed, and a representative gel for RT-
PCR amplification can be found in Appendix 6. For ChIP-qPCR, the average Ct in each 
treatment and control was analyzed using the ΔΔCt method given by the formula: ΔΔCt 
(ChIP − IgG) = (Mean Ct (ChIP) − Mean Ct (Input)) − (Mean Ct (IgG) − Mean Ct 
(Input)). After determining the ΔΔCt, we used this to calculate a fold-change compared to 
the IgG control, given by the formula: Fold Change = 2^(−ΔΔCt (ChIP− IgG)). For RT-
qPCR, the average Ct in each treatment was analyzed by the 2^−ΔΔCt method, 
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normalized to glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and vehicle-treated 
samples.  
 
Data Analysis  
The data are presented as mean ± SEM, with n values indicating the number of 
independent experiments performed with separate cell populations. Each n value 
represents the average of multiple sample replicates for each experiment. GraphPad 
Prism 5 (GraphPad Software, San Diego, CA, USA) was used for data analysis. Data 
were assessed for normality using Bartlett’s test and statistically significant differences 
were tested by unpaired Student’s t-test, or between groups using one or two-way 
ANOVA with Dunnett’s, Tukey’s or Bonferroni’s post hoc multiple comparison test as 
appropriate, with statistical significance defined as p ≤ 0.05. For cell counting, an 
independent and blinded observer determined the number of cells with nuclear 
aggregations on 63x magnification images. Each image had at least 20 cells, and 5 
images were counted for each replicate of each treatment. The total number of cells in all 
5 images was pooled to determine the percentage of cells with nuclear aggregations. 
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Table 3-1. ChIP-qPCR and RT-qPCR primers used in the chapter. 
 
Gene  Direction  Primer, 5’-3’  
   
ChIP-qPCR  
Human APP  Forward  GCCAGACCACAACCTCGTTT  
 Reverse  TTGGGAACTTGCGTGGCAAA  
RT-qPCR  
Human SATB1 Forward  GTAGAGCTAGCGAGGGAGAGA 
 Reverse TTGTTGTTGTGACGAGGCCG 
Human Total APP  Forward  AACCAGTGACCATCCAGAAC  
 Reverse ACTTGTCAGGAACGAGAAGG  
Human APP-KPI  Forward  GTCTGTGGAAGAGGTGGTTC  
 Reverse GTCAAAGTTGTTCCGGTTG  
Human GAPDH  Forward  TGTTGCCATCAATGACCCCTT  
 Reverse CTCCACGACGTACTCAGCG  
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3.3 Results 
 
Aβ-induced 82-kDa ChAT aggregates co-localize with special AT-rich binding protein 1 
To assess the distribution of SATB1 in SH-SY5Y cells that stably express 
heterologous 82-kDa ChAT, we first confirmed SATB1 mRNA and protein levels in 
these cells. When measured by qPCR, we found a significant 1.47 ± 0.15-fold (p < 0.05, 
n = 3) increase in SATB1 mRNA levels in SH-SY5Y cells stably expressing 82-kDa 
ChAT compared to empty vector. When measured by immunoblotting, we observed 
increased band density for SATB1 in SH-SY5Y cells stably expressing 82-kDa ChAT 
compared to empty vector (Fig. 3-1). Quantification of the steady-state levels of SATB1 
compared to actin revealed a significant increase in steady-state SATB1 protein levels in 
82-kDa ChAT expressing cells (1.16 ± 0.1) compared to vector expressing cells (0.81 ± 
0.1). 
We targeted SATB1 as potentially having a role in Aβ-induced 82-kDa ChAT 
aggregation. First, the expression of 82-kDa ChAT in cells influences the subcellular 
localization of SATB1 protein in response to acute Aβ treatment (Fig. 3-2). When 
assessed by confocal microscopy, SATB1 protein is distributed in cells between the 
cytoplasm and nucleus, with the protein level in the nucleus being higher at the nuclear 
periphery. This subcellular distribution of SATB1 did not differ between vehicle-treated 
cells that do not express 82-kDa ChAT (Fig. 3-2A[a–c]) and cells that do express the 
ChAT protein (Fig. 3-2B[c]), and is not altered by Aβ1-42-treatment for vector-expressing 
cells (Fig. 3-2A[d–f]). Importantly however, in Aβ-treated cells that express 82-kDa 
ChAT, the SATB1 protein in the nucleus forms aggregates (Fig. 3-2B[j]). 82-kDa ChAT 
protein distribution is diffuse and slightly punctate in nuclei of vehicle-treated cells (Fig. 
3-2B[a–g]), but in cells treated with Aβ1-42 aggregates of 82-kDa ChAT (Fig. 3-2B[h–n]) 
and SATB1 co-localize in the nucleus (Fig. 3-2B[l]). 
To further evaluate the interaction between 82-kDa ChAT and SATB1 after 
cellular exposure to Aβ1–42, we used super-resolution ground-state depletion microscopy  
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Figure 3-1. 82-kDa ChAT expression in SH-SY5Y cells increases SATB1 protein 
expression. 
Representative immunoblot showing SATB1 steady-state protein levels in SH-SY5Y 
cells that either stably express 82-kDa ChAT or an empty vector. Densitometric 
quantification of band intensity revealed significantly greater SATB1 steady-state levels 
in cells expressing 82-kDa ChAT compared to cells expressing empty vector. * p < 0.05, 
n = 4. 
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Figure 3-2. Aβ-induced 82-kDa ChAT aggregates are co-localized with SATB1. 
(A) SH-SY5Y cells expressing empty vector were treated with either vehicle (a–c) or 
100 nM oligomeric Aβ1–42 (d–f) for 4 h. SATB1 was localized to nucleus and 
cytoplasm, with diffuse expression in nucleus in both vehicle and Aβ-treated cells. The 
left panel shows Hoechst staining, center panel shows SATB1 immunostaining, and right 
panel is the overlay. (B) SH-SY5Y cells stably expressing 82-kDa ChAT treated with 
vehicle (a–g) or 100 nM oligomeric Aβ1–42 (h–n) for 4 h. After treatment with Aβ, 82-
kDa ChAT (i) formed nuclear aggregates (arrows). SATB1 nuclear expression was 
greater than in control cells and showed aggregate formation (j) in the same region as the 
82-kDa ChAT aggregates (l). Scale bar 5 μm; n = 5, with at least 6 cells imaged per 
treatment. 
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followed by individual molecule return (SR-GSDIM) (Fig. 3-3). First, we analysed the 
SR-GSDIM images for co-localization of 82-kDa ChAT and SATB1, indicated by the 
pixels in Fig. 3-3A[b,d] and defined as a distance between the two proteins of less than 
2/3rd protein size. In control cells, there is a small amount of co-localization of the two 
proteins (Fig. 3-3A[a,b]) that is increased significantly after exposure to Aβ1-42 (Fig. 3-
3A[c,d]). Quantification revealed 4.6 ± 0.14% of co-localized pixels in control images, 
with this increased significantly by 50% (6.9 ± 0.51%) in Aβ-treated cells (Fig. 3-3A[e]). 
While this method allowed co-localization analysis between the two proteins, it was 
difficult to observe the nuclear aggregates under these conditions. Therefore, we digitally 
magnified the SR-GSDIM images to a 500 nm scale, in order to evaluate the relationship 
between the nuclear aggregates of 82-kDa ChAT protein (Fig. 3-3B[a]) and SATB1 
protein (Fig. 3-3B[b]). When SATB1 aggregate localization was overlaid with that of 82-
kDa ChAT, there was a close association between the two proteins, compared to regions 
outside of the aggregate (Fig. 3-3B[c]). 
Based on the observed interaction between 82-kDa ChAT and SATB1 by 
confocal and SR-GSDIM imaging, we next used co-immunoprecipitation to determine 
whether we could observe a direct interaction between these proteins (Fig. 3-4). We used 
several different buffer and salt conditions in the Co-IP, but were not able to detect a 
protein-protein interaction between SATB1 and ChAT. The conditions tested included a 
Triton X-100 buffer containing 150 mM NaCl, a concentration of salt that is needed to 
lyse the SH-SY5Y nuclei (Fig. 3-4A; n = 2). We also tested buffer containing 450 mM 
NaCl to release proteins associated with heterochromatic chromatin, but also did not 
detect SATB1 in the co-IP (Fig. 3-4B; n = 2). We were also unable to detect total levels 
of SATB1 following lysis with buffer containing 450 mM NaCl.  
Though we could not confirm whether 82-kDa ChAT and SATB1 proteins were 
interacting directly, we next explored whether modulators of the NAD-dependent 
deacetylase sirtuin 1 (SIRT1) could alter 82-kDa ChAT or SATB1 subcellular 
localization. SIRT1 can deacetylate histones and other proteins, and has been shown 
previously to deacetylate SATB1 leading to the formation of S/MARs (Xue et al. 2012). 
We used three pharmacological approaches to accomplish this, by exposing cells to the  
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Figure 3-3. Super-resolution analysis of 82-kDa ChAT co-localization with SATB1. 
(A) Co-localization analysis for SR-GSDIM images of 82-kDa ChAT and SATB1. (b) 
and (d) are the co-localization results for the respective SR-GSDIM image of vehicle (a) 
and 100 nM Aβ1–42 (c) treatments. (e) The percentage of co-localized pixels was 
increased significantly in Aβ-treated cells. **p < 0.01 (Student’s t-test, n = 5). (B) 
Digitally magnified SR-GSDIM images for 82-kDa ChAT (a) and SATB1 (b) levels after 
100 nM oligomeric Aβ1–42 for 4 h. The boxed region shows an Aβ-induced aggregate of 
82-kDa ChAT and SATB1. The overlay (c) revealed SATB1 protein within the 82-kDa 
ChAT accumulation. Scale bar 500 nm; n = 6, with at least 4 cells imaged per treatment. 
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Figure 3-4. Co-immunoprecipitations (Co-IPs) for 82-kDa ChAT and SATB1. 
SH-SY5Y cells stably expressing 82-kDa ChAT were treatmed for 4 h with vehicle or 
100 nM Aβ1-42. Co-IPs for 82-kDa ChAT were carried out with anti-CTab antibody in 
buffer containing 0.1% Triton X-100 and 150 mM (A) or 450 mM (B) NaCl. No SATB1 
was detected in for 150 mM or 450 mM NaCl Co-IPs, regardless of whether 5 µl or 45 µl 
of the immunocaptured proteins eluted from Dynabeads (50 µl total in 2x Laemmli 
sample buffer) were loaded on SDS-PAGE gels. 82-kDa ChAT was detected in both the 
Co-IP samples and the total lysate (50 µg). Total SATB1 is present in the total lysate for 
the 150 mM NaCl buffer, but was not detected in the 450 mM NaCl buffer. Actin is 
shown as a loading control for total lysate samples.  
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SIRT1 activator resveratrol (Ye et al. 2013), the SIRT1 co-factor NAD+ (Davenport et 
al. 2014), or the specific SIRT1 inhibitor 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-
carboxamide (EX527) (Peck et al. 2010). 
We treated cells with resveratrol to activate SIRT1 in the absence of Aβ1-42 (Fig. 
3-5A). We chose doses of resveratrol that were previously demonstrated to have effects 
on SIRT1 activity in SH-SY5Y cells (Chong and Maiese 2008; Wu et al. 2011). No 
aggregates of either of the two proteins are observed in the nuclei of cells treated for 5 h 
with 25 μM resveratrol (Fig. 3-5A[a–g]). However, when the concentration of resveratrol 
is increased to 50 μM, numerous aggregates of both 82-kDa ChAT and SATB1 are 
observed in cell nuclei (Fig. 3-5A[h–n]). 
Next we treated cells with the SIRT1 co-factor NAD+ for 3 h prior to the addition 
of either vehicle or 100 nM Aβ1-42 for 4 h. Following the addition of 2.5 mM NAD+ and 
100 nM Aβ1-42, we observed multiple nuclear aggregates of both 82-kDa ChAT and 
SATB1 in cell nuclei (Fig. 3-5B[a-g]). When the concentration of NAD+ was increased 
to 5 mM, the aggregates of both SATB1 and 82-kDa ChAT increased in size, but became 
less compact (Fig. 3-5B[h-n]).  
In other experiments, we pre-treated cells with the SIRT1-specific inhibitor 
EX527 for 1 h prior to exposure to Aβ1-42 (Fig. 3-5C). Importantly, aggregates of 82-kDa 
ChAT are not observed in cells that were pre-treated with 1 μM EX527 for 1 h prior to 
the addition of either vehicle (Fig. 3-5C[a–e]) or 100 nM Aβ1-42 for 4 h (Fig. 3-5C[f–j]). 
We found that 10 ± 2% of cells contain aggregates after pre-treatment with EX527 alone. 
Compared to Aβ1-42 alone (40 ± 2%), the number of aggregates is significantly reduced in 
cells pre-treated with EX527 prior to exposure to Aβ1-42 (10% ± 2%) (Fig. 3-5C[k]). As 
an additional control we included treatment of cells with a reverse Aβ1-42 peptide, which 
did not result in the production of significant 82-kDa ChAT aggregates compared to 
control. 
We assessed whether SATB1 was necessary for the formation of the Aβ-induced 
aggregates of 82-kDa ChAT using small-interfering RNA (siRNA) targeted to SATB1 
(Fig. 3-6). Compared to non-transfected (1.08 ± 0.03), mock transfected (1.05 ± 0.08),  
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Figure 3-5. Activation of SIRT1 is required for 82-kDa ChAT/SATB1 aggregate 
formation. 
(A) SH-SY5Y cells stably expressing 82-kDa ChAT and treated with the SIRT1 activator 
resveratrol at 25 μM for 5 h (a–g) did not result in formation of aggregates of either 82-
kDa ChAT or SATB1 proteins. Treatment with 50 μM resveratrol promoted aggregate 
formation (arrows on h–n) of both 82-kDa ChAT (i) and SATB1 (j) proteins that were 
co-localized (l,n). Scale bar 5 μm; n = 5 with at least 5 cells imaged for each treatment. 
(B) Cells were pretreated for 3 h with the SIRT1 co-factor NAD+ prior to 4 h treatment 
with 100 nM Aβ1–42. Cells treated with 2.5 mM NAD+ had multiple nuclear aggregates 
of both 82-kDa ChAT and SATB1 (a-g). Cells treated with 5 mM NAD+ had larger, 
more diffuse aggregates of 82-kDa ChAT and SATB1. n = 3 with at least 5 cells imaged 
for each treatment. (C) Cells were pretreated with the SIRT1 inhibitor EX527 for 1 h 
prior to 4 h treatment with vehicle (a–e) or 100 nM oligomeric Aβ1–42 (f–j). Pretreatment 
of cells with EX527 prior to Aβ-exposure prevented the formation of 82-kDa ChAT 
aggregates (k). n = 5, ***p < 0.001 (one-way ANOVA).  
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and non-targeted control siRNA (1.13 ± 0.07), we observed a 29% reduction in SATB1 
protein levels after transfection of cells with SATB1 siRNA for 24 h (0.76 ± 0.06) (Fig. 
3-6A). This resulted in a significant reduction in SATB1 steady-state protein levels 
compared to untransfected, mock transfected and control siRNA cells. We next counted 
the percentage of cells that had at least one nuclear aggregate in cells that were treated 
with either vehicle for 4 h, 100 nM Aβ1-42 for 4 h or 50 μM resveratrol for 5 h (Fig. 3-6B). 
We found no significant differences for non-transfected cells (26 ± 2%), cells transfected 
with control siRNA (26 ± 4%), or transfection with SATB1 siRNA (26 ± 3%) in vehicle-
treated cells. For cells that were treated with Aβ1-42, transfection with SATB1 siRNA 
significantly reduced the number of 82-kDa ChAT aggregates observed to 37 ± 3% 
compared to cells that were non-transfected (60 ± 7%) or cells transfected with control 
siRNA (60 ± 2%). Surprisingly, after resveratrol treatment we observed no significant 
differences for SATB1 siRNA transfected cells (50 ± 8%) compared to control siRNA 
(57 ± 4%) or non-transfected (55% ± 3%) cells.  
Representative images can be found in Figure 3-7 for cells treated for 4 h with 
100 nM Aβ1-42 (A) or for 5 h with 50 uM resveratrol (B) after SATB1 siRNA 
transfection. Treatment with Aβ1-42 resulted in aggregates of both 82-kDa ChAT and 
SATB1 (Fig. 3-7A[a-e], white arrows) or 82-kDa ChAT only (orange arrows). These 
aggregates were also observed when cells were transfected with non-specific control 
siRNA (Fig. 3-7A[f-j]). In agreement with the data from cell counting experiments, when 
cells were transfected with SATB1 siRNA and then treated with Aβ1-42 we observed only 
a few cells that contained aggregates (Fig. 3-7A[k-o]). Interestingly, these were 
aggregates of 82-kDa ChAT only (orange arrows). Similar to Figure 3-5, when we 
treated cells with 50 uM resveratrol we observed multiple nuclear aggregates of both 82-
kDa ChAT and SATB1 (Fig. 3-7B[a-e], white arrows), or 82-kDa ChAT only (orange 
arrows). We also observed these aggregates when cells were transfected with control 
siRNA (Fig. 3-7B[f-j]). Finally, when we treated cells with SATB1 siRNA followed by 
resveratrol treatment, we observed multiple aggregates of 82-kDa ChAT alone (Fig. 3-
7B[k-o], orange arrows), with very few aggregates of both 82-kDa ChAT and SATB1 
(white arrows).  Together with the cell counting data, these data indicate that SATB1 is 
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Figure 3-6. SATB1 siRNA knockdown alters 82-kDa ChAT and SATB1 Aβ-induced 
nuclear aggregate formation 
(A) Representative immunoblot showing SATB1 steady-state protein levels in SH-SY5Y 
cells stably expressing 82-kDa ChAT and either non-transfected, mock transfected with 
no siRNA, transfected with untargeted control siRNA, or transfected with siRNA 
targeted to SATB1 for 24 h. Quantification revealed a 29% reduction in SATB1 protein 
expression compared to controls. n = 5, **p < 0.01, *p < 0.05 (one-way ANOVA with 
Tukey’s post hoc test). (B) SH-SY5Y cells stably expressing 82-kDa ChAT were either 
non-transfected, transfected with untargeted control siRNA, or transfected with siRNA 
targeted to SATB1 for 24 h, followed by either 100 nM oligomeric Aβ1–42 for 4 h or 
50 μM resveratrol for 5 h. The number of cells positive for nuclear aggregates of 82-kDa 
ChAT were quantified by a blinded observer as a percentage of the total number of cells 
counted. After Aβ1–42 exposure, the percentage of 82-kDa ChAT aggregates were 
significantly reduced after SATB1 siRNA knockdown compared to non-transfected or 
control siRNA transfected cells. We observed no significant differences for resveratrol or 
vehicle treatment. n = 3 independent experiments with at least 100 cells counted per 
treatment group, ***p < 0.001, *p < 0.05 (two-way ANOVA with Bonferroni’s post hoc 
test). 
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Figure 3-7. SATB1 siRNA knockdown prevents Aβ-induced, but not resveratrol-
induced, 82-kDa ChAT aggregate formation in nuclei. 
(A) SH-SY5Y cells stably expressing 82-kDa ChAT were either non-transfected, 
transfected with untargeted control siRNA, or transfected with siRNA targeted to SATB1 
for 24 h, followed by treatment with 100 nM Aβ1-42 for 4 h. Cells that were not 
transfected with siRNA (a-e) or that were transfected with control siRNA (f-j) had 
aggregates of 82-kDa ChAT that were induced by Aβ1-42 treatment that overlapped with 
SATB1 aggregates (white arrows; orange arrows indicate 82-kDa ChAT aggregate only). 
For cultures that were transfected with SATB1 siRNA, there were few cells with 
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aggregates of 82-kDa ChAT protein and no SATB1 aggregates (k-o). For these 
experiments, n = 3 with at least 100 cells imaged per treatment. (B) SH-SY5Y cells 
stably expressing 82-kDa ChAT were either non-transfected, transfected with untargeted 
control siRNA, or transfected with siRNA targeted to SATB1 for 24 h, followed by 50 
µM resveratrol for 5 h. Cells that were not transfected with siRNA (a-e) or that were 
transfected with control siRNA (f-j) contained Aβ1-42-induced aggregates of 82-kDa 
ChAT that overlapped with SATB1 aggregates (white arrows; orange arrows indicate 82-
kDa ChAT aggregate only). Cells that were transfected with SATB1 siRNA contained a 
similar number of aggregates of 82-kDa ChAT, but these aggregates did not overlap with 
SATB1 (k-o). For these experiments, n = 3 with at least 100 cells imaged per treatment, 
scale bar = 10 µm. 
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required for the Aβ1-42-induced aggregates. In addition, SIRT1 activation can produce 
aggregates of 82-kDa ChAT, but this is not dependent on SATB1 expression. 
  
82-kDa ChAT and SATB1 associate with chromatin at synapse and cell stress genes 
82-kDa ChAT and SATB1 proteins are co-localized after cells are exposed to Aβ, 
therefore we performed ChIP-seq for SATB1 as a comparison to 82-kDa ChAT (Fig. 3-
8). We found 2884 peaks for SATB1 after vehicle treatment, and 5857 peaks for SATB1 
after Aβ1-42 treatment, with 36 peaks overlapped and 35 additional peaks within 200 nt of 
one another. Similar to 82-kDa ChAT, we observed that 57.1% of peaks were found in 
intergenic regions after vehicle treatment for SATB1, compared to 44.4% after Aβ1-42-
exposure. Moreover, the decrease in intergenic regions after exposure of cells to Aβ1-42 
was explained by an increase in peaks found in introns (47.3%) and promoters (12.6%) 
compared to vehicle (37.9% and 7.6%, respectively). We again observed that the average 
peak length was significantly reduced after Aβ1-42 treatment for SATB1 (146.6 ± 2.2 nt) 
compared to vehicle treatment (173.9 ± 4.9 nt) (Fig. 3-8A). Using the DREME tool, we 
observed that both vehicle and Aβ1-42 treatment of cells resulted in the same TC2-3AT 
motif seen in the 82-kDa ChAT samples (Fig. 3-8B). In addition, peaks for SATB1 from 
cells treated with either vehicle or Aβ1-42 contained the SATB1 motif (A/T)3-nC(A/T)3-6 
seen in the Aβ-exposed 82-kDa ChAT sample. Examples of ChIP-seq tracks from 
random genomic targets for SATB1 at GAB2 and MAGI2 genes and treated with either 
vehicle or Aβ are shown in Fig. 3-8C. We identified no relationship between the peaks 
for SATB1 and H3K27ac. Additional tracks can be found in Figure 3-9 for chromosomes 
1, 7 and 10, the full GAB2 and MAGI2 genes, as well as a region of the APP gene for 
SATB1 (see Fig 2-5 for 82-kDa ChAT). Chromosomes 7 and 10 showed large peaks for 
SATB1 flanking the centromeres that overlapped the 82-kDa ChAT peaks (Fig. 3-9A).  
Based on the observed relationship for both 82-kDa ChAT and SATB1 at the 
centromeres, we extended the analysis to determine if there was enrichment of 82-kDa 
ChAT and SATB1 at either centromeres or telomeres. Enrichment was defined as a peak  
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Figure 3-8. SATB1 has altered genome association after exposure of cells to Aβ. 
(A) ChIP-seq analysis was performed for SATB1 using SH-SY5Y cells stably expressing 
82-kDa ChAT and exposed to either vehicle or 100 nM oligomeric Aβ1-42. Genomic 
features identified for SATB1. Aβ treatment increases SATB1 association with introns 
and promoters. Treatment with Aβ1-42, significantly decreased average peak length for 
SATB1. ***p < 0.001 (Student’s t-test). (B) The top DREME motif hits for SATB1 after 
vehicle or Aβ1-42-exposure revealed a TC2-3AT motif, and a known SATB1 binding 
motif. (C) Example ChIP-seq tracks for SATB1 after vehicle or Aβ1-42-exposure of cells 
for regions of GAB2 and MAGI2 genes corresponding to the same regions in Fig. 2C. 
Peaks are highlighted in green for Aβ1-42 peaks. There were no vehicle related peaks in 
these regions. H3K27Ac is overlaid to show active transcription initiation sites. 
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Figure 3-9. Examples of ChIP-seq tracks for SATB1. 
(A) ChIP-seq tracks for chromosomes 1, 7 and 10 for SATB1 in cells treated with either 
vehicle or Aβ1-42. For chromosome 1, there was a portion of data not covered at the start 
of the q-arm. No other chromosome had a gap in data coverage. For chromosomes 7 and 
10, there was a large peak of coverage flanking the centromeres. (B) ChIP-seq tracks for 
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GAB2 and MAGI2 whole genes, as well as for a region of APP, for SATB1 in cells 
treated with either vehicle or Aβ1-42. Peaks are highlighted in green for SATB1 Aβ1-42 
peaks and purple for SATB1 vehicle peaks. H3K27Ac is overlayed to show active 
transcription initiation sites.  
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region with at least 20% of the maximum peak intensity normalized to input values and 
with a false discovery rate (FDR) < 0.05, as described (Zhao et al. 2015). Given that 
chromatin organizers, such as CCCTC-binding insulator protein (CTCF) and SATB1, 
have been shown to organize chromatin loops into large megabase pair (Mb) wide 
regions (Kumar et al. 2007; Junier et al. 2012), we defined flanking regions of 
centromeres or telomeric association as 1 Mb from the centromere start site or the end of 
the chromosome, respectively. Based on these criteria, we observed that 13 chromosomes 
had p arm centromere association, 10 chromosomes that had q arm association, and 9 
chromosomes had peaks within the centromere (Table 3-2). Only chromosomes 6, 11 and 
X had no centromeric association for either 82-kDa ChAT or SATB1.  By contrast, only 
8 chromosomes had telomeric association for either protein. In most cases, the peaks 
overlapped for both proteins and were not affected by treatment with either vehicle or 
Aβ1-42. There were a few exceptions to this; on chromosome 7, there was enrichment 
within the centromere for all treatments except for SATB1 after cells were treated with 
vehicle. On chromosome 13, associations within the centromeres was observed for 82-
kDa ChAT after vehicle or Aβ1-42-exposure, but not for SATB1. Finally, on chromosome 
17 there was enrichment within the centromere for all treatments except for 82-kDa 
ChAT after cells were treated with Aβ1-42. Taken together, these data suggest that both 
82-kDa ChAT and are enriched at centromeres, with some telomeric associations. 
We next annotated peaks contained in intergenic components for SATB1 and 
compared these to the gene annotations for 82-kDa ChAT. We found that, similar to the 
gene annotations for 82-kDa ChAT, there was a higher number of associated genes after 
exposure of cells to Aβ1-42 for SATB1 (4672) compared to vehicle treatment (3700 and 
2615, respectively) (Fig. 3-10A). An important finding was that there were more genes in 
common between 82-kDa ChAT and SATB1 after exposure of cells to Aβ1-42 (885) than 
there were for common genes for either 82-kDa ChAT (820) or SATB1 (617) in either of 
the conditions. We found 138 genes associated with all treatments. We next evaluated 
what functional groups the genes were associated with using the DAVID server. For 
SATB1, there were no significant gene ontology (GO) terms (defined as p < 1.0E-05 and 
–log(FDR) > 1.5) for vehicle treated cells (Appendix 7), but for Aβ (Appendix 8), we 
found significant GO enrichment for nucleotide (p = 8.45E-08, -log(FDR) = 3.9) and  
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Table 3-2. Centromere (C) and Telomere (T) enrichment for 82-kDa ChAT and 
SATB1 ChIP-seq. (?) indicates missing or incomplete data. 
  
 
Chromosome  
82-kDa ChAT 
(Vehicle) 
82-kDa ChAT  
(Aβ) 
SATB1  
(Vehicle) 
SATB1  
(Aβ) 
C T C T C T C T 
1 (?) p arm (?) p arm (?) p arm (?) p arm 
2 p arm 
q arm 
 
-- 
p arm 
q arm 
 
-- 
p arm 
q arm 
 
-- 
p arm 
q arm 
 
-- 
3 q arm -- q arm -- q arm -- q arm -- 
4 p arm 
within 
q arm 
 
 
-- 
p arm 
within 
q arm 
 
 
-- 
p arm 
within 
q arm 
 
 
-- 
p arm 
within 
q arm 
 
 
-- 
5 within -- within -- within -- within -- 
6 -- -- -- -- -- -- -- -- 
7 p arm 
within 
q arm 
 
 
p arm 
p arm 
within 
q arm 
 
 
p arm 
 
p arm 
q arm 
 
 
p arm 
p arm 
within 
q arm 
 
 
p arm 
8 p arm -- p arm -- p arm -- p arm -- 
9 p arm 
(?) q arm 
 
q arm 
p arm 
(?) q arm 
 
q arm 
p arm 
(?) q arm 
 
q arm 
p arm 
(?) q arm 
 
q arm 
10 within 
q arm 
 
-- 
within 
q arm 
 
-- 
within 
q arm 
 
-- 
within 
q arm 
 
-- 
11  
-- 
q arm 
(?) p arm 
 
-- 
q arm 
(?) p arm 
 
-- 
q arm 
(?) p arm 
 
-- 
q arm 
(?) p arm 
12 within -- within -- within -- within -- 
13 p arm 
within 
 
q arm 
p arm 
within 
 
q arm 
 
p arm 
 
q arm 
 
p arm 
 
q arm 
14 p arm -- p arm -- p arm -- p arm -- 
15 p arm 
q arm 
 
-- 
p arm 
q arm 
 
-- 
p arm 
q arm 
 
-- 
p arm 
q arm 
 
-- 
16 p arm -- p arm -- p arm -- p arm -- 
17 p arm 
within 
 
-- 
 
p arm 
 
-- 
p arm 
within 
 
-- 
p arm 
within 
 
-- 
18 q arm p arm -- p arm q arm p arm q arm p arm 
19 p arm 
within 
 
-- 
p arm 
within 
 
-- 
p arm 
within 
 
-- 
p arm 
within 
 
-- 
20 within 
q arm 
 
-- 
within 
q arm 
 
-- 
within 
q arm 
 
-- 
within 
q arm 
 
-- 
21 p arm 
q arm 
 
-- 
p arm 
q arm 
 
-- 
p arm 
q arm 
 
-- 
p arm 
q arm 
 
-- 
22 p arm 
within 
 
q arm 
p arm 
within 
 
q arm 
p arm 
within 
 
q arm 
p arm 
within 
 
q arm 
X -- -- -- -- -- -- -- -- 
Y q arm q arm q arm q arm q arm q arm q arm q arm 
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Figure 3-10. 82-kDa ChAT and SATB1 associate with shared cell membrane and 
stress related genes after Aβ-exposure. 
(A) Number of genes associated with ChIP-seq peaks for 82-kDa ChAT and/or SATB1 
after treatment of cells with vehicle or 100 nM oligomeric Aβ1-42. There was increased 
gene association between the proteins after exposure of cells to Aβ. (B) Gene ontology 
analysis for groups of gene associations found by ChIP-seq. 82-kDa ChAT and SATB1 
had significant associations with genes encoding proteins involved in synapse function, 
cell adhesion and cell membrane function with both treatments. For genes associated with 
both 82-kDa ChAT and SATB1 after exposure to Aβ1-42, there were significant gene 
associations for nucleoside binding and programmed cell death (box). Gene ontology 
terms are presented with the -log value of the FDR. 
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ATP-binding (p = 1.01E-07, -log(FDR) = 3.8), zinc (p = 3.88E-06, -log(FDR) = 2.2) and 
zinc-finger (p = 1.16E-05, -log(FDR) = 1.8), nucleus (p = 8.11E-07, -log(FDR) = 2.9), 
and homophilic cell adhesion (p = 6.93E-07, -log(FDR) = 2.9). We also explored GO 
enrichment for genes that were found in more than one condition (Fig. 3-10B, 
Appendices 9-11). After exposure of cells to Aβ1-42, we found significant GO terms 
related to nucleoside binding (p = 3.63E-12, -log(FDR) = 8.3), synapse (p = 1.42E-07, -
log(FDR) = 3.7), and cell projection (p = 1.00E-05, -log(FDR) = 1.8) for both 82-kDa 
ChAT and SATB1 (see Appendices 9,10 for additional significant GO terms). Similarly, 
we found synapse, membrane and cell adhesion GO terms for SATB1 and 82-kDa ChAT 
regardless of treatment with either vehicle or Aβ1-42 (Appendix 11). We also found the 
GO term regulation of programmed cell death (p = 6.15E-05, -log(FDR) = 2.9) for both 
82-kDa ChAT and SATB1 after Aβ-exposure. Similar to 82-kDa ChAT, we also found 
peaks for SATB1 in several APP binding and metabolism related genes (Table 3-3). Of 
interest, APP had peaks for both 82-kDa ChAT and SATB1 only after exposure of cells 
to Aβ1-42. 
 
82-kDa ChAT and SATB1 are associated with APP, leading to altered gene expression 
To validate peaks found within the ChIP-seq dataset, we chose to examine a peak 
found after exposure of cells to Aβ1-42 for both SATB1 and 82-kDa ChAT on the APP 
gene at intron 13 (Table 3-3), that were within 160 nt of one another. APP has previously 
been found to have altered transcription in AD patients following transcriptome analysis 
(Karim et al. 2014), and after MAPK activation by anisomycin in SH-SY5Y cells (Guo et 
al. 2011). Combined with recent evidence demonstrating that 82-kDa ChAT is implicated 
in alterations in APP processing (Albers et al. 2014), we identified APP as a potential 
target for an 82-kDa ChAT/SATB1 S/MAR. Using the in silico MAR-Wiz S/MAR 
prediction tool (Singh et al. 1997), we identified a predicted S/MAR ~55 kb upstream of 
the 3′ end of APP that was ~2 kb upstream of the ChIP-seq peaks (Fig. 3-11A). Pathak et 
al. (2014) identified DNA associated with nuclear matrix S/MARs from D. melanogaster  
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Table 3-3. APP-interacting genes with 82-kDa ChAT and/or SATB1 association by 
ChIP-seq 
 
. 
  
 
Gene 
 
Function 
82-kDa ChAT 
(Vehicle) 
SATB1 
(Vehicle) 
82-kDa 
ChAT (Aβ) 
SATB1 
(Aβ) 
Microarray 
fold change  
ADAM10 Alpha secretase 
proteolytic cleavage of 
APP 
 
Intron 1 
 
-- 
 
Intron 14 
 
-- 
 
2.4 
ADAM12 matrix 
metalloproteinase, 
multiple catalytic targets 
 
Intron 3 
 
-- 
 
Intron 2 
 
-- 
 
n/a 
ADAM17 MAP-kinase signalling, 
APP cleavage 
 
Intron 1 
 
-- 
 
-- 
 
-- 
 
1.2 
APBA2 
(x11β) 
signal transduction, APP 
binding  
 
-- 
 
Intron 3 
 
Promoter 
 
-- 
 
2.2 
APBB1 APP binding, involved in 
APP signaling 
 
Promoter 
 
-- 
 
-- 
 
Intron 1 
 
n/a 
APBB2 APP binding, involved in 
signaling 
 
Intron 1 
 
-- 
 
Intron 6 
 
Intron 10 
 
n/a 
APP β-amyloid precursor, 
synapse maintenance 
 
-- 
 
-- 
 
Intron 13 
 
Intron 13 
 
n/a 
APPBP2 Binds to APP 
intracellular domain 
 
Intron 4 
 
-- 
 
-- 
 
-- 
 
1.4 
NAE1 APP binding, can drive 
APP-mediated apoptosis 
 
-- 
 
-- 
 
Intron 7 
 
-- 
 
n/a 
RTN1 Modulates β-secretase 
activity, APP binding 
near cleavage site 
 
 
-- 
 
 
Intron 1 
 
 
Intron 1, 3 
 
 
-- 
 
 
14.8 
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embryos using next generation sequencing (NCBI Sequence Read Archive accession 
number: SRX443533). We identified 3 peaks in the APP homolog App1 associated with 
potential S/MARs, with one peak found in the same region as the ChIP-seq peaks (Fig. 3-
11A). In addition, the region containing the ChIP-seq peaks had several sequence 
similarities with known SATB1 binding motifs (Yasui et al. 2012). We tested for 
enrichment of both SATB1 and 82-kDa ChAT using ChIP followed by quantitative PCR 
(ChIP-qPCR) (Fig. 3-11B). For 82-kDa ChAT, we observed a 1.6 ± 0.5-fold enrichment 
after vehicle treatment, which was significantly higher after Aβ1-42-exposure (9.8 ± 2.9-
fold). We found a 4.9 ± 0.9-fold enrichment for SATB1 after vehicle treatment, compared 
to 2.4 ± 0.5-fold after exposure of cells to Aβ1-42, though there was no statistical 
difference between the treatments. 
Next, we used RT-qPCR to assess any potential changes to APP steady-state 
mRNA levels (Fig. 3-12A). Using SH-SY5Y cells stably expressing either 82-kDa ChAT 
or empty vector, we found no significant changes in total APP steady-state mRNA levels 
after exposure for 4 h 100 nM Aβ1-42 (0.96 ± 0.02-fold, 1.00 ± 0.05-fold respectively). 
Several groups have reported that APP mRNA isoforms (including APP751 and 770) 
containing the Kunitz-type serine protease inhibitor domain (APP-KPI) are increased in 
AD patients, which correlates to increases in Aβ1-42 (Moir et al. 1998; Preece et al. 2004). 
Therefore we tested whether there were any Aβ-induced changes in APP-KPI mRNA 
steady-state levels, and observed that there is significantly increased expression of APP-
KPI mRNA steady-state levels in vector-expressing cells (1.18 ± 0.09-fold) compared to 
cells expressing 82-kDa ChAT (0.86 ± 0.03-fold). 
Finally, we assessed whether siRNA knockdown targeted to SATB1 could alter 
steady-state levels of total APP mRNA or the Aβ-induced change in APP-KPI mRNA 
observed in 82-kDa ChAT-expressing cells (Fig. 3-12B). After exposure for 4 h with 
100 nM Aβ1-42, we observed no significant changes in total APP steady-state mRNA 
levels for SH-SY5Y cells stably expressing 82-kDa ChAT after a mock transfection, 
control siRNA or siRNA targeted to SATB1 compared to cells that were not transfected. 
When we measured APP-KPI steady-state mRNA levels, we observed significantly  
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Figure 3-11. 82-kDa ChAT and SATB1 associate with the APP gene after Aβ-
exposure. 
(A) Schematic showing exons (boxes) and introns (horizontal lines) for the D. 
melanogaster Appl and human APP genes. Blue arrows indicate S/MARs regions on Appl 
identified by Pathak et al. (2014), the red arrow a predicted S/MAR in APP by in silico 
analysis, and the black arrow a ChIP-seq peak found for 82-kDa ChAT and SATB1 after 
Aβ1-42-exposure. ATC/ATG rich sequences are highlighted in this region. ChIP-seq 
tracks for 82-kDa ChAT and SATB1 are also shown for this region. (B) Verification of 
82-kDa ChAT and SATB1 ChIP-seq peaks on APP. 82-kDa ChAT showed significantly 
increased fold-enrichment after exposure of cells to 100 nM oligomeric Aβ1-42 for 4 h, 
while SATB1 did not significantly change its association with the region after either 
vehicle or Aβ1-42 treatment. n = 6, **p < 0.01 (two-way ANOVA with Bonferroni’s post-
hoc test). 
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Figure 3-12. 82-kDa ChAT and SATB1 expression prevents an increase in APP 
isoforms containing the Kunitz-protease inhibitor domain (KPI). 
(A) APP steady-state mRNA expression in 82-kDa ChAT or vector-expressing cells after 
exposure to 100 nM oligomeric Aβ1-42. Data are presented as fold-enrichment compared 
to reference (GAPDH) mRNA levels and vehicle-treated cells (dashed-line). Vector-
expressing cells showed higher steady-state mRNA levels of isoforms containing KPI 
compared to 82-kDa ChAT-expressing cells. n = 4, **p < 0.01 (two-way ANOVA with 
Bonferroni’s post-hoc test). (B) APP steady-state mRNA expression in 82-kDa ChAT-
expressing cells after exposure to 100 nM oligomeric Aβ1-42 after either no transfection, a 
mock transfection, transfection with untargeted control siRNA, or transfection with 
siRNA targeted to SATB1. Data are presented as fold-enrichment compared to reference 
(GAPDH) mRNA levels and vehicle-treated cells (dashed-line). There were no 
significant changes in total APP mRNA levels for any of the treatments. (C) Cells 
transfected with SATB1 siRNA showed higher steady-state mRNA levels of APP 
isoforms containing KPI compared to non-transfected 82-kDa ChAT-expressing cells. 
n = 5, ***p < 0.001 (one-way ANOVA with Dunnett’s post-hoc test). 
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increased expression of APP-KPI levels in cells expressing 82-kDa ChAT and transfected 
with SATB1-targeted siRNA (1.14 ± 0.01-fold) compared to non-transfected cells 
(0.88 ± 0.05-fold) (Fig. 3-12C). There were no significant differences for mock 
transfected cells (0.91 ± 0.03-fold) or control siRNA transfected cells (0.95 ± 0.03-fold) 
compared to non-transfected cells. 
 
82-kDa ChAT and SATB1 associate with chromatin at S/MARs 
Because SATB1 is involved in the anchoring of S/MARs to the nuclear matrix, 
and we showed that both SATB1 and 82-kDa ChAT associated with a predicted S/MAR 
on APP, we asked whether 82-kDa ChAT may also be localized at S/MARs. We used 
motifs used by the in silico MAR-Wiz tool (Singh et al. 1997), along with known SATB1 
motifs (Yasui et al. 2002) and select motifs discovered in the D. melanogaster S/MAR 
dataset (Pathak et al. 2014; Table 3-4). In addition to the analysis of 82-kDa ChAT and 
SATB1, we also included a ChIP-seq dataset for Alpha Thalassemia/Mental Retardation 
Syndrome X-Linked (ATRX) (NCBI GEO database accession number: GSE22162; Law 
et al. 2010), as this protein is involved in chromatin reorganization, but has not 
previously been associated with S/MARs (Law et al. 2010; Kernohan et al. 2014; Levy et 
al. 2015). ATRX had a total of 6368 peaks, with an average peak length of 483.4 ± 2.4 nt. 
Due to the large differences in peak lengths, we examined the number of motifs found in 
each peak weighted by the inverse of the peak length divided by a scaling factor of 100 
(Fig. 3-13). Overall, we found that ATRX (0.9 ± 0.002%) had significantly fewer 
weighted motifs/peak compared to both 82-kDa ChAT and SATB1 after both vehicle and 
Aβ1-42-exposure. Surprisingly, after Aβ1-42 treatment of cells, SATB1 (1.4 ± 0.007%) was 
also significantly reduced compared to all treatments other than ATRX. We also tested 
the weighted motifs/peak for the 5 motifs that had the highest number of associated 
peaks. For motifs 1 (an origin of replication motif) and 20–21 (SATB1 motifs), we saw a 
similar pattern as the overall data, indicating that 82-kDa ChAT and SATB1 peaks 
significantly associated with genomic regions containing S/MAR binding sites. 
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Table 3-4. Motifs used in S/MAR analysis 
 
Motifs 1-18 were used previously to determine S/MAR association (Singh et al. 1997), 
motifs 19-21 are SATB1 binding motifs (Yasui et al. 2002) and motifs 22-26 were 
identified in a D. melanogaster S/MAR study (Pathak et al. 2014). 
  
Number  Name  Motif  
1  Origin of Replication Signal 1  ATTA  
2  Origin of Replication Signal 2  ATTTA  
3  Origin of Replication Signal 3  ATTTTA  
4  TG-Rich Signal 1  TGTTTTG  
5  TG-Rich Signal 2  TGTTTTTTG  
6  TG-Rich Signal 3  TTTTGGGG  
7  Curved DNA Signal 1  AAAA(N7)AAAA(N7)AAAA  
8  Curved DNA Signal 2  TTTT(N7)TTTT(N7)TTTT  
9  Curved DNA Signal 3  TTTAAA  
10  Kinked DNA Signal 1  TA(N3)TG(N3)CA  
11  Kinked DNA Signal 2  TA(N3)CA(N3)TG  
12  Kinked DNA Signal 3  TG(N3)TA(N3)CA  
13  Kinked DNA Signal 4  TG(N3)CA(N3)TA  
14  Kinked DNA Signal 5  CA(N3)TA(N3)TG  
15  Kinked DNA Signal 6  CA(N3)TG(N3)TA  
16  mtopo-II Signal  (A/G)N(T/C)NNCNNG(T/C)NG(
G/T)TN(T/C)n(T/C)  
17  dtopo-II Signal  GTN(A/T)A(T/C)ATTNATNN(A/
G)  
18  AT-Rich Signal  (A/T)6  
19  SATB1 Motif 1  (A/T)3-n(C/G)(A/T)3-6  
20  SATB1 Motif 2  (A/T/[C OR G])20+  
21  SATB1 Motif 3  (A/T)2+(C)(A/T)2+; palindrome  
22  Drosophila MAR Motif 1  A12+  
23  Drosophila MAR Motif 2  (AG)8 or (AC)8  
24  Drosophila MAR Motif 3  (AGC)5  
25  Drosophila MAR Motif 4  (AACAGC)2  
26  Drosophila MAR Motif 5  (AAAAA[C/G/T])2  
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Figure 3-13. 82-kDa ChAT and SATB1 have significant enrichment for S/MAR 
motifs. 
Mean weighted S/MAR motifs (Table 3-4)/ChIP-seq peak computed as the number of 
motifs/peak length*100. Both vehicle and Aβ1-42-treated cells for 82-kDa ChAT and 
SATB1 had a higher number of weighted motifs/peak compared to ATRX for all motifs. 
A similar pattern was found for the 5 highest represented motifs. $$$ p < 0.001 compared 
to ATRX, aaa p < 0.001 compared to Aβ1-42-treated SATB1, &&& p < 0.001 compared 
to vehicle-treated 82-kDa ChAT, and ### p < 0.001 and # p< 0.05 compared to vehicle-
treated SATB1.   
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Table 3-5. G-quadraplex (G3+N1-20G3+N1-20G3+N1-20G3+) motifs found in ChIP-seq 
datasets 
 
  
Sample  Peaks with G-Quadraplex 
motifs  
Total G-Quadraplex motifs  
ATRX  732  1327  
82-kDa ChAT (Vehicle)  113  204  
SATB1 (Vehicle)  60  109  
82-kDa ChAT (Aβ)  89  121  
SATB1 (Aβ)  30  41  
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As a control, we also determined the number of motifs in each peak of the ATRX-
binding G-quadruplex motif: G3+N1-20G3+N1-20G3+N1-20G3+ (Table 3-5; Law et al. 2010). 
For ATRX we found 732 peaks with at least one G-quadruplex motif and 1327 motifs 
total. By comparison, for 82-kDa ChAT we found only 113 peaks and 204 motifs after 
vehicle treatment, and 89 peaks with 121 motifs after Aβ1-42-exposure. For SATB1, we 
found 60 peaks and 109 motifs after vehicle treatment, and 30 peaks with only 41 motifs 
after Aβ1-42-exposure. These data indicate that G-quadruplex motifs are enriched in 
ATRX, but not for 82-kDa ChAT or SATB1. 
Pathak et al. (2014) found that the inter-MAR distance in the D. melanogaster 
genome ranged from <1 kb to 150 kb, with an average distance of 16 kb and a peak of 
inter-MAR distances at approximately 5 kb. Due to the potential association with 
S/MARs, we also assessed whether there was any pattern to the spacing between 
successive peaks across each chromosome (Fig. 3-14). We found that the distance 
between peaks for each treatment ranged from <1 kb to 28 Mb, except for ATRX which 
had an upper range of 56 Mb. For 82-kDa ChAT, 75% of peaks were less than 1.4 Mb 
apart after either vehicle or Aβ1-42 treatment of cells. For SATB1, 75% of peaks were less 
than 1.1 Mb apart following Aβ1-42-exposure, with this number increasing to 3.8 Mb after 
vehicle treatment. For ATRX, 75% of peaks were less than 0.5 Mb apart. Through kernel 
density estimation with an upper bound of 4.0 Mb, we found that there were peaks in the 
distributions of the distance between successive peaks, indicative that regular patterned 
spacing was present. For 82-kDa ChAT, the peak occurred at a spacing of 125.0 kb after 
vehicle treatment, and 123.9 kb after Aβ1-42-exposure. We also found regular spacing for 
SATB1 after exposure to Aβ1-42 (92.5 kb) and for ATRX (31.2 kb). Interestingly, we did 
not observe any pattern to the inter-peak distances for SATB1 after vehicle exposure. 
These data show that, after Aβ exposure, both SATB1 and 82-kDa ChAT have regular 
patterned spacing on the genome similar to S/MAR genome spacing. 
As a comparison to the genomic patterned spacing observed for 82-kDa ChAT, 
we tested whether there was patterning to the nuclear protein localization using SR-
GSDIM. Images of 82-kDa ChAT immunostaining in nuclei of vehicle-treated cells by 
either epi-fluorescence or SR-GSDIM microscopy are shown in Figure 3-15[a,b  
133 
 
 
 
Figure 3-14. Analysis of the inter-peak spacing of 82-kDa ChAT and SATB1. 
Distribution of inter-peak distances for ChIP-seq peaks. For each graph, the shape of the 
graph was estimated using a kernel density estimation. Indicated by a single curve, the 
kernel density estimation revealed regular patterned spacing for ATRX and 82-kDa 
ChAT, and for SATB1 after Aβ1–42 cell treatment. SATB1 did not show any patterned 
inter-peak spacing after vehicle treatment.   
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Figure 3-15. 82-kDa ChAT has patterned protein distribution in nuclei of SH-SY5Y 
cells. 
SR-GSDIM imaging for SH-SY5Y cells stably expressing 82-kDa ChAT treated with for 
4 h either vehicle or 100 nM Aβ1-42. Epi-fluorescence images show diffuse staining for 
vehicle-treated cells (a) and nuclear aggregates after Aβ treatment (d). SR-GSDIM 
images show diffuse punctate staining for both vehicle (b) and Aβ (e) treated cells. 
Enlarged ROIs for vehicle-treated cell (c), and a region either outside (f) or within (g) an 
Aβ-induced 82-kDa ChAT aggregate. Scale bars on (b) 3 μm and on (c) 500 nm; n = 6 
with at least 4 cells per treatment. For each ROI, clusters were identified and the average 
inter-cluster distance was quantified (h). Vehicle-treated ROIs or Aβ-induced aggregates 
showed even spacing between clusters (arrows on h), while clusters from ROIs outside an 
aggregate did not show even spacing. Cluster size did not vary significantly for any of the 
conditions (red box on h,i). n = 3 with 2 cells used for each ROI in each condition. 
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respectively], with an enlarged region of interest (ROI, Fig. 3-15[c]). For Aβ-treated 
cells, we observed nuclear aggregates of 82-kDa ChAT when cells were imaged in both 
epi-fluorescence mode (Fig. 3-15[d]) and in SR-GSDIM [e] mode. SR-GSDIM imaging 
showed 82-kDa ChAT predominantly in multimeric clusters in vehicle-treated (Fig. 3-
15[c]) and Aβ-exposed regions not associated with an aggregate (Fig. 3-15[f]), or within 
an aggregate (Fig. 3-15[g]). Using a Fourier transform, we quantified the spacing 
between clusters in these ROIs. Two peaks were apparent in the Fourier analysis (Fig. 3-
15[h]), the first corresponding to the average cluster size and the second indicating 
regular spacing between clusters. We found that in 38% of vehicle-treated cells and in 
10% of regions containing an Aβ-induced aggregate the clusters displayed even spacing, 
while regions in Aβ-exposed cells not associated with an aggregate did not contain any 
regular patterning. In vehicle-treated cells, the peak of inter-cluster distance was found to 
be 145 nm, while in regions containing an Aβ-induced aggregate this distance was 
reduced to 106 nm. We measured the size of the individual clusters and found no 
significant difference in any of the conditions (box on Fig. 3-15[h,i]). 
 
82-kDa ChAT interacts with RNA splicing, nuclear matrix and chromatin organization 
proteins, shown by mass spectrometry  
The 82-kDa ChAT protein interacts with SATB1 to promote the formation of 
S/MARs. Therefore, we asked what other proteins may be in complex with these proteins 
and if this impacts the potential roles for 82-kDa ChAT in gene expression changes after 
cell exposure to Aβ. We identified putative 82-kDa ChAT-interacting proteins by Co-IP 
from nuclear extracts followed by identification of proteins by MALDI-TOF mass 
spectrometry (Fig. 3-16). First, we compared SH-SY5Y cells expressing an empty vector 
to cells having stable heterologous expression of 82-kDa ChAT (Fig. 3-16A). SDS-
PAGE gels resulting from separation of proteins in these samples showed multiple bands 
for 82-kDa ChAT-expressing cells after either vehicle or 100 nM Aβ1-42 treatment, but 
not for vector-expressing cells. As a control, total nuclear lysate samples, each containing 
5 g of protein, were run in parallel for each treatment to ensure that the original samples 
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had similar concentrations of protein per volume. Next, we identified unique bands in 82-
kDa ChAT-expressing samples that were present in vehicle and/or Aβ1-42 treated samples 
and not seen in vector-expressing cells, and sent several of these for protein identification 
by MALDI-TOF (Fig. 3-16B). For this gel, the IP prepared from the vector-expressing 
cells treated with vehicle did not work properly, but the Aβ1-42 treatment did. Since we 
have observed previously that Aβ treatment did not affect the distribution of bands 
present in vector-expressing cells (Fig. 3-16A), we were confident that unique bands seen 
in 82-kDa ChAT expressing samples were specific to those samples.  
Using this approach, we identified 12 unique proteins and the 82-kDa ChAT 
protein itself (Fig. 3-16B, table; Fig. 3-17). Many of the proteins identified were related 
to mRNA splicing and transport, including: DNA helicase II, which is involved in 
transcription and replication, but can also bind to naturally occurring double-stranded 
pre-mRNAs (Tuteja et al. 1994; Zhang and Grosse 1997; Portal et al. 2015); 
heterogeneous nuclear ribonucleoprotein C (C1/C2), isoform CRA_c (HNRNPC) and 
Heterogeneous nuclear ribonucleoproteins A1 and A2/B1 (HNRNPA1/A2B1) are 
involved in pre-mRNA splicing and transport (He and Smith 2009; McCloskey et al. 
2012); M-phase phosphoprotein 4/ interleukin enhancer binding factor 3 (ILF3), which in 
neurons is involved in Tau mRNA transport from the nucleus to the axon (Larcher et al. 
2004); and splicing factor proline- and glutamine-rich (SFPQ), involved in pre-mRNA 
splicing and the formation of the spliceosome complex (Cristobo et al. 2011; Cosker et 
al. 2016; Knott et al. 2016). In the Aβ1-42-treated samples, we also identified pre-RNA 
splicing factor 8 (PRP8), which functions as a nuclear scaffolding for the spliceosome 
complex to form (reviewed in Grainger and Beggs 2005). Though this band was present 
in the vehicle-treated sample, when we tested the sample there were no identifiable 
proteins. In a second repeat of the vehicle-treated samples, we identified Matrin3, a 
nuclear scaffolding protein previously found to interact with 82-kDa ChAT by co-
immunoprecipitation (unpublished data from our lab). Though it is part of the nuclear 
scaffold, Matrin3 has also been demonstrated to play a role in post-transcriptional pre-
mRNA stabilization and the regulation of alternative splicing events (Zeitz et al. 2009; 
Salton et al. 2011; Coelho et al. 2015). Vimentin, a cytosolic scaffolding protein present 
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in developing neurites in cultured hippocampal cells and in hippocampal dendrites of AD 
patients, was also identified (Boyne et al. 1996; Levin et al. 2009).  
Additional proteins identified included heat-shock protein 90 (HSP90), which is 
integral for the stabilization and folding of other proteins (reviewed in Wegele et al. 
2004); and in Aβ1-42-treated samples we identified heat-shock protein 70 or heat shock 
cognate 71 (HSP70/HSC70; MASCOT identification could not distinguish between these 
two proteins) which are both involved in identifying proteins that are incorrectly folded 
and either facilitates their refolding or directs them to the proteasome for degradation 
(Lüders et al. 2000; Wegele et al. 2004). Finally, we found structural maintenance of 
chromosomes protein 1A isoform 1 (SMC1A) in the Aβ1-42-treated sample. SMC proteins 
are involved in chromatin condensation, looping, DNA repair and recombination, and cell 
division in mitotic cells (reviewed in Hirano 2002; and Jessberger 2002). 
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Figure 3-16. 82-kDa ChAT co-immunoprecipitation and identification of interacting 
proteins. 
(A) SH-SY5Y cells were treated for 4 h with either vehicle or 100 nM Aβ1-42 prior to 
nuclear isolation and immunoprecipitation for 82-kDa ChAT. Immunoprecipitated 
proteins were separated by SDS-PAGE and stained with Imperial Protein Stain. Sample 
aliquots containing 5 µg of total nuclear lysate protein were run in parallel ensure that the 
original samples had similar concentrations of protein per volume. Vector-expressing 
cells had a few non-specific bands, while 82-kDa ChAT expressing cells had multiple 
unique bands. (B) Representative gel used for spot picking and mass spectrometry 
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analysis. Bands that were picked and successfully analyzed are numbered. The 
corresponding identified protein is shown in the accompanying table. n.s. = no 
statistically significant protein identified.  
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Figure 3-17. 82-kDa ChAT protein interactions as revealed by mass spectrometry 
analysis. 
Potential interacting proteins as revealed by immunoprecipitation for 82-kDa ChAT in 
SH-SY5Y cells treated for 4 h with either vehicle or 100 nM Aβ1-42. Mass spectrometry 
analysis found several proteins related to RNA splicing and transport. Other proteins 
included chromatin remodelling, transcription, scaffolding, and protein maintenance 
related proteins. * protein was identified in vehicle-treated samples only; ** protein was 
found in Aβ1-42-treated samples only   
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3.4 Discussion 
 
In this chapter, we demonstrated that both 82-kDa ChAT and SATB1 facilitate 
and participate in an epigenetic response at S/MARs in human neural cells. Specifically, 
we found that (1) 82-kDa ChAT and SATB1 co-localize in cell nuclei after Aβ1–42 
treatment of cells; (2) the presence of Aβ-induced aggregates of 82-kDa ChAT and 
SATB1 in cell nuclei are dependent on the presence of both proteins; (3) SATB1 had a 
similar genomic distribution as 82-kDa ChAT, and increased its association with gene 
introns and promoters at synapse and membrane associated genes after cells were 
exposed to Aβ1–42; (3) 82-kDa ChAT and SATB1 are both necessary to prevent an 
increase in an isoform of APP after treatment of cells with Aβ1–42;  (4) 82-kDa ChAT and 
SATB1 are associated with S/MARs and have features of chromatin organizers; and (5) 
82-kDa ChAT associates with RNA splicing/transport and chromatin organization-related 
proteins, identified by mass spectrometry. 
When we observed the subcellular localization of 82-kDa ChAT and SATB1 after 
exposure of cells to oligomeric Aβ1-42, we determined that SATB1 formed aggregates in 
nuclei that were co-localized with the ChAT aggregates. We were unable to determine 
whether 82-kDa ChAT and SATB1 were directly interacting by Co-IP due to technical 
difficulties with this approach in this situation. Further investigation by both Co-IP and 
other methods (i.e. Förster or bioluminescence resonance energy transfer) could help 
clarify whether these proteins can interact directly. It is an interesting observation that 
these Aβ1-42-induced aggregates are dependent on the presence of both 82-kDa ChAT and 
SATB1 in nuclei and that both SIRT1 activation and exposure of cells to Aβ result in 
SATB1 entry into the nuclear interior, but that 82-kDa ChAT aggregates can be produced 
independently by resveratrol treatment. Resveratrol is known to increase SIRT1 activity 
(Ye et al. 2013), but also increases mitochondrial activity through PGC-1alpha activity 
(Lagouge et al. 2006), promotes the oxidative stress response via induction of manganese 
superoxide dismutase (Tanno et al. 2010), and may have both anti- and pro-oxidant 
properties (Roemer and Mahyar-Roemer 2002; Ahmad et al. 2003). Though Xue et al. 
(2012) showed that SIRT1 deacetylates SATB1 to promote the formation of S/MARs at 
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the β-globulin locus, SIRT1 is a histone and protein deacetylase which has several other 
non-SATB1 targets (Brunet et al. 2004; Stünkel et al. 2007; Liu et al. 2009). A further 
possible explanation for the resveratrol-induced aggregates after SATB1 siRNA 
knockdown is that we were only able reduce SATB1 levels by 29%. While this was 
sufficient to reduce AB-induced 82-kDa ChAT aggregation, it may not be a large enough 
SATB1 reduction to affect the resveratrol-induced aggregates. Whether the 82-kDa 
ChAT aggregates are related to an anti-oxidant response, what other SIRT1 targets could 
be contributing to 82-kDa ChAT nuclear aggregation, or whether further reductions in 
SATB1 could alter the resveratrol-induced 82-kDa ChAT aggregation requires further 
investigation.    
When we analyzed ChIP-seq datasets for 82-kDa ChAT and SATB1, we saw 
several similarities including increases in promoter and intragenic targets. We observed 
that both proteins had smaller peak lengths after exposure to Aβ1-42 (~130 nt after AB 
compared to ~190 nt after vehicle treatment for 82-kDa ChAT; ~145 nt after AB 
compated to ~175 nt after vehicle treatment for SATB1), which suggests targeted 
genomic associations as small peak lengths (~50-150 nt) are associated with sequence-
specific DNA targets and is a signature of transcription-factor binding (Pepke et al. 
2009). We observed that 82-kDa ChAT and SATB1 have associations with sequences 
that are enriched with S/MAR binding motifs, in particular SATB1 binding motifs and an 
origin of replication sequence. In addition, we also observed the same partial NFAT TC2-
3AT motif after both vehicle and Aβ1–42-treatment of cells for SATB1 as observed for 82-
kDa ChAT, further supporting the hypothesis that these proteins may form a complex. 
However, there were also important differences between the datasets. For 82-kDa ChAT 
there were a similar number of peaks after vehicle or Aβ-exposure, but for SATB1 there 
were more than double the number of associations found after Aβ-exposure. In addition, 
we found no significant GO terms for genes associated with 82-kDa ChAT after cells 
were treated with vehicle or Aβ alone, but for SATB1 after Aβ-exposure we found GO 
enrichment for several terms including nucleotide, ATP-binding, zinc and cell adhesion. 
Interestingly, however, when we considered genes that were found associated with either 
multiple treatments or multiple proteins, we found significant GO terms related to the 
synapse and membrane. This observation, combined with the DREME motif analysis 
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showing that both SATB1 and 82-kDa ChAT are enriched for multiple shared motifs, 
supports the hypothesis that 82-kDa ChAT and SATB1 may be forming a complex 
together with other proteins. 
It is important to note that this is the first report of whole genome ChIP-
sequencing in any cell type for either SATB1 or 82-kDa ChAT. Previously, only locus 
specific ChIP or chromatin conformation capture (3C) studies have been published for 
SATB1 (Kumar et al. 2007; Li et al. 2007; Gong et al. 2010; Fessing et al. 2011; Gong et 
al. 2011; Xue et al. 2012; Yang et al. 2015), and to the author’s knowledge no other 
studies have reported that 82-kDa ChAT associates with DNA. There are a number of 
novel genome-wide patterns that have been observed from these datasets that provide 
valuable information on the nature of these protein-DNA interactions. For example, we 
observed that a subset of the genome associations for 82-kDa ChAT had regular 
patterned spacing and, at the nano-resolution level, that 82-kDa ChAT forms patterned 
clusters with the distance between clusters decreasing after Aβ-exposure. We found a 
subset of SATB1 genome associations with regular patterned spacing after cells were 
exposed to Aβ1-42, but not for vehicle-treated cells. Patterned spacing on the genome has 
been previously reported for chromatin organizers, and is a feature of S/MARs on the D. 
melanogaster genome (Pathak et al. 2014). These data are especially interesting in light 
of the centromeric associations seen for both 82-kDa ChAT and SATB1.    
When we analyzed ChIP-seq patterns for 82-kDa ChAT and SATB1, it was 
evident that both proteins were highly-enriched in regions flanking the centromere, and in 
some cases within the centromere as well. Further, we found 82-kDa ChAT associated 
with SMC1A by Co-IP and mass spectrometry; SMC1A is involved in chromatin 
condensation and looping, as well as cell division (Hirano 2002; Jessberger 2002). 
Centromeres tend to be largely enriched with heterochromatin, with further condensation 
occurring during mitosis (Guenatri et al. 2004; Nakano et al. 2008). In post-mitotic cells, 
the centromere must remain heterochromatic for the entire lifespan of the cell, but cell 
cycle re-entry has been observed in neurons in brain of Alzheimer’s disease (AD) 
patients (McShea et al. 1997; Nagy et al. 1997). Further, neurons can undergo a 
senescence-like phenotype where they have been observed to re-enter the cell cycle 
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(Spremo-Potparević et al. 2008). In these cells, the centromere of the X-inactivated 
chromosome also becomes activated (Spremo-Potparević et al. 2008), though our data 
did not test the X-inactivated chromosome as SH-SY5Y cells were derived from a male.  
Several studies have demonstrated that ChIP-seq data can falsely identify 
centromere enrichment due to the presence of multiple tandem non-specific A/T-rich 
repeats (Nix et al. 2008; Teytelman et al. 2013). This is unlikely the case in our ChIP-seq 
dataset, as DNA input levels were subtracted from the data, enrichment was not found 
equally across all the centromeres, and on most chromosomes the enrichment was found 
in non-repeat rich centromere flanking regions. Further, a common theme found for both 
82-kDa ChAT and SATB1 was association with A/T-rich motifs (including multiple A/T-
rich S/MAR motifs), both in genic and non-genic regions.  Enrichment of 82-kDa ChAT 
and SATB1 near these regions may be significant for the cessation of cell division, and 
thus further investigation should assess the contributions of 82-kDa ChAT and SATB1 to 
centromere organization. 
The present study found that 82-kDa ChAT and SATB1 are both enriched at an in 
silico predicted S/MAR on the APP gene after exposure of cells to Aβ1-42. While APP 
mRNA expression is altered in AD patients (Rockenstein et al. 1995; Karim et al. 2014), 
and increased after MAPK activation by anisomycin in SH-SY5Y cells (Guo et al. 2011), 
other studies suggest that there may be an increase in the isoforms that contain KPI in AD 
patients (Moir et al. 1998; Preece et al. 2004). These studies show that total APP mRNA 
steady-state levels are unchanged, but this alternative expression pattern correlates to an 
increase in soluble Aβ1-42 and to severity of cognitive impairment (Moir et al. 1998; 
Preece et al. 2004). We found previously that total APP mRNA steady-state levels were 
not changed when 82-kDa ChAT was expressed in primary neurons from APP/PS1 mice 
(Albers et al. 2014). Our current findings complement these studies, as we demonstrate 
that cells expressing 82-kDa ChAT have lower steady-state levels of KPI-containing 
isoforms of APP compared to vector-expressing cells, with no change in total APP 
mRNA levels. The change in APP-KPI was prevented when we used siRNA targeted to 
SATB1, demonstrating that SATB1 is also necessary for this change in gene expression. 
We postulate that expression of 82-kDa ChAT protein may contribute to preventing the 
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increased production of these KPI-containing isoforms in neurons after exposure to 
environmental stress, with this potentially disrupted when the subcellular localization of 
82-kDa ChAT is altered in aging, MCI or AD (Gill et al. 2007). It is important to note 
that the KPI-containing APP mRNA isoform is alternatively spliced to include exon 7 
(Sandbrink et al. 1994), while 82-kDa ChAT and SATB1 bind to a region in intron 13. 
While a linear genomic relationship between these two regions is unlikely, it is possible 
that SATB1/82-kDa ChAT-mediated loops could bring these regions close together. It 
will be important for future studies to understand how chromatin may be organized in 
these regions, in order to elucidate how the interaction of SATB1 and 82-kDa ChAT may 
influence the steady-state mRNA levels of APP-KPI. 
Though preliminary, the mass spectrometry results exploring proteins that may 
interact with 82-kDa ChAT provide valuable insight into the potential roles for the 
protein at chromatin. For example, an interaction with SMC1A may further support the 
hypothesis that 82-kDa ChAT associates with centromere and peri-centromere regions, as 
discussed above. It is interesting that 82-kDa ChAT could associate with many RNA 
splicing, spliceosome, and RNA transport proteins. RNA splicing occurs both temporally 
and spatially with transcription, and is regulated with RNA and spliceosome-binding 
proteins (Reviewed by Braunschweig et al. 2013). If 82-kDa ChAT associates with 
chromatin near spliceosomes, it could alter how pre-mRNAs are processed. Alternatively, 
changes to chromatin looping could alter how the transcript is produced. This could 
provide one potential explanation for the reduction in the APP-KPI isoform in 82-kDa 
ChAT-expressing cells after cells are exposure to Aβ. The 82-kDa ChAT protein and 
SATB1 protein are only associated with the APP gene after Aβ-exposure, and the 
resulting chromatin structural changes could restrict long-range access to the KPI-specific 
exon 7. Further, the nuclear spliceosome complex is anchored to the nuclear matrix 
(Bisotto et al. 1995; Coelho et al. 2015), and thus the 82-kDa ChAT association with 
RNA splicing proteins may be a result of an interaction with the nuclear matrix protein 
Matrin3 found in our mass spectrometry screen. Matrin3 has is involved in the regulation 
of alternative splicing (Coelho et al. 2015), and was found by co-immunoprecipitation 
with 82-kDa ChAT by our laboratory (unpublished data). If 82-kDa ChAT is 
constitutively associated with Matrin3 it may not only explain interactions with the 
146 
 
spliceosome, but also possibly the interaction of 82-kDa ChAT with S/MARs. Finally, 
82-kDa ChAT and/or SATB1-mediated looping changes could alter mRNA movement 
through the nuclear pore. Genes associated with the lamina-associated domains (LADs) 
that are localized near nuclear pores are often euchromatic to faciliatate transcriptional 
activation and rapid mRNA transport out of the nucleus (Brickner et al. 2012). If 82-kDa 
ChAT is restricting access to the nuclear pore via changes in chromatin looping, this 
could also explain how APP-KPI mRNA levels are altered in this model. 
An interesting finding from the mass spectrometry data was the identification of 
HSP70/HSC70 after cells were exposed to Aβ. HSP70 and HSC70 are both important for 
the identification of incorrectly folded proteins, and either facilitates their refolding or 
directs them to the proteasome for degredation (Lüders et al. 2000; Wegele et al. 2004). 
This is an important observation as both 69-kDa and 82-kDa ChAT have abnormally high 
cysteine residue contents (3.2% compared to the 2.26% present in most mammalian 
proteins [Miseta and Csutora 2000]), and cysteines are sensitive to oxidation by reactive 
oxygen species (Davies 2016; Fujii et al. 2016). Cell exposure to Aβ can lead to 
oxidation of proteins (reviewed in Butterfield 2002), oxidative stress can result in protein 
misfolding, dysfunction, and the induction of the heat-shock response (Kalmar and 
Greensmith 2009; reviewed in Pisoschi and Pop 2015), and our lab has previously 
demonstrated that 69-kDa ChAT can be ubiquitinated and targeted for proteosomal 
degregation (Morey et al. 2016). Combined with the finding that 82-kDa ChAT can be 
found in an insoluble protein fraction following cell exposure to Aβ, these observations 
lead to an interesting hypothesis that a portion of 82-kDa ChAT could be oxidized and 
misfolded following Aβ-exposure of cells, and then directed to the proteasome via the 
heat-shock family of chaperones. 
The data presented in this chapter demonstrates that 82-kDa ChAT participates in, 
and is required for, the binding of S/MARs to the nuclear matrix in human neural cells 
after acute exposure to oligomeric Aβ1-42. Together with the findings from the first 
objective, we suggest a model whereby 82-kDa ChAT is constitutively associated with 
chromatin, but is brought to SATB1 anchored S/MARs after cells are treated with Aβ 
(Fig. 3-18). These data support two separate hypotheses for the role of 82-kDa ChAT at 
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chromatin, whether at SATB1 anchored S/MARs or on other regions. First, 82-kDa 
ChAT may be altering pre-mRNA processing by interacting with the spliceosome. 
Evidence for this hypothesis includes 82-kDa ChAT mass spectrometry associations with 
RNA splicing, transport and spliceosome proteins and changes to the APP-KPI mRNA 
isoform due to Aβ-induced 82-kDa ChAT/SATB1 APP gene association. Given that 82-
kDa ChAT has features of chromatin organizers, one possibility is that 82-kDa ChAT 
associations with chromatin either restrict or allow access to specific exons for 
transcription. An interaction with the nuclear matrix protein Matrin3 could also help 
facilitate the interaction with the spliceosome. Both the potential interaction with Matrin3 
and possible involvement with the spliceosome require further investigation. 
Alternatively, or perhaps in addition to alternative RNA splicing, 82-kDa ChAT could be 
part of a complex with transcription factors (TFs), likely resulting in locus-dependent 
transcriptional activation and/or repression. DREME motif analysis suggests that 82-kDa 
ChAT and SATB1 are part of a multi-protein complex, with NFAT one possible TF 
involved.  Overall, our data suggest that cholinergic neurons can have an epigenetic 
response to Aβ-exposure, and given that the nuclear levels of 82-kDa ChAT decline with 
increasing age and the onset of cognitive impairment (Gill et al. 2007), the loss of this 
epigenetic response may have implications for the onset or progression of MCI and AD. 
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Figure 3-18. Model for 82-kDa ChAT and SATB1 chromatin association in SH-
SY5Y cells. 
82-kDa ChAT is constitutively associated with DNA, but is brought to SATB1 anchored 
S/MARs after exposure to oligomeric AB1-42. 82-kDa ChAT interacts with chromatin 
and the nuclear matrix, possibly through Matrin3. Through these interactions, 82-kDa 
ChAT may alter pre-mRNA processing/splicing via an interaction with the spliceosome, 
and/or alter transcriptional activation as part of a multi-protein TF complex. DREME 
motif analysis suggests that NFAT may be one of these TFs. See discussion for more 
detail. 
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Chapter 4  
4 Objective III- A role for nuclear 82-kDa ChAT in cholinergic synapse 
development  
 
 
Figure 4-1 was produced in collaboration with Mrs. Jennifer Winick-Ng, using the 
statistical programming software SAS. 
Figure 4-11 - data collection was produced in collaboration with Ms. Heather Rotz. 
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4.1 Introduction and Rationale 
 
We previously demonstrated that 82-kDa choline acetyltransferase (82-kDa 
ChAT) protein and special AT-rich sequence binding protein 1 (SATB1) are associated 
with scaffolding/matrix attachment regions after neuronal cells were exposed to Aβ 
(Winick-Ng et al. 2016). Among other outcomes, using DREME motif analysis of 
chromatin immunoprecipitation sequencing (ChIP-seq) peaks associated with both 82-
kDa ChAT and SATB1 in SH-SY5Y human neuroblastoma cells, we screened hundreds 
of known transcription factors (TF) for motifs that may be enriched in this dataset 
(Kheradpour and Kellis 2014). This results from this screen revealed motifs that had 
homology to nuclear factor of activated T cells (NFAT) DNA-binding motifs (see Fig 2-
14 in Chapter 2; Fig 2-4 and Fig 3-8 in Chapters 2 and 3, respectively). NFAT is a 
ubiquitously expressed TF that has been well characterized for the regulation of cytokine 
genes during T-cell activation (reviewed by Macian 2005). NFAT has also been shown to 
regulate T-cell development (Macian 2005; Benita et al. 2010), oncogenic growth in 
pancreatic cancer (König et al. 2010), and the development and growth of many cell 
types, including cardiac muscle cells (Chen and Cao 2009), skeletal muscle cells (Delling 
et al. 2000), pancreatic islet cells (Heit et al. 2006), and epidermal cells during embryonic 
development (Mammucari et al. 2005).  
In neurons, NFAT has an important role in synapse development and 
maintenance. NFAT null mice have impairments in axonal guidance and pathfinding 
(Graef et al. 2003; Nguyen and Di Giovanni 2008), as well as in vitro brain-derived 
neurotrophic factor (BDNF)-dependent neurite outgrowth (Groth and Mermelstein 2003). 
NFAT has also been shown to reduce pre-synaptic synaptic boutons and neurotransmitter 
release in Drosophila motor neurons (Freeman et al. 2011). Further, NFAT TFs are 
involved in cellular responses to neurotrophins as it binds to the inositol 1,4,5-
triphosphate receptor type 1 (IP3R1) promoter upon BDNF stimulation of cells, and is 
thus important for release of intracellular stores of Ca2+ and neuron signaling following 
stimulation (Groth and Mermelstein 2003). NFAT was also demonstrated to increase 
COX2 expression in cultured spinal neurons (Groth et al. 2007). This is noteworthy 
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considering elevated Cyclooxygenase-2 (COX-2) can lead to enhanced neurotransmission 
and long-term potentiation (Reviewed in Yang and Chen 2008).   
Importantly, elevated NFAT levels may also have a role in the synapse 
degeneration seen early in Alzheimer’s disease (AD) pathology. Soluble oligomeric Aβ-
induced Ca2+ entry has been shown to hyper-activate the Ca2+/calmodulin dependent 
protein phosphatase calcineurin, which dephosphorylates NFAT thereby revealing its 
nuclear import sequence (Wu et al. 2010). NFAT then enters the nucleus and, in 
combination with other TFs (e.g. activator protein 1 [AP-1], nuclear factor kappa-light-
chain-enhancer of activated B cells [Nf-κB], BDNF), alters transcription (Macián et al. 
2001; Groth and Mermelstein 2003; Fisher et al. 2006; Liu et al. 2012). Aβ-induced 
constitutive NFAT activation results in dendritic spine density reductions, simplification 
and degeneration, eventually leading to activation of the apoptotic pathway (Agostinho et 
al. 2008; Wu et al. 2010). There are also isoform specific changes to NFAT nuclear 
levels in both mild cognitive impairment (MCI) and AD patients; NFAT1 is increased in 
MCI but decreased in AD, NFAT3 is decreased in MCI and increased in AD, while 
NFAT2 levels have no observed changes in either MCI or AD (reviewed in Abdul et al. 
2010). Interestingly, the partial NFAT ChIP-seq motifs found for 82-kDa ChAT and 
SATB1 have homology with NFAT1 and NFAT2.   
The NFAT TFs have a role in synapse formation but may also be dysregulated 
during AD. Therefore, in this chapter we explore the hypothesis that 82-kDa ChAT has a 
role in changes to the expression of synapse and membrane related genes that have high 
NFAT DNA binding site enrichment. We test whether there are changes in expression for 
genes with 82-kDa ChAT peaks that have high NFAT DNA binding compared to empty 
vector when treated with either vehicle or oligomeric Aβ1-42. We further investigate 
whether this correlates to differences in protein expression, and test downstream 
phenotypic and morphological consequences associated with these changes.   
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4.2 Methods 
 
Cell culture and conditioned media experiments 
SH-SY5Y cells from American Type Culture Collection (Manassus, VA) that 
stably express either 82-kDa ChAT or empty vector (Albers et al. 2014) were grown in 
Dulbecco’s modified Eagle medium (DMEM) containing 8% fetal bovine serum (FBS) 
and differentiated using 10 μM all-trans-retinoic acid for 3 days, which produces 
substantial morphological and biochemical cholinergic differentiation of cells (Hashemi 
et al. 2003). Aβ oligomers were prepared as described (Chapter 2; Stine et al. 2003) from 
lyophilized Aβ1-42 or the reverse peptide purchased from rPeptide (Bogart, GA, USA). 
Cells were treated with either 100 nM oligomeric Aβ1–42, F12 media (vehicle) or 
recombinant human neuregulin 1 (NRG1) extracellular peptide (R&D Systems, 
Minneapolis, MN, USA) in PBS containing 0.02% bovine serum albumin (BSA) at the 
times and concentrations indicated.  
In some experiments, cells expressing 82-kDa ChAT or empty vector were 
cultured on 100 mm dishes for at least 4 days in retinoic acid at a density of 1.5x106 
cells/plate, with culture medium changed every 48 h. At 96, 144 and 192 h following 
plating, the culture media was removed from these cells and was used as “conditioned 
medium”. To test the effects of feeding cells with conditioned medium, SH-SY5Y cells 
that were expressing either 82-kDa ChAT or empty vector were divided into groups, then 
culture media was removed from the cells and cells were fed with either fresh DMEM 
containing 8% fetal bovine serum (FBS) and 10 μM all-trans-retinoic acid, or conditioned 
media from vector-expressing cells or conditioned media from 82-kDa ChAT-expressing 
cells to which 10 μM all-trans-retinoic acid was added. For protein phosphorylation 
experiments, 4 mL of either fresh or conditioned media was added to the receiving cells 
for the times indicated. For neurite outgrowth experiments, 3 mL of fresh or conditioned 
media was added to the receiving cells for the times indicated. To test the role of NRG1 
released from cells on outcome measures, 5 ug/mL anti-NRG1 antibody was added to 
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fresh media for 1 h with rotation at room temperature (RT) prior to these media being 
added to cells. As a control, some media was treated with 5 ug/mL anti-FLAG antibody. 
 
Antibodies  
Anti-NRG1 (sc-33269), anti-neuroligin 1 (NLGN1; sc-50393), anti-β-actin (sc-
1616-R) and anti-receptor tyrosine-protein kinase erbB-4 (ERBB4; sc-8050) antibodies 
were from Santa Cruz Biotechnology (Dallas, TX, USA); Anti-metabotropic glutamate 
receptor 5 (mGlu5; ab76316) and anti-phospho(Y1284) ERBB4 (p-ERBB4) antibodies 
were from Abcam Inc. (Toronto, ON, Canada). Anti-FLAG (F7425) antibody was from 
Sigma-Aldrich (Oakville, ON, Canada).  
 
Reverse transcription (RT) real-time PCR (qPCR)  
For reverse transcription-qPCR (RT-qPCR), RNA was isolated from cells 
expressing either 82-kDa ChAT or empty vector as described in Chapter 3 and previously 
(Albers et al. 2014). PCR amplification primers (Table 4-1) and subsequent 
quantification was also carried out as described in Chapter 3 and previously (Albers et al. 
2014). 
 
Cell lysis and immunoblotting 
Total cellular protein was obtained by lysing cells in radioimmunoprecipitation 
(RIPA) buffer as described in Chapter 3. Thirty to fifty μg of protein were separated on 
SDS–polyacrylamide gel electrophoresis (SDS-PAGE) gels, followed by transfer of 
proteins onto polyvinylidene difluoride (PVDF) membranes. Non-specific proteins were 
blocked in an appropriate buffer, then membranes were incubated in primary and 
secondary antibodies as shown in Table 4-2.  Immunoreactive bands were visualized 
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using Image Lab (Version 5.0, BioRad), and band density was then determined and 
normalized to β-actin immunoreactivity for each sample. 
For experiments testing effects of condition media, media conditioned by 82-kDa 
ChAT or vector-expressing SH-SY5Y cells was concentrated from 4 mL to 500 µL by 
centrifugation at 4000 x g for 60-75 min using a 3 kDa Amicon® Ultra centrifugal filter 
(EMD Millipore Ltd.). Concentrated media was then heated in 2x Laemmli sample buffer 
(126 mM Tris-HCl; pH 6.8, 20% (v/v) glycerol, 4% (w/v) SDS, 0.01% (w/v) 
bromophenol blue, and 5% (v/v) 2-mercaptoethanol) for 15 min at 95oC, with intermittent 
vortex mixing. In parallel, cells were lysed in RIPA buffer and total cellular protein 
isolated as above. Twenty uL of total lysate was heated in 1x Laemmli’s buffer at 95°C 
for 5 min. Media and cell lysate samples were separated on 16% SDS-PAGE gels, 
followed by immunoblotting as above.  
 
Confocal imaging 
For confocal imaging, cells were harvested as described previously, 
permeabilized and stained with 2.5 μg/mL Hoechst for 5 min.  Images were acquired and 
processed as described in Chapter 2. Following processing in ImageJ, differential contrast 
images were subjected to the “invert LUT” function to better visualize neurites. 
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Table 4-1. RT-qPCR primers used in this chapter. 
 
Gene  Direction  Primer, 5’-3’  
Human NRG1,    
variant HRG-β1 
Forward  AACTTGTTGGAACTCCGGGC 
Reverse  AGGTTATCACCGTCCTGCTC 
Human ERBB4,  
variant JM-a/CVT- 1 
Forward  CACCCAAGGGTGTAACGGTC 
Reverse GCTGCAATCAGGGGAGTTCT 
Human NLGN1  Forward  CTTACCTGTGAAGCTTGAGGC 
Reverse TGGGCATTGACTGCAGATTT 
Human NRXN1,  
variant α2 
Forward  GGCCACATAACCCTACCCTT 
Reverse CTTAAGCACGAAATGGTGCCG 
Human SHANK1 Forward  CCATGACTCGGATTCGGGAG 
Reverse CTTATGCAGTGCGGTCATGC 
Human DLGAP1, 
variant 1 
Forward  TCTCTCGAGTCCTTCCCGTC 
Reverse ATGTTCAACTGCTCTGGCCG 
Human GRM5, 
variant a/b 
Forward  GAGCTCCTCGTCGTTGTGAA 
Reverse CGTAACCAGGCGACTATGCT 
Human PLCB1, 
variant 1 
Forward  AGGATGTGCTGAATGGTGCG 
Reverse AAGGCGAAGAGAAGCCGAG 
Human DLG2, 
variant 1 
Forward  ACTCCTGTGGCAGTGGAAAG 
Reverse GCTCGGTCAGTATCTTATGGC 
Human GAPDH  Forward  TGTTGCCATCAATGACCCCTT 
Reverse CTCCACGACGTACTCAGCG 
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Table 4-2. Antibody conditions for western immunoblotting. 
 
Antibody   Buffer  Concentration 
β-Actin Block 5% Milk -- 
Primary  5% Milk 1:1000 
Secondary (rabbit) 5% Milk 1:10000 
NRG1 Block 5% Horse Serum -- 
Primary  5% Horse Serum 1:200 
Secondary (goat) 5% Horse Serum 1:5000 
NLGN1 Block 3% BSA -- 
Primary  3% BSA 1:1000 
Secondary (rabbit) 3% BSA 1:10000 
mGlu5 Block 5% Milk -- 
Primary  5% Milk 1:2000 
Secondary (mouse) 5% Milk 1:10000 
ERBB4 Block 5% BSA -- 
Primary  3% BSA 1:200 
Secondary (mouse) 3% BSA 1:10000 
p-ERBB4 Block 4% BSA -- 
Primary  3% BSA 1:750 
Secondary (rabbit) 3% BSA 1:10000 
  
167 
 
 
NRG1 enzyme-linked immunosorbent assay (ELISA) 
To detect and quantify NRG1 extracellular peptide in conditioned media collected 
from cells expressing either 82-kDa ChAT or empty vector, we used a DuoSet solid 
phase sandwich ELISA (R&D Systems) specific for human NRG1-β1 extracellular 
peptide (range 125 - 4000 pg/mL), according to the manufacturer’s specifications. 
Briefly, NRG1 capture antibody (4 µg/mL) was added to 96-well plates and incubated 
overnight at RT. Blocking solution (1% BSA in PBS) was added to wells of the plate for 
1 h at RT. Media samples were prepared from DMEM without FBS added, DMEM 
containing 8% FBS, media conditioned by cells expressing either empty vector or 82-kDa 
ChAT, or media samples concentrated as described above. To construct standard curves 
for the ELISA, recombinant NRG1 peptide was reconstituted in either PBS containing 
1% BSA or the non-concentrated conditioned media samples above over the 
concentration range of 0.125 to 4 ng/mL.  Samples were incubated on the ELISA plate 
for 2 h at RT, followed by the addition of NRG1 detection antibody (150 ng/mL in TBS-
T containing 2% normal goat serum and 1% BSA) for 2 h at RT. Following the addition 
of streptavidin-HRP for 20 min at RT, NRG1 was detected using a substrate solution (1:1 
mixture of H2O2 and tetramethylbenzidine) for 20 min. The reaction was halted using 2 N 
H2SO4, and the absorbance read at 450 nm using a Spectra Max M5 microplate reader 
(San Francisco, CA, USA). An additional reading was taken at 540 nm to account for 
background optical readings on the plate, and subtracted from the 450 nm readings. 
Concentrations in the media were determined by comparing optical densities (ODs) to a 
standard curve generated using the standards as described above. 
 
Data Analysis  
The data are presented as mean ± SEM and analyzed as described in Chapters 2 
and 3. Statistical significance was determined by one or two-way ANOVA, followed by 
Bonferroni’s post hoc multiple comparison test. Statistically significant changes in gene 
expression were determined by a one-sample t-test, as indicated. For all one-sample t-
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tests performed, the population mean was assumed to be equal to 1. For all measures, 
statistical significance was defined as p ≤ 0.05.  
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4.3 Results 
 
82-kDa ChAT associates with synapse-related genes, leading to changes in gene and 
protein expression 
The 82-kDa ChAT protein associates with chromatin at sequences with sequence 
homology to NFAT binding motifs, therefore we first assessed whether there was 
significant enrichment for NFAT binding motifs in 82-kDa ChAT chromatin 
immunoprecipitation-next generation sequencing (ChIP-seq) peaks from SH-SY5Y cells 
that were previously treated for 4 h with either vehicle or 100 nM Aβ1-42 (NCBI GEO 
accession: GSE73576; Winick-Ng et al. 2016). As a control, we compared enrichment 
from 82-kDA ChAT ChIP-seq peaks to a dataset for human Alpha Thalassemia/Mental 
Retardation Syndrome X-Linked (ATRX) (NCBI GEO database accession number: 
GSE22162; Law et al. 2010), a protein involved in chromatin looping and enriched at 
tandem G-quadraplex repeats (Law et al. 2010; Kernohan et al. 2014; Levy et al. 2015). 
We first tested the NFAT binding motif T(T/C)CCA as identified by Kheradpour and 
Kellis (2014), and the NFAT-specific sequence (T/C)GGAA(A/T/C) (Boise et al. 1993; 
Chen et al. 1998; Badran et al. 2002) for 82-kDa ChAT or ATRX enrichment (Fig. 4-
1A). As we determined previously, 82-kDa ChAT had average peak lengths of 192 ± 3.2 
nucleotides (nt) and 132.6 ± 2.2 nt for vehicle and Aβ1-42 treatments, respectively, while 
ATRX had an average peak length of 483.4 ± 2.4 (Chapters 2 and 3). Therefore, we 
determined the number of motifs in each peak weighted by the inverse of the peak length 
and divided by a scaling factor of 100. For the T(T/C)CCA motif, we found that there 
were significantly higher motifs/peak for 82-kDa ChAT treated with either vehicle (2.7 ± 
0.06) or Aβ1-42 (1.6 ± 0.04) when compared to ATRX (0.6 ± 0.004). The number of 
motifs/peak was also significantly higher after vehicle treatment compared to Aβ1-42. We 
saw a similar pattern for the (T/C)GGAA(A/T/C) motif, with 82-kDa ChAT peaks after 
vehicle treatment (3.6 ± 0.1) significantly higher than after Aβ1-42 treatment (2.1 ± 0.08). 
Again, both treatments were significantly increased compared to ATRX (0.4 ± 0.004).  
  
170 
 
 
 
Figure 4-1. 82-kDa ChAT has significant enrichment for NFAT and c-Fos motifs. 
Mean weighted NFAT (A) and c-Fos (B) DNA binding motifs/ChIP-seq peak, computed 
as the number of motifs/peak length*100. For NFAT motifs, SH-SY5Y cells expressing 
82-kDa ChAT and treated with vehicle had significantly higher motifs/peak than 82-kDa 
ChAT peaks after 4 h 100 nM Aβ1-42-exposure. For both NFAT and c-Fos motifs, the 
number of motifs/peaks for 82-kDa ChAT after vehicle and Aβ1-42 treatment were 
significantly higher than for peaks for human ATRX. *** p < 0.001. 
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NFAT has been previously shown to associate with and bind adjacent to AP-1 TF 
binding sites (Macián et al. 2001). AP-1 is produced by the dimerization of c-Fos and c-
Jun subunits (Nakabeppu et al. 1988; Kouzarides and Ziff 1988; Gustems et al. 2014), 
therefore we also assessed the number of motifs/peak for the c-Fos binding motifs 
TGA(C/G) and TGA(C/T) (Gustems et al. 2014; Fig. 4-1B). For both the TGA(C/G) and 
TGA(C/T) motifs, we found no significant differences in the number of motifs/peak for 
82-kDa ChAT after exposure of cells to either vehicle (2.3 ± 0.03 and 2.0 ± 0.02, 
respectively) or Aβ1-42 (2.2 ± 0.02 and 2.0 ± 0.02, respectively). However, the number of 
motifs/peak for 82-kDa ChAT in either treatment was significantly higher than ATRX 
(1.7 ± 0.01 for TGA(C/G) and 1.4 ± 0.01 for TGA(C/T)). Together, these data 
demonstrate that 82-kDa ChAT ChIP-seq peaks are enriched for both NFAT and c-Fos 
motifs, with Aβ1-42-exposure reducing the number of NFAT motifs/peak. NFAT was 
shown previously to be involved in axon growth and guidance, as well as synapse 
maturation during synapse development (Graef et al. 2003; Groth and Mermelstein 2003; 
Nguyen and Di Giovanni 2008). NFAT is also activated after neuron stimulation, and 
following acute exposure to Aβ (Groth and Mermelstein 2003; Wu et al. 2010).  
Interestingly, by gene ontology (GO), we showed that the ChIP-seq peaks for both 82-
kDa ChAT and SATB1 were significantly associated with synapse and membrane related 
genes regardless of vehicle or Aβ treatment (Chapters 2 and 3). Additionally, we found 
significant GO enrichment for calcium-related genes (p = 1.4E-06, -log(FDR) = 2.8) in 
genes that had peaks associated with both 82-kDa ChAT and special AT-rich sequence 
binding protein 1 (SATB1). Therefore, we determined the percentage of peaks that had 
the NFAT binding motif T(T/C)CCA for 82-kDa ChAT and SATB1 for all peaks, or for 
peaks found in genes related to synapse, membrane, or calcium regulation GO groups 
(Fig. 4-2).   
For 82-kDa ChAT associated peaks, we found that 42% of all peaks had at least 
one motif after vehicle treatment, and 41% after Aβ treatment. Though there were no 
overall differences, we did find some interesting changes in individual GO groups. For 
example, for genes in the ‘calcium’ GO group, we found 32% of peaks with at least 1 
motif after vehicle treatment, with this increasing to 56% after Aβ-exposure of cells. For 
the ‘synapse’ and ‘tyrosine kinase’ groups in the vehicle treated cells group, we found  
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Figure 4-2. NFAT binding motifs in gene ontology groups for 82-kDa ChAT and 
SATB1. 
Percentage of peaks with at least one NFAT motif T(T/C)CCA from different gene 
ontology (GO) groupings for 82-kDa ChAT and SATB1 after SH-SY5Y cells were 
exposed to either 4 h vehicle or 100 nM Aβ1-42. There were no differences for 82-kDa 
ChAT associated peaks overall, however the percentage of peaks with motifs increased 
after Aβ-exposure for peaks from calcium-related genes and synapse related genes (for 
genes that had 82-kDa ChAT peaks but no SATB1 peaks). For synapse related genes 
(that had peaks for both 82-kDa ChAT and SATB1) and tyrosine kinase related genes, 
the percentage of 82-kDa ChAT peaks with motifs was reduced. For SATB1 related 
peaks, there was an overall increase in the percentage of peaks that had motifs after cells 
were exposed to Aβ, with similar increases for each GO group. 
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33% and 56% of peaks with at least one motif, respectively. In contrast, following cell 
exposure to Aβ, this was reduced to 17% for synapse and 20% for tyrosine kinase, 
respectively. However, when we considered synapse related genes that only had peaks for 
82-kDa ChAT, 40% of peaks had at least one motif after vehicle treatment with this 
increasing to 57% after cells were exposed to Aβ. For SATB1, we found that 44% of 
peaks had at least one T(T/C)CCA NFAT binding motif after vehicle treatment, with this 
increasing to 62% after treatment with Aβ. All of the individual GO groups tested had 
similar increases after Aβ-exposure. 
Based on these observations, we decided to target synapse and calcium-related 
genes that had ChIP-seq peaks for 82-kDa ChAT after cells were exposed to either 
vehicle or Aβ. From this analysis, we chose 9 genes related to synapse formation and 
maintenance for further analysis (Table 4-3).  NRG1 encodes the protein neuregulin 1 
(NRG1), a membrane bound protein involved in synapse development and response to 
neuronal stimulation of NMDA and AMPA receptors (Gerecke et al. 2004; Bjarnadottir 
et al. 2007; Chen et al. 2010; Ting et al. 2011). ERBB4 encodes receptor tyrosine-protein 
kinase erbB-4 (ERBB4; also known as HER4), a membrane bound protein involved in 
signal transduction and cholinergic synapse formation (Zhu et al. 1995; Neddens and 
Buonanno 2011; Woo et al. 2011; Reviewed in Iwakura and Nawa 2013). NRXN1 
encodes neurexin 1 (NRXN1), which forms a complex with neuroligin 1 (NLGN1; 
encoded by NLGN1). NRXN1 and NLGN1 anchor the pre- and post- synaptic 
membranes together, respectively (Craig and Kang 2007; Choi et al. 2011). SHANK1 and 
DLGAP1 encode SHANK and GKAP that together are part of the post-synaptic 
scaffolding (Tao-Cheng et al. 2015). Typically, this scaffolding complex is also 
composed of post-synaptic density protein 95 (PSD-95) (Hayashi et al. 2009), but PSD-
93 (encoded by DLG2) is highly expressed in cholinergic post-synaptic scaffolding and 
has also been shown to complex with both SHANK and GKAP (Parker et al. 2004). 
GRM5 encodes the metabotropic glutamate receptor 5 (mGlu5), which has been shown to 
promote cholinergic synapse formation during neuron development in rat neural 
progenitor cells (Zhao et al. 2014). Finally, PLCB1 encodes phospholipase C-1 
(PLCB1) which is involved in intracellular signaling of extracellular ligands for mGlu5   
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Table 4-3. Locations for 82-kDa ChAT ChIP-seq peaks for synapse-related genes. 
 
 
 
 
 
 
 
 
 
 
 
 
Gene 
 
82-kDa ChAT 
(Vehicle) 
 
Number 
of Peaks 
 
82-kDa ChAT 
(100 nM Aβ) 
 
Number 
of Peaks 
 
NRG1 
 
50 kb downstream 
 
1 
 
Promoter, Exon 2 
 
2 
 
ERBB4 
 
100 kb downstream 
 
1 
100 kb upstream,    
Intron 1 
 
2 
 
NLGN1 
Intron 1 (near 
promoter), Intron 2 
 
2 
Intron 2, 
40 kb downstream 
 
3 
 
NRXN1 
 
Intron 3 
 
2 
 
Intron 5 
 
1 
 
SHANK1 
 
-- 
 
-- 
15 kb downstream, 
40 kb upstream 
 
2 
 
DLGAP1 
 
Intron 5 
 
1 
 
Intron 4 
 
1 
 
GRM5 
 
Intron 3 
 
1 
 
-- 
 
-- 
 
PLCB1 
 
Intron 4 
 
1 
 
Intron 4 
 
1 
 
DLG2 
Intron 7, Intron 8, 
Intron 9, 4 kb 
downstream 
 
6 
 
Intron 7 
 
1 
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(Hannan et al. 2001; Domenici et al. 2003). PLC-1 phosphorylation results in inositol 
1,4,5-trisphosphate (IP3) formation (Nash et al. 2002; Kammermeier and Worley 2007). 
IP3-mediated Ca2+ release has been shown to activate multiple cell signaling pathways in 
cholinergic neurons, including Ca2+/calmodulin-dependent protein kinase (CAMK) and 
protein kinase C (PKC) (Shindo et al. 1996; Slonimsky et al. 2006; Nakamuta et al. 
2011). 
Based on the observed ChIP-seq interactions for 82-kDa ChAT at synapse and 
membrane related genes, we next tested whether there were changes in expression of 
genes in Table 4-3 in SH-SY5Y cells expressing 82-kDa ChAT compared to empty 
vector. For each gene, we compared the expression level in cells expressing 82-kDa 
ChAT to cells expressing empty vector using a one-sample t-test, with an expected 
theoretical mean of 1 for the vector expressing cells (Fig. 4-3). Using this approach, we 
determined that NRG1 (1.7 ± 0.2 fold), NLGN1 (1.4 ± 0.2), NRXN1 (1.5 ± 0.1), SHANK1 
(1.4 ± 0.1), and GRM5 (1.9 ± 0.2) all were significantly increased in 82-kDa ChAT 
expressing cells compared to cells expressing an empty vector. We found no significant 
differences for ERBB4 (1.1 ± 0.2), DLGAP1 (1.2 ± 0.1), PLCB1 (1.2 ± 0.2), or DLG2 
(1.6 ± 0.4). 
We also observed ChIP-seq peak changes for 82-kDa ChAT after 4 h exposure of 
cells to 100 nM Aβ1-42, therefore tested whether there were also Aβ1-42-induced changes 
in expression for the genes in Table 4-3 in cells expressing 82-kDa ChAT compared to 
empty vector (Fig. 4-4). Compared to vehicle treatment, there were no changes in 
expression of any of the genes tested in either vector or 82-kDa ChAT expressing cells 
after 1 h exposure to 100 nM Aβ1-42. In cells expressing 82-kDa ChAT and treated for 2 h 
with Aβ1-42, we observed significant increases in gene expression for NLGN1 (1.7 ± 0.1 
fold), NRXN1 (1.9 ± 0.1) and PLCB1 (2.8 + 0.3) compared to vector expressing cells (0.8 
± 0.1, 1.0 ± 0.04 and 0.9 ± 0.1, respectively). These changes were no longer significant 
after 4 h treatment with Aβ1-42, but after 8 h of treatment, GRM5 (1.3 ± 0.1) and DLG2 
(1.5 ± 0.2) were significantly increased in 82-kDa ChAT expressing cells compared to 
vector cells (0.9 ± 0.05, 0.7 ± 0.1, respectively). Finally, we determined that in 82-kDa  
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Figure 4-3. 82-kDa ChAT expression in SH-SY5Y cells alters gene expression of 
synapse related genes. 
Steady-state mRNA expression of synapse related genes in 82-kDa ChAT expressing 
cells compared to vector expressing cells. Data are presented as fold-enrichment 
compared to reference (GAPDH) mRNA levels and vector expressing cells (dashed-line). 
82-kDa ChAT expressing cells have higher steady-state mRNA levels for NRG1, 
NLGN1, NRXN1, SHANK1, and GRM5. *p < 0.05, **p < 0.01, ***p < 0.001 (one-sample 
t-test with theoretical mean = 1), n = 8. 
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Figure 4-4. 82-kDa ChAT expression in SH-SY5Y cells alters gene expression of 
synapse related genes after exposure to oligomeric Aβ1-42. 
Steady-state mRNA expression of synapse related genes in 82-kDa ChAT or vector-
expressing SH-SY5Y cells after exposure to 100 nM oligomeric Aβ1-42 for various time 
points. Data are presented as fold change compared to GAPDH and vehicle-treated cells 
(represented by the dashed-line). There were no changes in mRNA levels after 1 h, 
however NLGN1, NRXN1, and PLCB1 were significantly increased in 82-kDa ChAT 
expressing cells after 2 h exposure to Aβ1-42 (n = 4). Gene expression changes were no 
longer significant after 4 h of Aβ1-42-exposure. GRM5 and DLG2 were significantly 
increased in 82-kDa ChAT expressing cells after 8 h of Aβ1-42-exposure. After 24 h of 
Aβ1-42 treatment, NLGN1 was significantly increased and NRXN1 was significantly 
decreased in 82-kDa ChAT expressing cells. n = 5 *p < 0.05, **p < 0.01, ***p < 0.001 
(two-way ANOVA with Bonferroni’s post-hoc test). 
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ChAT expressing cells treated with Aβ1-42 for 24 h NLGN1 is significantly 
increased compared to that measured in vector expressing cells treated for 24 h with Aβ1-
42 (1.7 ± 0.3 compared to 1.0 ± 0.1), while NRXN1 is significantly reduced (0.5 ± 0.1 
compared to 1.1 ± 0.1). Though not significant, NRG1 was also reduced in 82-kDa ChAT 
expressing cells (0.7 ± 0.1) compared to vector expressing cells (1.2 ± 0.1; α = 0.006 , p = 
0.009, ns) after 24 h treatment with Aβ1-42. 
SH-SY5Y cells expressing 82-kDa ChAT had altered expression for synapse and 
membrane related genes compared to cells expressing an empty vector. Therefore, we 
evaluated whether there were also differences in steady-state protein levels for NRG1, 
mGlu5 or NLGN1 in 82-kDa ChAT compared to vector expressing cells that had been 
treated with either vehicle or 100 nM Aβ1-42 for 24 h (Fig. 4.5). For all three proteins, we 
did not observe any differences in steady-state levels after 24 h of Aβ1-42-exposure 
compared to vehicle treatment. Though there were no differences due to treatment, we 
observed a significant increases in steady-state protein levels when we compared protein 
levels in 82-kDa ChAT-expressing cells to empty vector for NRG1 (1.4 ± 0.1, 0.5 ± 0.1 
respectively for vehicle treatment; 1.4 ± 0.2, 0.5 ± 0.1 respectively for Aβ1-42), mGlu5 
(1.5 ± 0.2, 0.3 ± 0.1 respectively for vehicle treatment; 1.8 ± 0.2, 0.3 ± 0.2 respectively 
for Aβ1-42) and NLGN1 (1.2 ± 0.1, 0.8 ± 0.05 respectively for vehicle treatment; 1.2 ± 
0.1, 0.9 ± 0.1 respectively for Aβ1-42). 
 
82-kDa ChAT expression in SH-SY5Y cells results in NRG1-dependent neurite outgrowth 
SH-SY5Y cells that stably express heterologous 82-kDa ChAT have higher 
steady-state levels of synapse formation and maintenance related genes and proteins 
compared to cells expressing an empty vector. Therefore, we tested whether there were 
related morphologic and phenotypic changes in these cells after cholinergic 
differentiation with retinoic acid. In Figure 4.6, we assessed the morphology of SH-
SY5Y cells differentiated for 7 days with retinoic acid. In particular, we focused on 
processes extending from the cell body, greater than 2 cell bodies in length. Since we  
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Figure 4-5. 82-kDa ChAT expression in SH-SY5Y cells alters steady-state protein 
levels of neuregulin 1, neuroligin 1 and the metabotropic glutamate receptor 5. 
(A) Representative western immunoblots showing NRG1, mGlu5 and NLGN1 steady-
state protein levels in SH-SY5Y cells stably expressing 82-kDa ChAT or empty vector 
and treated with either vehicle or 100 nM Aβ1-42 for 24 h. β-actin is shown as a loading 
control. All 3 proteins had higher band density in 82-kDa ChAT expressing cells. (B) 
Quantification of band density relative to β-actin confirmed significantly increased 
steady-state protein levels for NRG1, mGlu5 and NLGN1 in 82-kDa ChAT expressing 
cells. For all 3 proteins there was no effect of treatment with either vehicle or Aβ1-42. 
n = 5, *p < 0.05, **p < 0.01, ***p < 0.001 (two-way ANOVA with Bonferroni’s post hoc 
test). 
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Figure 4-6. 82-kDa ChAT expressing SH-SY5Y cells grow highly branched NRG1-
dependent neurites. 
Representative images for 82-kDa ChAT or vector expressing SH-SY5Y cells 
differentiated for 7 d with retinoic acid. Cells expressing 82-kDa ChAT (a) have short, 
branched (indicated by *) cell processes (neurites) that interconnect, while cells 
expressing empty vector (d) have longer neurites with few branches. When cells are 
grown for 7 d in the presence of retinoic acid and anti-NRG1 antibody, 82-kDa ChAT 
expressing cells (b) grow fewer neurites that do not have branches. Vector-expressing 
cells (e) grown with anti-NRG1 produce neurites that appear similar to cells grown in the 
absence of antibody. Cells expressing either 82-kDa ChAT (c) or empty vector (f) that 
were grown in the presence of anti-FLAG antibody had neurites that look similar to cells 
grown in the absence of antibody. Three independent experiments were performed with 
at least 5 images (10-30 cells/image) captured per replicate. Scale bar = 10 µm.  
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cannot determine whether these processes are axonal or dendritic, we refer to them as 
‘neurites’. Cells expressing 82-kDa ChAT have neurites extending from the cell body 
that are highly branched and interconnected with adjacent cell processes (Fig. 4.6[a]). In 
contrast, cells expressing an empty vector have longer neurites than 82-kDa ChAT 
expressing cells, but these neurites have fewer branches (Fig. 4.6[d]).  
NRG1 is cleaved within the cell membrane to produce a 6-8 kDa extracellular 
epidermal growth factor (EGF) domain peptide that promotes synapse development 
(Gerecke et al. 2004; Luo et al. 2011; Ting et al. 2011; Merballi et al. 2012). Therefore 
we assessed whether depletion of NRG1 peptide from the culture media using an 
antibody directed to the peptide would alter the neurite growth in either vector or 82-kDa 
ChAT expressing cells. We incubated fresh culture media with anti-NRG1 antibody for 1 
h prior to using this to feed either vector or 82-kDa ChAT expressing cells; fresh media 
containing antibody was added to cells every 48 h. Importantly, cells expressing 82-kDa 
ChAT fed with media containing anti-NRG1 antibody produced few neurites with almost 
no branching (Fig. 4.6[b]), whereas media containing the anti-NRG1 antibody had no 
effect on neurites produced in cells expressing an empty vector (Fig. 4.6[e]). As a 
control, we added an antibody against the FLAG polypeptide protein tag to fresh culture 
medium as SH-SY5Y cells do not express the peptide and the antibody should have no 
effect on cell morphology. Cells expressing either 82-kDa ChAT (Fig. 4.6[c]) or empty 
vector (Fig. 4.6[f]) grown in medium containing anti-FLAG antibody showed no changes 
to neurite morphology when compared to cells grown in medium containing no antibody. 
These results demonstrate that 82-kDa ChAT expressing cells have more complex 
neurites compared to vector expressing cells. In addition, the 82-kDa ChAT cells produce 
neurites that are dependent on extracellular NRG1, whereas neurites from vector 
expressing cells are not. 
Next, based on the assumption that 82-kDa ChAT expressing cells may be 
producing elevated levels of the extracellular NRG1 EGF domain peptide, we grew either 
vector or 82-kDa ChAT expressing SH-SY5Y cells for 7 d in either fresh media or media 
that was conditioned on 82-kDa ChAT or vector expressing cells for 48 h. All   
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Figure 4-7. Media conditioned on 82-kDa ChAT expressing SH-SY5Y cells alters 
neurite outgrowth of vector expressing cells. 
Representative images for 82-kDa ChAT or vector expressing SH-SY5Y cells 
differentiated for 7 d with retinoic acid. Cells expressing 82-kDa ChAT (a) have short, 
branched (indicated by *) cell processes (neurites) that interconnected, while cells 
expressing empty vector (d) had longer neurites with few branches. When cells were 
grown for 7 d in the presence of media conditioned on vector expressing cells for 48 h, 
82-kDa ChAT (b) and vector (e) expressing cells grew neurites that had few branches. 
82-kDa ChAT expressing cells (c) grown for 7 d in the presence of media conditioned for 
48 h on cells expressing 82-kDa ChAT also grew neurites with few branches. Vector 
expressing cells (f) grown in the presence of 82-kDa ChAT conditioned media grew 
neurites that had many more branches than cells grown (d). n = 3 with at least 5 images 
(10-30 cells/image) per replicate, scale bar = 10 µm. 
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experiments were done in the presence of retinoic acid, and we assessed the 
morphological and phenotypic changes in these cells. Figure 4.7 shows that, in 
agreement with the previous experiment, 82-kDa ChAT expressing cells grown in fresh 
media produce neurites that are complex and highly branched (Fig. 4.7[a]). Vector 
expressing cells again had neurites with few branches (Fig. 4.7[d]).  When we treated 
cells with media conditioned on vector expressing cells, both 82-kDa ChAT (Fig. 4.7[b]) 
and vector (Fig. 4.7[e]) expressing cells grew neurites with few branches. Surprisingly, 
82-kDa ChAT expressing cells grown in 82-kDa ChAT conditioned media also grew 
neurites with few branches (Fig. 4.7[c]). Interestingly, when we grew vector expressing 
cells in 82-kDa ChAT conditioned media the cells grew neurites with extensive 
branching (Fig. 4.7[f]).  
 
Cells that express 82-kDa ChAT have a more robust ERBB4 phosphorylation response 
following agonist stimulation 
82-kDa ChAT expression in SH-SY5Y cells increases the steady-state NRG1 
protein levels, resulting in extracellular NRG1 dependent neurite outgrowth. One possible 
mechanism to explain this interaction may be long-term NRG1 EGF domain stimulation 
of ERBB4, a membrane bound epidermal growth factor receptor. Long-term, low level 
release of NRG1 can promote the recruitment of ERBB2 to ERBB4, forming a 
heterodimer (Graus-Porta et al. 1997; Sweeney et al. 2000; Gerecke et al. 2004; Iwakura 
and Nawa 2013) (Fig. 4.8). ERBB4 can recruit and form dimers with ERBB1-4, but 
NRG1 can only bind ERBB3 and ERBB4 (Graus-Porta et al. 1997; Sweeney et al. 2000). 
In the heterodimer state, NRG1 binding promotes tyrosine phosphorylation of ERBB4 
and the maintenance of the receptors at the cell surface (Sweeney et al. 2000; Iwakura 
and Nawa 2013). NRG1 dependent signaling to ERBB4 and recruitment of the 
ERBB2:ERBB4 heterodimer has been shown previously to induce neurite extension and 
branching in cultured E18 hippocampal cells (Gerecke et al. 2004). Gerecke et al. (2004) 
showed that the NRG1 dependent neurite branching involved the p42/44 extracellular 
signal-regulated kinase (ERK) and PKC signaling pathways via mGlu5 activation, but not  
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Figure 4-8. Long-term NRG1 signaling promotes ERBB4 phosphorylation. 
(A) NRG1 is cleaved in the membrane by ADAM or BACE enzymes to produce a 6-8 
kDa extracellular NRG1 EGF domain peptide. Long-term, low levels of NRG1 EGF 
domain peptide binds to ERBB4 and promotes the recruitment of ERBB2 and (B) the 
formation of an ERBB2:ERBB4 heterodimer. (C) ERBB2:ERBB4 heterodimers are 
tyrosine phosphorylated via autophosphorylation, leading to enhanced signaling to 
mGlu5 receptors. Downstream signaling promotes synapse formation and maintenance. 
See results for more detail. 
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PI3K or p38 mitogen activated protein kinase (MAPK) pathways. In BACE null mice 
with impaired NRG1 processing, binding of ERBB4 to post-synaptic density (PSD) 
proteins is also impaired which correlates to reduced dendritic spine density (Savonenko 
et al. 2008).  
Exposure to acute NRG1 results in low levels of ERBB4 tyrosine phosphorylation 
and internalization of the ERBB4 receptor (Fig. 4.9) (Kwon et al. 2005; Li et al. 2007; 
Syed et al. 2010; Seshadi et al. 2015). Previous research has suggested that this is likely 
due to preferential ERBB4:ERBB4 homodimerization, which has a lower 
phosphorylation state then the higher affinity ERBB2:ERBB4 heterodimer (Sweeney et 
al. 2000; Mei and Xiong 2008). Further, ERBB4 phosphorylation is impaired when 
ERBB2 is not available for heterodimer formation (Graus-Porta et al. 1997). This is 
further supported by the observations that high levels of exogenous NRG1 peptide 
exposure reverses long-term potentiation (LTP) in the cornu ammonis area 1 (CA1) 
region of the mouse hippocampus (Kwon et al. 2005), and blocks LTP induction at CA1 
synapses in hippocampal slices (Huang et al. 2000). Importantly, Bjarnadottir et al. 
(2007) showed that low doses of NRG1 increases tetanus and theta-burst induced LTP in 
the CA1, but higher doses suppress LTP. 
Based on our results above, expression of 82-kDa ChAT in SH-SY5Y cells 
promotes NRG1-dependent neurite outgrowth, but that neurite outgrowth in vector-
expressing cells is NRG1-independent. Since NRG1 can stimulate the phosphorylation of 
the EGF receptor ERBB4 (Sweeney et al. 2000; Iwakura and Nawa 2013), we assessed 
whether there were differences in ERBB4 phosphorylation (p-ERBB4) levels after 
differentiated SH-SY5Y cells were exposed to fresh media or media that was conditioned 
on either 82-kDa ChAT or vector expressing cells for 48 h (Fig. 4.10). Prior to the 
addition of the test media, cells were incubated in serum-free media for 1 h to remove 
ERBB4-bound serum proteins and allow the receptors to traffic to the cell surface. After 
1 min of exposure to fresh media containing FBS, both vector and 82-kDa ChAT 
expressing cells had increased p-ERBB4 levels (Fig. 4.10A). The levels of p-ERBB4 
were higher in 82-kDa ChAT expressing cells compared to cells expressing empty vector, 
with no detectable differences in total ERBB4 levels (n = 2). 
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Figure 4-9. Acute NRG1 signaling reduces ERBB4 phosphorylation. 
(A) Acute release or over-expression of NRG1 EGF domain peptide binds ERBB4 and 
promotes the recruitment of ERBB4 and (B) the formation of an ERBB4:ERBB4 
homodimer. (C) ERBB4:ERBB4 heterodimers have low levels of tyrosine 
phosphorylation and are more rapidly internalized compared to heterodimers. This results 
in loss of signaling, leading to reductions in synapse formation and the inhibition of long-
term potentiation. See results for more detail. 
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Figure 4-10. 82-kDa ChAT expressing cells have enhanced ERBB4 phosphorylation 
in response to growth factors. 
(A) Representative immunoblot showing phosphorylated ERBB4 (p-ERBB4), total 
ERBB4 and β-actin steady-state levels in vector or 82-kDa ChAT expressing SH-SY5Y 
cells treated for 1 min with cell media containing no fetal bovine serum (FBS), 8% FBS 
or media containing FBS conditioned for 48 h on either 82-kDa ChAT or vector 
expressing cells. In each case, cells were grown in media containing no FBS for 1 h prior 
to the addition of test media. Both vector and 82-kDa ChAT expressing cells showed 
little or no p-ERBB4 following treatment with serum-free media or media conditioned on 
vector or 82-kDa ChAT expressing cells. Vector expressing cells treated with fresh FBS 
containing media had a low level of p-ERBB4, while 82-kDa ChAT expressing cells had 
a stronger immunoreactive band for p-ERBB4. There were no differences in total ERBB4 
levels. n = 2. (B) Vector or 82-kDa ChAT expressing cells were treated in the same 
conditions above for 5 min. Both vector and 82-kDa ChAT expressing cells had no p-
ERBB4 band for serum-free or conditioned media, as in (A). Both 82-kDa ChAT and 
vector expressing cells had a stronger band for the FBS-containing media treatment as 
compared to (A), with ChAT expressing cells again showing an increased response 
compared to vector cells. n = 4. (C) Cells treated for 20 min in the same condition as (A) 
again had no p-ERBB4 bands for serum-free media or conditioned media treatments. 
Vector expressing cells treated with media containing FBS had a lower level p-ERBB4 
band compared to the 5 min treatment, and compared to 82-kDa ChAT expressing cells. 
82-kDa ChAT cells treated with media containing FBS had no change in p-ERBB4 levels 
compared to 5 min. n = 2.  
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After 5 min, p-ERBB4 levels were increased in both cell lines after fresh media 
treatment, with 82-kDa ChAT expressing cells again having higher p-ERBB4 levels 
compared to cells expressing the empty vector (Fig. 4.10B, n = 4). After 20 min, p-
ERBB4 levels were reduced in vector expressing cells exposed to fresh media containing 
FBS compared to 5 min, but were similar to 5 min levels in cells expressing 82-kDa 
ChAT (Fig. 4.10C, n = 2). We did not detect phosphorylation changes for any time points 
for cells treated with serum-free media or media conditioned on either 82-kDa ChAT or 
vector expressing cells. In some cases, we observed an immunoreactive band with lower 
molecular mass in vector expressing cells that were treated with medium that was 
conditioned on vector expressing cells (visible in Fig. 4.10A), but this result was not 
consistent across replicate experiments and time points. 
Based on the observed increase in ERBB4 phosphorylation in 82-kDa ChAT 
expressing cells following exposure to fresh culture medium containing FBS, we 
hypothesized that these cells may also be more responsive to exogenous NRG1 EGF 
domain peptide treatment. Therefore, we treated SH-SY5Y cells expressing either vector 
or 82-kDa ChAT with recombinant NRG1 EGF domain peptide for 5 min and measured 
the resulting levels of p-ERBB4 (Fig. 4.11, n = 2). In vector expressing cells, we 
observed a low level of phosphorylation in untreated cells and cells treated with 1.25 ng 
NRG1 peptide. Following the addition of 2.5 ng NRG1 peptide, there was an observable 
increase in p-ERBB4, with this enhanced further following exposure to 5 ng NRG1. 
Increasing the dose to 10 ng NRG1 resulted in p-ERBB4 levels that were similar to 
untreated cells. In comparison, with 82-kDa ChAT expressing cells we observed higher 
levels of p-ERBB4, including in untreated cells, compared to vector expressing cells. 
Peak p-ERBB4 levels were observed with 1.25 ng NRG1 treatment, and p-ERBB4 levels 
in 82-kDa ChAT expressing cells treated with 2.5, 5 or 10 ng NRG1 being similar to 
untreated cells. 
Together with the observed increases in p-ERBB4 levels and duration following 
treatment with media containing FBS, these data suggest that ERBB4 receptors are 
activated at lower agonist concentrations in 82-kDa ChAT expressing SH-SY5Y cells 
compared to cells expressing an empty vector. To determine whether these observations   
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Figure 4-11. 82-kDa ChAT expression increases the response to NRG1 stimulation 
of p-ERBB4. 
Representative immunoblots showing phosphorylated ERBB4 (p-ERBB4) and β-actin 
steady-state levels in vector or 82-kDa ChAT expressing SH-SY5Y cells treated for 5 
min with recombinant NRG1 EGF domain peptide. Vector expressing cells showed 
increased p-ERBB4 levels after treatment with 2.5 and 5 ng of NRG1 peptide, with a 
peak at 5 ng. Treatment with 10 ng NRG1 resulted in p-ERBB4 levels close to untreated 
cells. 82-kDa ChAT expressing cells showed peak p-ERBB4 levels following 1.25 ng 
NRG1 peptide treatment, with 2.5, 5 and 10 ng NRG1 treatment resulting in p-ERBB4 
levels similar to untreated cells. The total levels of ERBB4 still need to be determined for 
this experiment n = 2. 
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may be due to increased levels of extracellular NRG1 EGF domain peptide released by 
82-kDa ChAT expressing cells, we endeavored to detect and quantify the levels of NRG1 
EGF domain peptide produced by cells expressing either empty vector or 82-kDa ChAT. 
First, we tried to detect NRG1 EGF peptide levels in media conditioned for 48 h on either 
82-kDa ChAT or vector expressing cells by immunoblotting, but were unsuccessful (data 
not shown). Interestingly, when we concentrated samples of these conditioned media by 
8-fold we were able to detect an immunoreactive band at 6 kDa for NRG1 in media 
collected from 82-kDa ChAT expressing cells, but not from the vector expressing cells 
(Fig. 4.12, n = 3). Actin from cell lysate was used as a loading control, with equal 
volumes loaded for vector and 82-kDa ChAT expressing cells. 
Next, we performed sandwich ELISAs with antibody directed to the NRG1 EGF 
domain peptide using media that was conditioned for 48 h on 82-kDa ChAT or vector 
expressing SH-SY5Y cells (Table 4.4). Optical density values were compared to a 
standard curve generated with recombinant NRG1 EGF domain peptide to determine a 
NRG1 concentration. We were not able to detect NRG1 peptide levels in media 
conditioned on 82-kDa ChAT or vector expressing cells over the concentration range 
tested (n = 8), and concentrating media 8-fold produced values that were also below the 
limit of detection (n = 2). Concentrating media could also concentrate any serum proteins 
present in the media. Therefore, to address whether the presence of FBS in the medium 
could alter the NRG1 concentrations measured by ELISA, we added recombinant NRG1 
peptide to either serum-free medium or medium containing 8% FBS (n = 1). When 
NRG1 peptide was added to serum-free medium, the concentration of the peptide 
measured was within ± 15% of the amount of peptide added. However, adding NRG1 
peptide to FBS-containing media resulted in detected NRG1 concentrations that were 
nearly 50% below the expected values, suggesting that serum proteins can reduce the 
detection of NRG1. Finally, we added exogenous NRG1 peptide to media conditioned on 
either vector or 82-kDa ChAT expressing cells, mainly observing that the measured 
NRG1 levels were ± 15% of expected values (Table 4.4, n = 1). Interestingly, one 
notable exception was in media conditioned on 82-kDa ChAT expressing cells and 
treated with the lowest detectable concentration of NRG1 for the ELISA (125 pg/mL), 
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where we detected an NRG1 concentration that was 52% higher than expected. More 
experiments are needed to confirm these ELISA results. 
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Figure 4-12. 82-kDa ChAT expression increases NRG1 extracellular peptide release 
in SH-SY5Y media. 
Representative immunoblot showing extracellular NRG1 EGF domain peptide detected 
in media samples conditioned on either vector or 82-kDa ChAT expressing SH-SY5Y 
cells for 48 h. Media was concentrated 8-fold following collection. Total protein was also 
isolated from cells in each condition and an equal volume of cell lysate was separated by 
electrophoresis to show β-actin as a loading control. An immunoreactive band was 
detected for NRG1 in 82-kDa ChAT expressing cells, but not for vector expressing cells. 
n = 3. 
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Table 4-4. NRG1 concentrations as measured by ELISA.  
n = 8 for conditioned media with 0 ng NRG1 added, n = 2 for concentrated media, n = 1 
for all other samples. 
 
Treatment 
(NRG1 peptide 
concentration) 
 
Measured Concentration 
 
Percentage Difference 
   
Serum-free media 
0 ng 0.034 ng -- 
0.125 ng 0.106 ng -15.3% 
1 ng 1.087 ng +8.6% 
4 ng 4.463 ng +11.6% 
8% FBS media 
0 ng 0.022 ng -- 
0.125 ng 0.095 ng -24.0% 
1 ng 0.505 ng -49.6% 
4 ng 2.221 ng -44.5% 
Vector cell conditioned media 
0 ng 0.008 ng -- 
0.125 ng 0.145 ng +15.7% 
1 ng 1.062 ng +6.2% 
4 ng 3.349 ng -16.3% 
82-kDa ChAT conditioned media 
0 ng 0.000 ng -- 
0.125 ng 0.190 ng +51.9% 
1 ng 0.958 ng -4.2% 
4 ng 3.100 ng -22.51% 
Concentrated media 
Vector -0.017 ± 0.004 ng -- 
ChAT -0.027 ± 0.002 ng -- 
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4.4 Discussion 
 
In this chapter, we explored the novel finding that 82-kDa ChAT associated with 
chromatin enriched with NFAT DNA-binding motifs at synapse development and 
maintenance related genes. This observation led us to find that (1) 82-kDa ChAT 
expression alters the expression of a group of related synapse and membrane genes; (2) 
These gene expression changes led to increased protein levels of mGlu5, NRG1 and 
NLGN1 which are all involved in synapse development; (3) 82-kDa ChAT expressing 
neural cells have increased neurite outgrowth and neuritic branching, dependent on 
extracellular NRG1; and (4) 82-kDa ChAT expression increased the response to agonist-
induced ERBB4 phosphorylation by growth factors and NRG1. Overall, these findings 
show how bioinformatics data can be used to inform a hypothesis related to gene 
expression and chromatin organization, which can be followed from gene and protein 
expression changes to morphologic and phenotypic outcomes. 
Using ChIP-seq data, we showed that 82-kDa ChAT had significant enrichment 
for NFAT DNA-binding motifs. It was important that we also found GO groups related to 
synapse, membrane and calcium, as NFAT has been shown previously to play an 
important role in axon/dendrite outgrowth and synapse formation during development 
(Graef et al. 2003; Groth and Mermelstein 2003). When we assessed gene expression 
changes for several synapse related genes that exhibited 82-kDa ChAT peaks containing 
NFAT motifs, we found that many of these genes had increased mRNA levels in SH-
SY5Y cells expressing 82-kDa ChAT compared to cells expressing an empty vector. 
Given their role in synapse formation during development we chose 3 of these genes to 
further investigate. We found large increases in protein expression for NRG1, mGlu5 and 
NLGN1 in cells expressing 82-kDa ChAT compared to empty vector. NFAT is activated 
after Aβ-exposure (Wu et al. 2010), 82-kDa ChAT peaks were present in altered genomic 
positions following 4 h of Aβ1-42-exposure and NFAT levels are altered in AD (Abdul et 
al. 2010). Therefore, we also chose to assess changes after exposure to oligomeric Aβ1-42. 
For varying times after Aβ1-42-exposure, we observed gene expression changes for many 
of the genes explored, but this did not result in 82-kDa ChAT-mediated protein 
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expression alterations for NRG1, mGlu5 or NLGN1 after 24 h of Aβ1-42-exposure. Given 
that we saw gene expression changes for NLGN1 at 2 h and GRM5 at 8 h we expected to 
see protein expression changes by 24 h, however there are several reasons that could 
account for this discrepancy. First, the Aβ1-42-induced effects on gene expression may be 
transient; by 4 h NLGN1 was no longer increased, and so there may not be a large effect 
on translation. Another possible explanation could be differences in protein expression 
that are not yet apparent, depending on the protein’s half-life. Finally, we saw a non-
significant decrease in NRG1 mRNA levels only after 24 h of Aβ1-42-exposure, and 
therefore did not expect to see protein expression changes for NRG1 after 24 h.  
Though we did not detect any protein related differences after exposure of cells to 
Aβ1-42, there was increased expression of NRG1, mGlu5 and NLGN1 in 82-kDa ChAT 
expressing cells when compared to empty vector. This was a significant finding, as all 
three of these proteins are important for cholinergic synapse development and the 
response to neurotransmission. All of the genes that we tested for differences in SH-
SY5Y cells expressing either empty vector or 82-kDa ChAT work together to regulate 
synapse development (Fig. 4-13). NRG1 is cleaved within the synaptic membrane by a 
disintegrin and metalloproteinase (ADAM) or β-secretase (BACE) enzymes to produce 
the NRG1 EGF domain peptide (Luo et al. 2011; Merballi et al. 2012). NRG1 binds 
preferentially to ERBB4, where moderate long-term binding promotes heterodimerization 
with ERBB2 and tyrosine phosphorylation (Tzahar et al. 1996; Graus-Porta et al. 1997; 
Sweeney et al. 2000; Gerecke et al. 2004; Savonenko et al. 2008). This phosphorylation 
leads to signaling events that, through the PSD-93/GKAP/Shank/Homer complex results 
to PLC-1 phosphorylation and downstream inositol 1,4,5-trisphosphate (IP3) formation 
via activation of mGlu5 (Tu et al. 1999; Alagarsamy et al. 2005; Dai et al. 2014). At the 
same time, ERBB4 (via PSD-95) can signal to NLGN1 which promotes new complex 
formation with NRXN1 and the stabilization of existing synaptic connections (Reviewed 
in Craig and Kim 2007; Mei and Xiong 2008). The result of these signaling events is the 
promotion of new synapse formation and maintenance of existing connections (Gerecke 
et al. 2004; Craig and Kim 2007; Mei and Xiong 2008; Ting et al. 2011). Importantly, 
synapse formation via mGlu5-mediated signaling has been shown to  
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Figure 4-13. ERBB4 signaling promotes cholinergic synapse maintenance and new 
synapse formation. 
(A) In cholinergic neurons, neuregulin 1 (NRG1) is cleaved within the post-synaptic 
membrane by either ADAM or BACE family members to produce a short extracellular 
EGF domain peptide. NRG1 binds to ERBB4 and promotes tyrosine phosphorylation 
which signals to mGlu5 through the PSD-93/GKAP/Shank/Homer complex. mGlu5 
activation leads to phosphorylation of phospholipase c, promoting synapse formation. (B) 
ERBB4 can also signal to neuroligin, which binds to neurexin on the pre-synaptic 
membrane to stabilize synaptic connections. ERBB4-neuroligin signaling promotes new 
synapse formation and maintenance of existing synapses. Neuroligin is cleaved within the 
membrane by ADAM10, which is also responsible for α-secretase cleavage of APP. 
Italics = Encoded genes with 82-kDa ChAT peak associations found by ChIP-seq 
(GSE73576). See results for more detail. 
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promote cholinergic synapse development in rat neural progenitor cells (Zhao et al. 
2014). NLGN1 is also cleaved by ADAM10, an ADAM family member that cleaves 
membrane-bound APP and NRG1 (Kuhn et al. 2010; Luo et al. 2011). ADAM10 also had 
ChIP-seq peaks for 82-kDa ChAT, but this was not explored in the current study. Based 
on these relationships, we assessed the morphological features of 82-kDa ChAT 
expressing cells, finding that they had more complex neurite formation than cells 
expressing empty vector, depending upon the extracellular NRG1 EGF domain peptide.  
 It is well established that high levels of p-ERBB4 lead to increased mGlu5 
activation through an interaction with the PSD93 or 95/GKAP/Shank/Homer complex 
(Gerecke et al. 2004; Savonenko et al. 2008). Low-moderate levels of NRG1 stimulation 
have been demonstrated to stabilize a PSD95 interaction (Huang et al. 2000). 
Hippocampal brain regions of schizophrenic patients with enhanced NRG1-induced 
activation of ERBB4 receptors show an increased interaction between ERBB4 and 
PSD95 (Hahn et al. 2006), indicating that the NRG1 stimulated ERBB4-PSD interaction 
is an important mechanism for downstream signaling. In our data, we observed that 82-
kDa ChAT expressing cells have increased and sustained p-ERBB4 in response to cell 
culture media containing FBS, and increased the response to recombinant NRG1 EGF 
domain stimulation of p-ERBB4. One conceivable explanation for these observations 
could be an increase in available surface receptors and resistance to desensitization, a 
possibility only if ERBB4 is recruiting ERBB2 for heterodimerization (Fig 4.8). NRG1 
binding to ERBB4 could also increase the likelihood of ERBB4 phosphorylation, in a 
manner that produces increased responses to stimulation. Though we are not aware of any 
studies supporting this possibility, 82-kDa ChAT expressing cells have peak p-ERBB4 
levels after lower recombinant NRG1 peptide treatment than vector expressing cells 
suggesting that they may be more sensitive to stimulation. Finally, it is possible that 
either ERBB4 or other surface receptor stimulation by either growth factors or NRG1 
results in NRG1 cleavage by ADAM/BACE and EGF domain peptide release into the 
extracellular space. This could account for both the enhanced/sustained p-ERBB4 levels 
following FBS stimulation and the lower NRG1 peptide concentration need to elicit p-
ERBB4 in 82-kDa ChAT expressing cells. Further studies will be needed to elucidate the 
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mechanisms related to the phosphorylation state of ERBB4 in 82-kDa ChAT expressing 
cells. 
In the data presented in this chapter, low levels of NRG1 stimulated p-ERBB4 
whereas higher levels inhibited this induction. Though the total levels of ERBB4 still 
need to be determined for this experiment, the initial data shows that ERBB4 
phosphorylation was stimulated by a lower NRG1 dose in 82-kDa ChAT expressing cells 
compared to cells expressing empty vector, but was also inhibited by lower doses. An 
important implication from these data may be related to the function of NRG1 in LTP. 
Exogenous NRG1 treatment has been described as an inverted U curve for LTP 
induction, very low and very high levels either do not support or supress LTP; however 
low-moderate levels can facilitate LTP (Bjarnadottir et al. 2007; Li et al. 2007; Syed et 
al. 2010). This may be due to moderate levels of NRG1 increasing ERBB4-PSD 
interactions (Hahn et al. 2006; Li et al. 2007), and at high levels disrupting this 
interaction (Li et al. 2007). p-ERBB4 signals to mGlu5 via the PSD/GKAP/Shank/Homer 
complex (Tu et al. 1999; Alagarsamy et al. 2005; Dai et al. 2014), and mGlu5 is critical 
for LTP induction (Rodrigues et al. 2002; Sourdet et al. 2003). Collectively, these data 
suggest that 82-kDa ChAT expressing cells could be more likely to have LTP induction, 
but also to LTP suppression. In support of this hypothesis, when we added 82-kDa ChAT 
conditioned media to vector expressing cells, we saw neurite branching similar to 82-kDa 
ChAT cells grown in new media. However, when we added 82-kDa ChAT conditioned 
media to cells expressing 82-kDa ChAT, it inhibited neurite outgrowth. If extracellular 
NRG1 is produced in higher levels by 82-kDa ChAT expressing cells it would explain 
both of these observations. Therefore further experiments are needed to confirm whether 
these changes are NRG1 and/or ERBB4-dependent. 
Based on the NRG1 dependent neurite outgrowth in 82-kDa ChAT expressing 
cells, increased response to p-ERBB4 stimulation by FBS and recombinant NRG1, and 
effects of 82-kDa ChAT conditioned media on vector expressing cells, we tested whether 
we could measure NRG1 in the media of 82-kDa ChAT or vector expressing cells. We 
were able to detect an ~6 kDa NRG1 immunoreactive band in concentrated media 
samples conditioned on 82-kDa ChAT expressing cells, but not in vector expressing cells. 
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However, when we attempted to measure NRG1 levels by ELISA we were unable to 
detect NRG1 in conditioned media, whether or not it was concentrated. In fact, when we 
tested concentrated media NRG1 values fell below values for blank samples, which 
indicated that a factor present in the media maybe blocking antibody binding. We 
therefore also explored whether adding FBS to media could alter NRG1 detection. 
Though only the first replicate, when we added 0.125 ng/mL recombinant NRG1 peptide 
to media containing FBS we detected NRG1 levels ~25% below expected values, and 
>50% below expected values for when we added 1 or 4 ng/mL NRG1 to the media. We 
also observed that high levels (4 ng/mL) of NRG1 peptide, but not low NRG1 treatment 
(0.125 ng/mL), added to vector or 82-kDa ChAT conditioned media also produced lower 
than expected (16-20%) values of NRG1. Given that media conditioned on cells for 48 h 
would have some FBS content, these data support the assumption that FBS may be 
partially blocking the NRG1 capture antibody, and could explain why low levels of 
NRG1 could be more easily detected. Interestingly, when we added 0.125 ng/mL NRG1 
to conditioned media from vector expressing cells we measured a NRG1 concentration 
16% higher than expected, and when we added the same amount to 82-kDa ChAT 
expressing cells we measured a NRG1 concentration 52% higher than expected. 
Therefore, it may be possible that the NRG1 concentration in unconcentrated 82-kDa 
ChAT conditioned media is ~50-60 pg/mL, which is below the 125 pg/mL detection limit 
of the ELISA assay. More testing is needed to verify this, including producing a NRG1 
standard curve in the 100-250 pg/mL range in conditioned media, and comparing it to 
standard curves generated in serum-free, low serum and high serum cell culture media.  
The data presented in this chapter supports a model whereby 82-kDa ChAT 
association with chromatin at synapse related genes results in increased neurite outgrowth 
and complexity (Fig. 4.14). We show that 82-kDa ChAT associates with synapse related 
genes at NFAT enriched sequences (possibly in complex with NFAT and AP-1), leading 
to increased steady-state protein levels of NRG1, mGlu5 and NLGN1. NRG1 is cleaved 
in the membrane to produce the NRG1 EGF domain, which binds to ERBB4 and 
promotes p-ERBB4. These changes coincide with increased p-ERBB4 responses, 
possibly due to increased extracellular NRG1 release and ERBB4 binding, increased 
surface receptors, or a combination of some or all of these factors. Previous research  
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Figure 4-14. Proposed model for the role of 82-kDa ChAT in neurite outgrowth and 
complexity. 
(1) 82-kDa ChAT, possibly in complex with NFAT and AP-1, increases gene expression 
of NRG1, GRM5 and NLGN1, leading to increased protein expression of NRG1, mGlu5 
and NLGN1, respectively. (2) This results in increased cell-surface expression of all three 
proteins. (3) NRG1 is cleaved within the membrane to produce the extracellular NRG1 
EGF domain, which binds ERBB4 and increases its phosphorylation. (4) Through 
unknown mechanisms, phosphorylated ERBB4 may signal to (A) mGlu5, causing 
downstream signaling leading to increased synapse formation; and/or (B) NLGN1 to 
promote complex formation with neurexin 1, leading to increased synapse formation and 
stabilization. See discussion for more detail.  
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suggests that signaling from p-ERBB4 to mGlu5 and NLGN1 may then result in the 
observed increases in neurite complexity seen in 82-kDa ChAT expressing cells, though 
this remains to be investigated in this model system. 
We have demonstrated that NRG1, mGlu5 and NLGN1 are increased in 82-kDa 
ChAT expressing cells, that the cells are more responsive to p-ERBB4 by NRG1 and 
growth factors, and that the cells produce complex neuritic branching. However, there are 
still a few additional experiments that are needed to support the data presented in this 
chapter. For example, additional experiments will help determine how 82-kDa ChAT 
expressing cells have an increased and sustained p-ERBB4 response to growth factors 
and exogenous NRG1. We can differentiate 82-kDa ChAT or vector expressing cells in 
the presence of NRG1 antibody to see if that reverses the increased p-ERBB4 response to 
agonist stimulation. Cell-surface biotinylation in both reducing and non-reducing 
conditions can be used to determine how many surface receptors are present, whether 
they are in a complex with ERBB2 or other EGF receptors, and to test an interaction with 
PSD93. Another key experiment will be to co-culture 82-kDa ChAT and vector 
expressing cells, separated by a permeable transwell insert, in the presence or absence of 
NRG1 antibody. By measuring p-ERBB4 levels following agonist stimulation in vector 
expressing cells, we can clarify whether NRG1 or another factor released by the 82-kDa 
ChAT expressing cells could alter the response to ERBB4 phosphorylation in other cells. 
In other experiments we can repeat neurite outgrowth experiments with low dose EGFR 
inhibitors, in order to explore whether EGF receptors such as ERBB4 are the main signal 
transduction pathway involved. It will also be important to culture vector expressing cells 
in the presence of exogenous NRG1 to show whether this produces similar neurite 
branching to 82-kDa ChAT expressing cells. We can assess downstream signaling 
pathways by measuring PLCB1 phosphorylation, IP3 formation, or looking at 
downstream PKC and/or ERK activation of NF-κB or AP-1. For example, atypical PKC-ι 
overexpression has been shown to be involved in NF-κB-mediated neuronal 
differentiation of PC12 cells (Wooten et al. 1999). Finally, we can determine whether 
NFAT is required for the observed protein expression changes using siRNA knockdown, 
and can assess how 82-kDa ChAT could be altering gene expression using ChIP for RNA 
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Polymerase II and histone acetylation/methylation markers at gene promoters or near 
peak binding sites. 
If 82-kDa ChAT expression in human cholinergic neurons results in increased 
synaptic complexity during development and synapse maintenance in adulthood, the 
potential importance of these findings should not be understated. Increased synaptic 
connections to cholinergic projection areas have implications for normal processing in 
these regions and for the response to stimulation. For example, synapse complexity and 
level of dendritic arborization in the hippocampus correlate with the magnitude of LTP 
response (Toni et al. 1999; Alonso et al. 2004; Chen et al. 2010). Increasing dendritic 
arborization in the CA3 of mice leads to improvements in spatial memory tasks (Vollala 
et al. 2011), and stress-induced reductions in hippocampal dendritic spine density 
correlates to LTP attenuation and long-term depression induction (Chen et al. 2010). 
Disruptions in normal synapse development can lead to neurological diseases, such as 
schizophrenia (Reviewed in Faludi and Mirnics 2011; Yin et al. 2012). NRG1 has been 
identified as a schizophrenia susceptibility gene (Stefansson et al. 2002; Stefansson et al. 
2003; Norton et al. 2006), and NRG1 levels are abnormally increased in schizophrenia 
patients (Chong et al. 2008; Pitcher et al. 2011). Importantly, the same NGR1 
schizophrenia susceptibility haplotype on 8p12 was found significantly associated with 
late-onset Alzheimer’s disease (AD) patients; correlated to increased cognitive deficits 
and rapid decline (Go et al. 2005). In the same study, Go et al. (2005) reported a 
significant NRG1 single-nucleotide polymorphism (rs392499) also associated with these 
late-onset patients. In AD, initial gain-of-function LTP induction is followed quickly by 
synapse dysfunction and degeneration in the hippocampus and frontal cortex, and is one 
of the earliest markers of the toxic effects of Aβ (Reviewed in Selkoe 2002; Lacor et al. 
2007; Reviewed in Arendt 2009). It is noteworthy that synapse dysfunction is also 
correlated with memory impairments seen early in AD (DeKosky and Scheff 1990). 
Further, mGlu5 has been shown to bind to oligomeric Aβ-cellular prion protein (PrP(C)) 
complexes, leading to dendritic spine loss and learning and memory impairments (Um et 
al. 2013), which may mean that increases in mGlu5 not only promote synapse 
maintenance but also increase sensitivity to Aβ toxicity. Finally, NFAT isoform nuclear 
levels are altered in both MCI and AD (Abdul et al. 2010). The data presented in this 
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chapter supports the hypothesis that NFAT and 82-kDa ChAT work together to alter the 
gene and protein expression of mGlu5, NLGN1 and NRG1, leading to increased 
complexity of neurite branching. Therefore, 82-kDa ChAT expression during 
development may have important implications for cognition, learning and memory. In 
addition, altered localization of 82-kDa ChAT during MCI or AD (Gill et al. 2007) may 
have implications for the etiology and progression of AD or other neurodegenerative 
diseases.   
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Chapter 5  
5 Discussion 
 
The studies presented in this thesis describe a novel role for nuclear localized 82-
kDa choline acetyltransferase in chromatin organization, gene expression, neurite 
outgrowth and in an epigenetic response to cellular perturbations. Broadly, by performing 
the first full genome sequencing chromatin immunoprecipitation study for both 82-kDa 
ChAT and special-AT rich binding protein 1 (SATB1), we found that 82-kDa ChAT 
associates with chromatin at gene promoters and introns in cholinergic cells. Following 
exposure of cultured neural cells to oligomeric Aβ1-42, 82-kDa ChAT was co-localized 
with SATB1, with both proteins increasing these genic associations. Both 82-kDa ChAT 
and SATB1 were localized to scaffolding/matrix attachment regions (S/MARs) and had 
features of chromatin organizers. 82-kDa ChAT and SATB1 associations with the APP 
gene resulted in Aβ-induced gene expression reductions of an amyloid precursor protein 
(APP) mRNA transcript variant that is increased in AD patients and which correlates to 
increases in Aβ1-42. The 82-kDa ChAT protein exhibited features of chromatin organizers 
in vehicle-treated cells, and associated at DNA binding motifs for transcription factors 
involved in synapse formation (Fig 3-18). This led us to find that 82-kDa ChAT is 
involved in neurite outgrowth and complexity during cholinergic differentiation (Fig 4-
14). 
 
5.1 Limitations of the current studies 
 
There were a number of important limitations to consider from the presented data. 
First, most of the results presented in this thesis are from in vitro cell models of 
cholinergic expression in differentiated SH-SY5Y cell neuroblastoma cells. It will be 
important for future studies to verify the results in this thesis using other cholinergic cell 
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types, including human IMR32 and LA-N-2 neuroblastoma cells to address whether the 
results are cell-line specific. Additionally, though these cells have morphological and 
phenotypic characteristics of cholinergic neurons following differentiation (Hashemi et 
al. 2003), cells derived from neuroblastoma lines likely have gene and protein expression 
characteristics that would not reflect neurons in brain (Reviewed in Gordon et al. 2013). 
Further, cell culture conditions do not fully reflect the environment in the brain without 
supporting glial cells. Future studies using in vivo models to address these limitations are 
discussed below. 
An additional consideration for the presented data is that, though the depth of the 
data obtained from studies involving ChIP-seq is extensive and can inform a number of 
novel hypotheses, the data must be verified by further molecular analyses. A good 
example of this was the ChIP-seq peak identified for SATB1 on APP. The ChIP-seq data 
showed a peak at the region for SATB1 following cell exposure to Aβ, but no peak in 
vehicle treated cells. However, when we verified this pattern using ChIP-qPCR we found 
that there was no statistical difference in the genic association with this region. The 
apparent inconsistency could be due to stringency on the peak calling. We used 
p<0.00001 for the peak calling, which is the default peak calling p-value for Galaxy.org, 
and necessary to produce data that has low false positives and confidence in the data. 
However, this high level of stringency also has the potential for false negatives. When we 
reduce the stringency to p<0.001, we now see a peak in the vehicle sample for SATB1, 
but also ~2000 more peaks for that sample. As this was the first whole genome 
sequencing study for SATB1 and baseline binding occupancy is unknown, decreasing the 
stringency of peak calling could introduce a higher false positive rate. Therefore, we 
decided to use the p<0.00001 value, even though it did not show a peak for SATB1 in the 
vehicle treatment. An additional limitation was that we were only able to perform the 
ChIP-seq from stably transfected cells that were derived from a single clone, and with 
only one repeat for each treatment. Thus, it will be important for future studies to verify 
ChIP associations for both 82-kDa ChAT and SATB1 on other genomic regions by ChIP-
qPCR, and to establish baseline values in regions where 82-kDa CHAT and SATB1 are 
not predicted to bind. 
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5.2 Future studies that expand the presented data  
 
The data presented in this thesis point to an important role for 82-kDa ChAT in 
chromatin organization, leading to an epigenetic response to Aβ-exposure and changes to 
neurite development. We found that 82-kDa ChAT alters gene expression of synapse 
related genes, as well as the APP mRNA isoforms containing the Kunitz-type serine 
protease inhibitor domain (Moir et al. 1998; APP-KPI) in response to exposure of cells to 
Aβ. There are some clues in the data presented as to the reasons for these changes, 
including interactions of 82-kDa ChAT with spliceosome machinery and the nuclear 
matrix protein Matrin3 identified by mass spectrometry, and the observed changes to the 
alternatively spliced APP-KPI mRNA isoform. Additionally, 82-kDa ChAT may be in 
complex with the NFAT transcription factor, involved in synapse formation and 
maintenance. However, there are a number of interesting hypotheses and questions that 
have still yet to be explored, as discussed below. 
The data obtained to date provide an intriguing hypothesis that 82-kDa ChAT is 
involved in mRNA splicing of transcripts from synapse formation-related genes. 
However, we have not yet determined the mechanisms of how the 82-kDa ChAT-
chromatin interaction leads to these changes in gene expression; whether this is through 
mRNA splicing changes, promoter activation or other mechanisms. Additionally, we did 
not explore whether alterations in chromatin organization could be responsible for the 
observed changes in synapse-related gene expression. It is possible that these findings are 
linked, and chromatin looping changes lead to altered gene utilization or mRNA stability. 
Since we found gene ontology (GO) terms related to synapse and membrane for both 82-
kDa ChAT and SATB1 after both vehicle and Aβ-treatment of cells, we can also 
hypothesize that these genes may be part of an inter-Topologically Associated Domain 
(TAD) locus since NRG1 (chromosome 8 [Chr8]), GRM5 (Chr11), and NLGN1 (Chr3) 
are all on different chromosomes and thus unlikely to be within the same TAD. 82-kDa 
ChAT could also be involved in transcription elongation, as the chromatin organizer 
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Alpha Thalassemia/Mental Retardation Syndrome X-Linked (ATRX) prevents the 
stalling of RNA polymerase II (RNA Pol II) at intragenic regions by interfering with G-
quadraplex structure (Levy et al. 2015). It will therefore be important for future studies to 
use chromatin conformation capture techniques to identify gene and locus specific 
chromatin looping changes and global chromatin organization. Moreover, ChIP for RNA 
Pol II and histone markers should also be employed to assess promoter-specific activation 
and intragenic transcription elongation. 
Another interesting finding is the exciting possibility that 82-kDa ChAT could 
bind directly to DNA. We demonstrated that 82-kDa ChAT has tandem DNA-binding 
motifs at AT-rich regions and associates with chromatin at regions enriched with AT-rich 
S/MAR binding motifs. However, these data were indirect and did not prove a direct 82-
kDa ChAT-DNA interaction. Thus, we used electrophoretic mobility shift assays 
(EMSAs) with purified recombinant 82-kDa ChAT with the goal of determining if there 
is a direct DNA oligomer interaction. When we incubated 82-kDa ChAT with ATC-rich 
DNA oligomers we were able to observe a shifted band that was stronger than a non-
specific band at the same height. This indicated that there may be direct DNA-binding, 
but the biotinylated-DNA EMSA requires further optimization (i.e. less DNA input, 
different oligomers, different electrophoresis conditions, comparisons to recombinant 69-
kDa ChAT). As an alternative approach, we could perform the EMSA using 32P-labelled 
DNA, or other techniques such as microplate ELISA-based assays, or in vivo methods 
such as proximity ligation assays, fluorescence resonance energy transfer (FRET) or 
atomic force microscopy. Understanding whether 82-kDa ChAT binds directly to DNA, 
and how this interaction occurs will be important for further elucidating how the protein 
can alter chromatin organization or gene expression. 
As outlined in Chapter 4, there are a number of experiments that are still required 
to address how 82-kDa ChAT expression alters chromatin organization and gene 
expression resulting in altered neurite outgrowth and complexity. We showed that the 82-
kDa ChAT increases neurite complexity, dependent on extracellular neuregulin 1 
(NRG1) peptide. NRG1 also has increased protein levels in cells expressing 82-kDa 
ChAT. Interestingly, receptor tyrosine-protein kinase erbB-4 (ERBB4), which has a 
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binding site for NRG1 (Tzahar et al. 1996; Sweeney et al. 2000; Savonenko et al. 2008), 
had increased phosphorylation in response to agonist activation in 82-kDa ChAT-
expressing cells. In addition, ERBB4 phosphorylation has been shown previously to 
result in downstream signaling that promotes synapse formation and maintenance (Zhu et 
al. 1995; Gerecke et al. 2004; Reviewed in Iwakura and Nawa 2013). However to date, 
we have not yet tested whether there is a direct link between NRG1, ERBB4 and these 
downstream signals, or how 82-kDa ChAT leads to the observed gene expression 
changes.  Some of the essential experiments include: cell surface biotinylation to assess 
ERBB4 receptor density and complex formation; measuring downstream signal 
transduction pathways; and ChIP/chromatin conformation capture techniques to address 
the mechanisms for gene expression changes (see Chapter 4 for more detail). These 
experiments will help elucidate the pathway from gene expression changes to phenotype 
changes observed in these cells, with implications for neurodevelopmental changes in 
human cholinergic cells. As these proteins are also involved in synapse maintenance and 
the response to stimulation, we can also consider the implications for aging individuals 
with lower 82-kDa ChAT expression and individuals with mild cognitive impairment 
(MCI) and AD where the nuclear localization is lost (Gill et al. 2007). 
 
5.3 New studies and hypotheses generated from the presented data  
 
There were a number of experiments that yielded novel data that were not part of 
the main hypothesis of this thesis, which could be extended to future studies. As 
discussed in Chapter 3, one significant finding from the ChIP-sequencing data was the 
discovery that both 82-kDa ChAT and SATB1 are associated with regions within and 
flanking the centromeres. Centromere organization is required for cell cycle regulation, 
and essential in neural cells to maintain a post-mitotic state (DeBeauchamp et al. 2008; 
Spremo-Potparević et al. 2008; Fernius et al. 2013). We also found, by mass 
spectrometry, an association with structural maintenance of chromosomes protein 1A 
isoform 1 (SMC1A), a protein involved in chromatin condensation and looping, as well 
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as cell division (Hirano 2002; Jessberger 2002). Further, we have observed that SH-
SY5Y cells expressing 82-kDa ChAT have slower growth in vitro both prior to and 
following differentiation (unpublished observations). Moreover, microarray revealed that 
IMR32 cells transiently expressing 82-kDa ChAT have gene expression changes for cell 
cycle related genes (NCBI GEO database accession number: GSE3506; Albers et al. 
2014). Combined with the findings that 82-kDa ChAT is involved in chromatin 
organization, and promotes neurite complexity during differentiation, these data 
collectively suggest that 82-kDa ChAT could play an important role in cholinergic 
differentiation by promoting neuronal phenotype changes. The cessation of cell division 
is an important part of neuronal development and cell maintenance in adulthood 
(reviewed in Herrup and Yang 2007; Frade and Ovejero-Benito 2015). This importance is 
exemplified in AD where neurons can re-enter the cell cycle accompanied with abnormal 
centromere division (Spremo-Potparević et al. 2008). Therefore, future studies should be 
designed to explore the role of 82-kDa ChAT in cell cycle regulation. 
The ChIP-seq data also revealed a significant gene ontology (GO) term 
‘programmed cell death’ for peaks associated with both 82-kDa ChAT and SATB1 after 
cells were treated with Aβ. This GO term included 46 genes, many of which with 
interesting functions related to cell survival or apoptosis. Some of these included DLC1, 
which encodes deleted in liver cancer 1 (DLC1), is involved in caspase-3 and Bcl-2 
mediated apoptosis (Zhang et al. 2009) and was 2.9 fold increased in our 82-kDa ChAT 
gene expression microarray (Albers et al. 2014); DCC, encoding DCC (deleted in 
colorectal cancer), which prevents apoptosis when bound by its ligand netrin-1, but 
initiates apoptosis in the absence of ligand (Mehlen et al. 1998); and XRCC2, which 
encodes X-ray repair cross complementing 2 (XRCC2) and is involved in DNA double-
stranded break repair (Johnson et al. 1999). One additional interesting gene was 
PRUNE2, which encodes Prune homolog 2 (PRUNE2). PRUNE2 is involved in many 
cellular pathways, including apoptosis, synapse function and neuronal differentiation 
(Machida et al. 2006; Valencia et al. 2007; Li et al. 2012; Tatsumi et al. 2015), and was 
identified as an AD susceptibility gene by genome wide association studies (GWAS) 
(Potkin et al. 2009; Bertram 2011). Therefore, it will be important for future studies to 
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address how 82-kDa ChAT may help respond to the environmental stress or DNA 
damage.  
In addition to the GO term ‘programmed cell death’, there were a number of 
additional significant GO terms for 82-kDa ChAT and SATB1 that would of interest for 
future studies (Appendix 10). Some of these included ‘nucleotide binding’ (114 genes), 
‘protein kinase activity’ (55 genes) and ‘GTP-ase binding’ (18 genes), all of which could 
have interesting implications for transcriptional processing, cell signaling and cell 
organization. It may be important to understand these additional pathways, as it could 
explain how we have previously observed gene expression changes without ChIP-
association. For example, we previously found that transient 82-kDa ChAT expression in 
primary neurons altered GGA3 gene expression, leading to increased lysosomal 
degradation of β-secretase (Albers et al. 2014), but we did not find that 82-kDa ChAT 
was associated with GGA3 in our ChIP-seq dataset. Though it is possible our ChIP-seq 
parameters were too stringent to pick up this interaction, it is more likely that GGA3 
expression was altered through another, as yet unknown, mechanism. Though the 
regulation of GGA3 transcription is largely unknown, Kametaka et al. (2005) showed 
that epidermal growth factor receptor (EGFR) activation results in transient 
phosphorylation of GGA3 and increased association of GGA3 with membranes. We 
found the GO term ‘protein kinase activity’ for 82-kDa ChAT and SATB1 in our ChIP-
seq data, and observed increases in the magnitude and duration of receptor tyrosine-
protein kinase ERBB4 phosphorylation in 82-kDa ChAT expressing cells. Therefore an 
intriguing hypothesis is that 82-kDa ChAT alters EGFR responses through ERBB4 or 
other protein kinases, which results in transient GGA3 phosphorylation and increased 
lysosomal degradation of the β-secretase BACE1. Thus, the link between GGA3-
mediated trafficking of BACE1 and ERBB4 phosphorylation would be an intriguing 
target for future study. As another example, the aforementioned microarray changes in 
cell cycle genes (such as CCND1 [encoding Cyclin D1] which was increased 4.1 fold) 
did not correspond to any ChIP-seq findings, again implying that other mechanisms or 
gene expression changes may be related to the observed gene expression changes. 
Exploring other possible pathways that could affect the expression of these genes will be 
important for future studies. 
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 One finding from the ChIP-seq dataset that is of particular interest for AD is that 
82-kDa ChAT has associations with many genes identified as AD susceptibility genes by 
genome-wide association studies (GWAS) meta-analysis (Bertram 2011). These included 
the aforementioned PRUNE2, but also several others including: BIN1, which encodes 
BIN1 (bridging integrator 1, also known as amphiphysin) and is involved in synaptic 
vesicle endocytosis and recycling (David et al. 1996; Hayashida et al. 2015); CR1, which 
encodes CR1 (complement receptor 1), involved in immune responses and Aβ-clearance 
(Crehan et al. 2012; Hazrati et al. 2012); and EFNA5, which encodes Ephrin A5 and is 
involved in motor neuron growth and axon guidance (Eberhart et al. 2000; Eberhart et al. 
2004). EFNA5, along with DLGAP1 (also found by ChIP-seq in this study) has also been 
shown to have single-nucleotide polymorphisms (SNPs) associated with obsessive-
compulsive disorder (OCD; Li et al. 2015). We also found the GWAS-identified gene 
GAB2, which encodes GAB2 (GRB2-associated-binding protein 2) that interacts with 
many receptor tyrosine kinases and membrane proteins such as APP (Reviewed in Pan et 
al. 2010). GAB2 has 10 SNPs associated with AD in apolipoprotein E ε4 carriers 
(Reiman et al. 2007). Finally, we found ChIP-associations with the GWAS-identified 
genes MAGI2 (a synaptic scaffolding molecule; Danielson et al. 2012) and MTHFD1L 
(important for folate metabolism; Momb et al. 2013), whose potential contributions to 
AD have not yet been explored. Whether 82-kDa ChAT alters the expression of these 
genes, and whether this has implications for AD susceptibility would be of interest for 
future studies.     
In addition to the GWAS-identified genes, we also observed ChIP-seq peaks for 
many genes that either interacted with APP, or were involved in APP processing (Table 
3.3). Several of the genes identified also had microarray changes (Albers et al. 2014), but 
we have currently only verified APP itself. APP processing is important for synapse 
maintenance and regulation of neural activity (Furukawa et al. 1996; Furukawa et al. 
1996b; Kojro et al. 2001; Stein et al. 2004), and β-secretase mediated cleavage results in 
Aβ1-42 production (Chow et al. 2010). Importantly, 82-kDa ChAT expression in primary 
neurons from APP/presenilin 1 (PS1) double trangenic mice reduces Aβ1-42 secretion and 
BACE1 expression levels (Albers et al. 2014). Together with the observed reductions in 
APP-KPI mRNA levels found in the present study, these data suggest that 82-kDa ChAT-
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mediated gene expression changes result in altered APP processing. Therefore it is of 
great interest whether 82-kDa ChAT expression in neural cells alters the expression of 
other genes that alter APP processing, and what contribution these changes have to the 
observed reductions in Aβ1-42 production. 
Another interesting piece of data was the finding that 82-kDa ChAT may 
associate with Matrin3. Though the present study showed the Matrin3 interaction by 
mass spectrometry, the interaction was also previously found by mass spectrometry and 
confirmed by co-immunoprecipitations performed in our lab (unpublished data). An 
interaction with Matrin3 could explain the finding that 82-kDa ChAT associates with 
S/MARs as well as the mass spectrometry associations with nuclear spliceosome-related 
proteins. Matrin3 has been shown to play a role in post-transcriptional pre-mRNA 
stabilization and the regulation of alternative splicing events (Zeitz et al. 2009; Salton et 
al. 2011; Coelho et al. 2015), which fits well with the data showing that the APP-KPI 
mRNA isoform has altered expression in 82-kDa ChAT expressing cells following Aβ-
exposure. There are many unanswered questions that are important for future research 
including: Are 82-kDa ChAT and Matrin3 directly binding to one another? What is the 
relationship between 82-kDa ChAT, Matrin3 and the spliceosome complex? Does 82-
kDa ChAT have a role in exon availability for transcription and/or pre-mRNA splicing or 
stability?   
 
5.4 Future studies for 82-kDa ChAT that have not yet been explored  
 
There are a number of interesting and important questions about 82-kDa ChAT 
expression and function that were not addressed in the current studies. For example, in 
Figure 1.5, we hypothesize that 82-kDa ChAT could alter gene expression through 
multiple mechanisms, including transcription factor (TF) and/or histone modifier 
recruitment, direct histone acetylation, or changes to acetylcholine availability. The data 
presented in this thesis shows that 82-kDa ChAT is associated with chromatin, has a role 
in chromatin organization with SATB1, and may be in complex with the NFAT TF. 
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However, we did not address the other hypotheses regarding changes to histone 
acetylation. Since SATB1 recruits histone modifying proteins to S/MARs (Yasui et al. 
2002; Cai et al. 2003; Galande et al. 2007), it is possible that STAB1 is recruiting 82-kDa 
ChAT in this model to modify histone acetylation. Though 82-kDa ChAT is unlikely able 
to mediate the N-acetylation required for histone acetylation (Grant and Berger 1999) 
based on the structural features of its catalytic domain (Kim et al. 2005), Britton et al. 
(2013) showed that histone H3 can be acetylated by O-acetylation at several serine and 
threonine residues. If 82-kDa ChAT is acting as a histone acetyltransferase and thus 
altering access to DNA for TFs or RNA Pol II, it could partially explain differences in 
exon availability for transcription, especially if there are SATB1-mediated chromatin 
looping changes following Aβ-exposure.   
As a result of the observed changes to neurite outgrowth and neurite complexity, 
there are a number of new questions related to 82-kDA ChAT’s involvement in 
cholinergic neurodevelopment. When is 82-kDa ChAT expressed in development? Can 
82-kDa ChAT influence the development or synaptic properties of other neural cells (i.e. 
glutamatergic, GABAergic, etc.) or glial cells? These are important considerations given 
that chromatin organization is critical for neurodevelopment (Williams et al. 2006; 
reviewed in Alexander and Lomvardas 2014). Dysregulation of chromatin organizers has 
been linked to intellectual disability, schizophrenia and autism spectrum disorder 
(Grayson et al. 2006; Gong et al. 2008; LaSalle and Yasui 2009; Gregor et al. 2013; 
McCarthy et al. 2014; Cotney et al. 2015), and all of these developmental disorders 
display hippocampal related changes correlated to memory and learning impairments 
(DeLong 1992; Heckers and Konradi 2002; Weiss et al. 2003; Dager et al. 2007; Zhang 
et al. 2015; Zhang et al. 2016). Since cholinergic neurons project to the hippocampus 
(Aznavour et al. 2002; Bloem et al. 2014), changes in synapse formation in these cells 
could influence hippocampal function. Epilepsy has also been linked to developmental 
changes in the hippocampus (Reviewed in Huang 2014), and more recently there has 
been evidence of developmental hippocampal structural alterations in patients with OCD 
(Hong et al. 2007). Given that 82-kDa ChAT is specifically expressed in humans and 
other primates, understanding how 82-kDa ChAT contributes to neural circuitry in the 
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hippocampus may also be important for understanding learning and memory differences 
between humans and other mammals.     
An important extension of the data presented will be to determine if we can 
recapitulate our findings in an in vivo model. As discussed above, cells derived from 
neuroblastoma lines likely have gene and protein expression characteristics that would 
not reflect neurons in brain, and are grown in conditions that may not fully reflect the 
environment in brain (Gordon et al. 2013). Thus, it will be important to also consider 
these factors and try to determine whether these changes can occur in an animal model of 
human 82-kDa ChAT expression in cholinergic neurons. Recently, our lab has developed 
a transgenic mouse model of basal forebrain specific expression of 82-kDa human ChAT. 
Though this mouse is still undergoing characterization, we can use this mouse model to 
address whether findings from these studies are supported in an in vivo model. Is 82-kDa 
ChAT associated with chromatin in cholinergic neurons in this mouse model and does 
this lead to altered gene expression of NLGN1, NRG1, GRM5, SATB1 and others? Does 
82-kDa ChAT expression in this model lead to increased synapse formation in 
cholinergic projection regions, such as the hippocampus or prefrontal cortex? These mice 
can also be crossed with a mouse model of AD, for example transgenic mice expressing 
an APP/PS1 double mutation that rapidly produces Aβ1-42, to test if there is an impact on 
APP metabolism (Albers et al. 2014). The 82-kDa ChAT/APP/PS1 triple transgenic mice 
are also invaluable to ask whether 82-kDa ChAT has a role in responses of neurons to 
Aβ1-42-induced stress. Using these mice, we can determine if 82-kDa ChAT forms nuclear 
aggregates in response to Aβ in vivo, whether it associates with SATB1, and whether 
these proteins lead to gene expression changes of APP-KPI or other genes. Finally, we 
can determine whether 82-kDa ChAT expression leads to phenotype changes in APP/PS1 
mice; if changes in synapse formation and maintenance result in neuroprotection from the 
toxic effects of Aβ1-42 and/or protect from the memory and learning impairments 
observed in this mouse model.   
Finally, it is still unknown how 82-kDa ChAT nuclear localization is established. 
We have previously shown that 82-kDa ChAT has a unique NLS that results in stable 
nuclear localization (Resendes et al. 1999; Gill et al. 2003). However, we do not know 
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what molecular chaperone(s) may be responsible for nuclear import, and whether nuclear 
export is different between 82-kDa and 69-kDa ChAT. These questions are particularly 
relevant, given the observed mislocalization of 82-kDa ChAT in the cytoplasm of 
cholinergic cells from patients with mild cognitive impairment (MCI) and AD (Gill et al. 
2007). Other epigenetic and transcription mediators are also mislocalized following long-
term Aβ-exposure and in MCI and AD, including DNA methyltransferase (DNMT), 
RNA Pol II, repressor element 1-silencing transcription (REST), and H3K4me3 
(Mastroeni et al. 2013; Lu et al. 2014; Mastroeni et al. 2015). These changes may be due 
to importin-α and/or Ran-GTP mediated changes in cholinergic cells (Lee et al. 2006; 
Mastroeni et al. 2013), and thus would be good targets for initial experiments addressing 
82-kDa ChAT nuclear import. In addition, preliminary confocal imaging experiments 
performed in our laboratory suggests that long-term Aβ-exposure may reduce nuclear 
levels of 82-kDa ChAT (unpublished data). Determining the mechanisms of nuclear 
import and export are key for understanding the changes that human cholinergic cells 
may undergo when nuclear localization is lost, and for identifying potential interventions 
for preventing or reversing the nuclear localization changes observed in MCI and AD.  
 
5.5 Overall conclusions and significance 
 
The data presented in this thesis represent a significant advancement in 
understanding the role of nuclear-localized 82-kDa ChAT in cholinergic nuclei. We 
showed that 82-kDa ChAT is involved in chromatin organization and gene expression 
changes at S/MARs in cholinergic nuclei, leading to an epigenetic response following 
Aβ-exposure. Many chromatin organizers are also involved in neurodevelopment, a 
feature that may also be true for 82-kDa ChAT. Neural cells expressing 82-kDa ChAT 
had gene expression changes leading to increased neurite complexity during cholinergic 
differentiation, supporting the hypothesis that 82-kDa ChAT may also be involved in 
neurodevelopmental synapse formation. It will be important for future studies to 
determine how 82-kDa ChAT alters gene expression, and whether there are resulting 
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changes to chromatin looping or access to promoters and exons. It will also be important 
to verify these results in 82-kDa ChAT and AD transgenic mouse models, and to further 
understand the phenotypic changes resulting from 82-kDa ChAT nuclear expression 
using these models. The nuclear levels of 82-kDa ChAT decline in aging and are 
mislocalized in individuals with MCI or AD (Gill et al. 2007), and synapse degeneration 
occurs early in the progression of AD (Reviewed in Selkoe 2002; Lacor et al. 2007; 
Reviewed in Arendt 2009). Therefore the loss of both the epigenetic response to Aβ and 
gene expression changes related to synapse formation and maintenance may have 
implications for the etiology or progression of MCI and AD.  
229 
 
5.6 References  
 
Alexander JM, Lomvardas S (2014) Nuclear architecture as an epigenetic regulator of 
neural development and function. Neuroscience, 264: 39-50. 
Albers S, Inthathirath F, Gill SK, Winick-Ng W, Jaworski E, Wong DY, Gros R, Rylett 
RJ (2014) Nuclear 82-kDa choline acetyltransferase decreases amyloidogenic 
APP metabolism in neurons from APP/PS1 transgenic mice. Neurobiol Dis, 69: 
32-42. 
Arendt T (2009) Synaptic degeneration in Alzheimer's disease. Acta Neuropathol, 118: 
167-179. 
Aznavour N, Mechawar N, Descarries L (2002) Comparative analysis of cholinergic 
innervation in the dorsal hippocampus of adult mouse and rat: a quantitative 
immunocytochemical study. Hippocampus, 12: 206-217. 
Bertram L (2011) Alzheimer's genetics in the GWAS era: a continuing story of 
'replications and refutations'. Curr Neurol Neurosci Rep, 11: 246-253. 
Britton LM, Newhart A, Bhanu NV, Sridharan R, Gonzales-Cope M, Plath K, Janicki 
SM, Garcia BA (2013) Initial characterization of histone H3 serine 10 O-
acetylation. Epigenetics, 8: 1101-1113. 
Cai S, Han HJ, Kohwi-Shigematsu T (2003) Tissue-specific nuclear architecture and 
gene expression regulated by SATB1. Nat Genet, 34: 42-51. 
Chow VW, Mattson MP, Wong PC, Gleichmann M (2010) An overview of APP 
processing enzymes and products. Neuromolecular Med, 12: 1-12. 
Coelho MB, Attig J, Bellora N, König J, Hallegger M, Kayikci M, Eyras E, Ule J, 
Smith CW (2015) Nuclear matrix protein Matrin3 regulates alternative splicing 
and forms overlapping regulatory networks with PTB. EMBO J, 34: 653-658. 
230 
 
Cotney J, Muhle RA, Sanders SJ, Liu L, Willsey AJ, Niu W, Liu W, Klei L, Lei J, Yin 
J, Reilly SK, Tebbenkamp AT, Bichsel C, Pletikos M, Sestan N, Roeder K, State 
MW, Devlin B, Noonan JP (2015) The autism-associated chromatin modifier 
CHD8 regulates other autism risk genes during human neurodevelopment. Nat 
Commun, 6: 6404. 
Crehan H, Holton P, Wray S, Pocock J, Guerreiro R, Hardy J (2012) Complement 
receptor 1 (CR1) and Alzheimer's disease. Immunobiology, 217: 244-250. 
Dager SR, Wang L, Friedman SD, Shaw DW, Constantino JN, Artru AA, Dawson G, 
Csernansky JG (2007) Shape mapping of the hippocampus in young children with 
autism spectrum disorder. AJNR Am J Neuroradiol, 28: 672-677. 
Danielson E, Zhang N, Metallo J, Kaleka K, Shin SM, Gerges N, Lee SH (2012) S-
SCAM/MAGI-2 is an essential synaptic scaffolding molecule for the GluA2-
containing maintenance pool of AMPA receptors. J Neurosci, 32: 6867-6980. 
David C, McPherson PS, Mundigl O, de Camilli P (1996) A role of amphiphysin in 
synaptic vesicle endocytosis suggested by its binding to dynamin in nerve 
terminals. Proc Natl Acad Sci U S A, 93: 331-335. 
Debeauchamp JL, Moses A, Noffsinger VJ, Ulrich DL, Job G, Kosinski AM, Partridge 
JF (2008) Chp1-Tas3 interaction is required to recruit RITS to fission yeast 
centromeres and for maintenance of centromeric heterochromatin. Mol Cell Biol, 
28: 2154-2166. 
DeLong GR (1992) Autism, amnesia, hippocampus, and learning. Neurosci Biobehav 
Rev, 16: 63-70. 
Eberhart J, Barr J, O'Connell S, Flagg A, Swartz ME, Cramer KS, Tosney KW, 
Pasquale EB, Krull CE (2004) Ephrin-A5 exerts positive or inhibitory effects on 
distinct subsets of EphA4-positive motor neurons. J Neurosci, 24: 1070-1078. 
231 
 
Eberhart J, Swartz M, Koblar SA, Pasquale EB, Tanaka H, Krull CE (2000) Expression 
of EphA4, ephrin-A2 and ephrin-A5 during axon outgrowth to the hindlimb 
indicates potential roles in pathfinding. Dev Neurosci, 22: 237-250. 
Fernius J, Nerusheva OO, Galander S, Alves Fde L, Rappsilber J, Marston AL (2013) 
Cohesin-dependent association of scc2/4 with the centromere initiates 
pericentromeric cohesion establishment. Curr Biol, 23: 599-606. 
Frade JM, Ovejero-Benito MC (2015) Neuronal cell cycle: the neuron itself and its 
circumstances. Cell Cycle, 14: 712-720. 
Galande S, Purbey PK, Notani D, Kumar PP (2007) The third dimension of gene 
regulation: organization of dynamic chromatin loopscape by SATB1. Curr Opin 
Genet Dev, 17: 408-414. 
Gerecke KM, Wyss JM, Carroll SL (2004) Neuregulin-1beta induces neurite extension 
and arborization in cultured hippocampal neurons. Mol Cell Neurosci, 27: 379-
393. 
Gill SK, Bhattacharya M, Ferguson SS, Rylett RJ (2003) Identification of a novel 
nuclear localization signal common to 69- and 82-kDa human choline 
acetyltransferase. J Biol Chem, 278: 20217-20224. 
Gill SK, Ishak M, Dobransky T, Haroutunian V, Davis KL, Rylett RJ (2007) 82-kDa 
choline acetyltransferase is in nuclei of cholinergic neurons in human CNS and 
altered in aging and Alzheimer disease. Neurobiol Aging, 28: 1028-1040. 
Gong X, Bacchelli E, Blasi F, Toma C, Betancur C, Chaste P, Delorme R, Durand CM, 
Fauchereau F, Botros HG, et al. (2008) Analysis of X chromosome inactivation in 
autism spectrum disorders. Am J Med Genet B Neuropsychiatr Genet, 147B: 830-
835. 
Furukawa K, Barger SW, Blalock EM, Mattson MP (1996) Activation of K+ channels 
and suppression of neuronal activity by secreted beta-amyloid-precursor protein. 
Nature, 379: 74-78. 
232 
 
Furukawa K, Sopher BL, Rydel RE, Begley JG, Pham DG, Martin GM, Fox M, 
Mattson MP (1996b) Increased activity-regulating and neuroprotective efficacy of 
alpha-secretase-derived secreted amyloid precursor protein conferred by a C-
terminal heparin-binding domain. J Neurochem, 67: 1882-1896. 
Gordon J, Amini S, White MK (2013) General overview of neuronal cell culture. 
Methods Mol Biol, 1078: 1-8. 
Grant PA, Berger SL (1999) Histone acetyltransferase complexes. Semin Cell Dev 
Biol, 10: 167-177. 
Grayson DR, Chen Y, Costa E, Dong E, Guidotti A, Kundakovic M, Sharma RP (2006) 
The human reelin gene: transcription factors (+), repressors (-) and the 
methylation switch (+/-) in schizophrenia. Pharmacol Ther, 272-286. 
Gregor A, Oti M, Kouwenhoven EN, Hoyer J, Sticht H, Ekici AB, Kjaergaard S, Rauch 
A, Stunnenberg HG, Uebe S, Vasileiou G, Reis A, Zhou H, Zweier C (2013) De 
novo mutations in the genome organizer CTCF cause intellectual disability. Am J 
Hum Genet, 93: 124-131. 
Hashemi SH, Li JY, Ahlman H, Dahlström A (2003) SSR2(a) receptor expression and 
adrenergic/cholinergic characteristics in differentiated SH-SY5Y cells. 
Neurochem Res, 28: 449-460. 
Hayashida M, Tanifuji S, Ma H, Murakami N, Mochida S (2015) Neural activity selects 
myosin IIB and VI with a specific time window in distinct dynamin isoform-
mediated synaptic vesicle reuse pathways. J Neurosci, 35: 8901-8913. 
Hazrati LN, Van Cauwenberghe C, Brooks PL, Brouwers N, Ghani M, Sato C, Cruts 
M, Sleegers K, St George-Hyslop P, Van Broeckhoven C, Rogaeva E (2012) 
Genetic association of CR1 with Alzheimer's disease: a tentative disease 
mechanism. Neurobiol Aging, 33: 2949.e5-2949.e12. 
Heckers S, Konradi C (2002) Hippocampal neurons in schizophrenia. J Neural Transm 
(Vienna), 109:891-905. 
233 
 
Herrup K, Yang Y (2007) Cell cycle regulation in the postmitotic neuron: oxymoron or 
new biology? Nat Rev Neurosci, 8: 368-378. 
Hirano T (2002) The ABCs of SMC proteins: two-armed ATPases for chromosome 
condensation, cohesion, and repair. Genes Dev, 16: 399-414. 
Hong SB, Shin YW, Kim SH, Yoo SY, Lee JM, Kim IY, Kim SI, Kwon JS (2007) 
Hippocampal shape deformity analysis in obsessive-compulsive disorder. Eur 
Arch Psychiatry Clin Neurosci, 257: 185-190. 
Huang T (2014) Early-life stress impacts the developing hippocampus and primes 
seizure occurrence: cellular, molecular, and epigenetic mechanisms. Front Mol 
Neurosci, 7: 8. 
Iwakura Y, Nawa H (2013) ErbB1-4-dependent EGF/neuregulin signals and their cross 
talk in the central nervous system: pathological implications in schizophrenia and 
Parkinson's disease. Front Cell Neurosci, 7: 4. 
Jessberger R (2002) The many functions of SMC proteins in chromosome dynamics. 
Nat Rev Mol Cell Biol, 3: 767-778. 
Johnson RD, Liu N, Jasin M (1999) Mammalian XRCC2 promotes the repair of DNA 
double-strand breaks by homologous recombination. Nature, 401: 397-399. 
Kim AR, Dobransky T, Rylett RJ, Shilton BH (2005) Surface-entropy reduction used in 
the crystallization of human choline acetyltransferase. Acta Crystallogr D Biol 
Crystallogr, 61: 1306-1310. 
Kojro E, Gimpl G, Lammich S, Marz W, Fahrenholz F (2001) Low cholesterol 
stimulates the nonamyloidogenic pathway by its effect on the alpha -secretase 
ADAM 10. Proc Natl Acad Sci U S A, 98: 5815-5820. 
Lacor PN, Buniel MC, Furlow PW, Clemente AS, Velasco PT, Wood M, Viola KL, 
Klein WL (2007) Abeta oligomer-induced aberrations in synapse composition, 
234 
 
shape, and density provide a molecular basis for loss of connectivity in 
Alzheimer's disease. J Neurosci, 27: 796-807. 
LaSalle JM, Yasui DH (2009) Evolving role of MeCP2 in Rett syndrome and autism. 
Epigenomics, 1: 119-130. 
Lee HG, Ueda M, Miyamoto Y, Yoneda Y, Perry G, Smith MA, Zhu X (2006) 
Aberrant localization of importin alpha1 in hippocampal neurons in Alzheimer 
disease. Brain Res, 1124: 1-4. 
Levy MA, Kernohan KD, Jiang Y, Bérubé NG (2015) ATRX promotes gene expression 
by facilitating transcriptional elongation through guanine-rich coding regions. 
Hum Mol Genet, 24: 1824-1835. 
Li J, Cui J, Wang X, Ma J, Niu H, Ma X, Zhang X, Liu S (2015) An association study 
between DLGAP1 rs11081062 and EFNA5 rs26728 polymorphisms with 
obsessive-compulsive disorder in a Chinese Han population. Neuropsychiatr Dis 
Treat, 11: 897-905. 
Li S, Hayakawa-Yano Y, Itoh M, Ueda M, Ohta K, Suzuki Y, Mizuno A, Ohta E, Hida 
Y, Wang MX, Nakagawa T (2012) Olfaxin as a novel Prune2 isoform 
predominantly expressed in olfactory system. Brain Res, 1488: 1-13. 
Lu T, Aron L, Zullo J, Pan Y, Kim H, Chen Y, Yang TH, Kim HM, Drake D, Liu XS, 
Bennett DA, Colaiácovo MP, Yankner BA (2014) REST and stress resistance in 
ageing and Alzheimer's disease. Nature, 507: 448-454. 
Machida T, Fujita T, Ooo ML, Ohira M, Isogai E, Mihara M, Hirato J, Tomotsune D, 
Hirata T, Fujimori M, Adachi W, Nakagawara A (2006) Increased expression of 
proapoptotic BMCC1, a novel gene with the BNIP2 and Cdc42GAP homology 
(BCH) domain, is associated with favorable prognosis in human neuroblastomas. 
Oncogene, 25: 1931-1942. 
Mastroeni D, Chouliaras L, Grover A, Liang WS, Hauns K, Rogers J, Coleman PD 
(2013) Reduced RAN expression and disrupted transport between cytoplasm and 
235 
 
nucleus; a key event in Alzheimer's disease pathophysiology. PLoS One, 8: 
e53349. 
Mastroeni D, Delvaux E, Nolz J, Tan Y, Grover A, Oddo S, Coleman PD (2015) 
Aberrant intracellular localization of H3k4me3 demonstrates an early epigenetic 
phenomenon in Alzheimer's disease. Neurobiol Aging, 36: 3121-3129. 
McCarthy SE, Gillis J, Kramer M, Lihm J, Yoon S, Berstein Y, Mistry M, Pavlidis P, 
Solomon R, Ghiban E, et al. (2014) De novo mutations in schizophrenia implicate 
chromatin remodeling and support a genetic overlap with autism and intellectual 
disability. Mol Psychiatry, 19: 652-658. 
Mehlen P, Rabizadeh S, Snipas SJ, Assa-Munt N, Salvesen GS, Bredesen DE (1998) 
The DCC gene product induces apoptosis by a mechanism requiring receptor 
proteolysis. Nature, 395: 801-804. 
Moir RD, Lynch T, Bush AI, Whyte S, Henry A, Portbury S, Multhaup G, Small DH, 
Tanzi RE, Beyreuther K, Masters CL (1998) Relative increase in Alzheimer's 
disease of soluble forms of cerebral Abeta amyloid protein precursor containing 
the Kunitz protease inhibitory domain. J Biol Chem, 273: 5013-5019. 
Momb J, Lewandowski JP, Bryant JD, Fitch R, Surman DR, Vokes SA, Appling DR 
(2013) Deletion of Mthfd1l causes embryonic lethality and neural tube and 
craniofacial defects in mice. Proc Natl Acad Sci U S A, 110: 549-554. 
Pan XL, Ren RJ, Wang G, Tang HD, Chen SD (2010) The Gab2 in signal transduction 
and its potential role in the pathogenesis of Alzheimer's disease. Neurosci Bull, 
26: 241-246. 
Potkin SG, Guffanti G, Lakatos A, Turner JA, Kruggel F, Fallon JH, Saykin AJ, Orro 
A, Lupoli S, Salvi E, Weiner M, Macciardi F; Alzheimer's Disease Neuroimaging 
Initiative (2009) Hippocampal atrophy as a quantitative trait in a genome-wide 
association study identifying novel susceptibility genes for Alzheimer's disease. 
PLoS One, 4: e6501. 
236 
 
Reiman EM1, Webster JA, Myers AJ, Hardy J, Dunckley T, Zismann VL, Joshipura 
KD, Pearson JV, Hu-Lince D, Huentelman MJ, Craig DW, Coon KD, Liang WS, 
Herbert RH, Beach T, Rohrer KC, Zhao AS, Leung D, Bryden L, Marlowe L, 
Kaleem M, Mastroeni D, Grover A, Heward CB, Ravid R, Rogers J, Hutton ML, 
Melquist S, Petersen RC, Alexander GE, Caselli RJ, Kukull W, Papassotiropoulos 
A, Stephan DA (2007) GAB2 alleles modify Alzheimer's risk in APOE epsilon4 
carriers. Neuron, 54: 713-720. 
Resendes MC, Dobransky T, Ferguson SS, Rylett RJ (1999) Nuclear localization of the 
82-kDa form of human choline acetyltransferase. J Biol Chem, 274: 19417-
19421. 
Salton M, Elkon R, Borodina T, Davydov A, Yaspo ML, Halperin E, Shiloh Y (2011) 
Matrin 3 binds and stabilizes mRNA. PLoS One, 6: e23882. 
Savonenko AV, Melnikova T, Laird FM, Stewart KA, Price DL, Wong PC (2008) 
Alteration of BACE1-dependent NRG1/ErbB4 signaling and schizophrenia-like 
phenotypes in BACE1-null mice. Proc Natl Acad Sci U S A, 105: 5585-5590. 
Selkoe DJ (2002) Alzheimer's disease is a synaptic failure. Science, 298: 789-791. 
Spremo-Potparević B, Zivković L, Djelić N, Plećas-Solarović B, Smith MA, Bajić V 
(2008) Premature centromere division of the X chromosome in neurons in 
Alzheimer's disease. J Neurochem, 106: 2218-2223. 
Stein TD, Anders NJ, DeCarli C, Chan SL, Mattson MP, Johnson JA (2004) 
Neutralization of transthyretin reverses the neuroprotective effects of secreted 
amyloid precursor protein (APP) in APPSW mice resulting in tau 
phosphorylation and loss of hippocampal neurons: support for the amyloid 
hypothesis. J Neurosci, 24: 7707-7717. 
Sweeney C, Lai C, Riese DJ 2nd, Diamonti AJ, Cantley LC, Carraway KL 3rd (2000) 
Ligand discrimination in signaling through an ErbB4 receptor homodimer. J Biol 
Chem, 275: 19803-19807. 
237 
 
Szabó GG, Holderith N, Gulyás AI, Freund TF, Hájos N (2010) Distinct synaptic 
properties of perisomatic inhibitory cell types and their different modulation by 
cholinergic receptor activation in the CA3 region of the mouse hippocampus. Eur 
J Neurosci, 31: 2234-2246. 
Tatsumi Y, Takano R, Islam MS, Yokochi T, Itami M, Nakamura Y, Nakagawara A 
(2015) BMCC1, which is an interacting partner of BCL2, attenuates AKT 
activity, accompanied by apoptosis. Cell Death Dis, 6: e1607. 
Tzahar E, Waterman H, Chen X, Levkowitz G, Karunagaran D, Lavi S, Ratzkin BJ, 
Yarden Y (1996) A hierarchical network of interreceptor interactions determines 
signal transduction by Neu differentiation factor/neuregulin and epidermal growth 
factor. Mol Cell Biol, 16: 5276-5287. 
Valencia CA, Cotten SW, Liu R (2007) Cleavage of BNIP-2 and BNIP-XL by 
caspases. Biochem Biophys Res Commun, 364: 495-501. 
Weiss AP, Schacter DL, Goff DC, Rauch SL, Alpert NM, Fischman AJ, Heckers S 
(2003) Impaired hippocampal recruitment during normal modulation of memory 
performance in schizophrenia. Biol Psychiatry, 53: 48-55. 
Williams RR, Azuara V, Perry P, Sauer S, Dvorkina M, Jørgensen H, Roix J, McQueen 
P, Misteli T, Merkenschlager M, Fisher AG (2006) Neural induction promotes 
large-scale chromatin reorganisation of the Mash1 locus. J Cell Sci, 119: 132-
140. 
Yasui D, Miyano M, Cai S, Varga-Weisz P, Kohwi-Shigematsu T (2002) SATB1 
targets chromatin remodelling to regulate genes over long distances. Nature, 419: 
641-645. 
Zhang CL, Houbaert X, Lepleux M, Deshors M, Normand E, Gambino F, Herzog E, 
Humeau Y (2015) The hippocampo-amygdala control of contextual fear 
expression is affected in a model of intellectual disability. Brain Struct Funct, 
220: 3673-3682. 
238 
 
Zhang Q, Gao X, Li C, Feliciano C, Wang D, Zhou D, Mei Y, Monteiro P, Anand M, 
Itohara S, Dong X, Fu Z, Feng G (2016) Impaired Dendritic Development and 
Memory in Sorbs2 Knock-Out Mice. J Neurosci, 36: 2247-2260. 
Zhang T, Zheng J, Jiang N, Wang G, Shi Q, Liu C, Lu Y (2009) Overexpression of 
DLC-1 induces cell apoptosis and proliferation inhibition in the renal cell 
carcinoma. Cancer Lett, 283: 59-67. 
Zhu X, Lai C, Thomas S, Burden SJ (1995) Neuregulin receptors, erbB3 and erbB4, are 
localized at neuromuscular synapses. EMBO J, 14: 5842-5848. 
Zeitz M, Malyavantham K, Seifert B, Berezney R (2009) Matrin 3: Chromosomal 
Distribution and Protein Interactions. J Cell Biochem, 108: 125-133. 
  
239 
 
Appendices 
 
Appendix 1- DNA fragment optimization for ChIP. 
5 uL of sonicated input DNA was run on a 1% agarose gel. DNA fragments ranged 
mainly from 300-500 bp. 
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Appendix 2- 82-kDa ChAT vehicle gene ontology. 
 
 
Appendix 3- 82-kDa ChAT Aβ gene ontology. 
 
 
Appendix 4- 82-kDa ChAT vehicle and Aβ gene ontology. 
 
 
  
Appendix 2 can be found in online supplemental information. 
Appendix 3 can be found in online supplemental information. 
Appendix 4 can be found in online supplemental information. 
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Appendix 5- EMSA optimization experiments 
Purified recombinant 82-kDa ChAT was incubated with annealed biotinylated DNA 
oligomers from Table 2.1 (only the ATC-Rich 1 motif was used for these experiments at 
125 fmol) and then separated on TBE electrophoresis gels. DNA and proteins were 
transferred to nylon membranes and exposed to stabilized streptavidin-horseradish 
peroxidase conjugate. (A) Increasing the incubation time from 20 min to 45 min 
increased the presence of a shifted immunoreactive DNA bands, but did not affect the 
background observed from samples incubated without added 82-kDa ChAT. Mixing the 
samples by rotation during incubation or increasing the incubation temperature to 37°C 
also increased the intensity of the non-specific band observed in samples that did not 
contain ChAT protein. (B) The addition of increasing amounts of an anti-ChAT antibody 
at 15 min prior to the end of the reaction period attenuated the intensity of the shifted 
band, with 2.5 µg appearing to have the greatest effect. The addition of the reducing 
agent TCEP resulted in an increase in the intensity of shifted immunoreactive band. DNA 
concentration was decreased to 100 fmol in these samples. N = 2. 
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Appendix 6- Representative PCR gel for primers used in RT-qPCR experiments. 
SH-SY5Y cells stably expressing either an empty vector or 82-kDa ChAT were treated 
with either vehicle or 100 nM oligomeric Aβ1-42. Total RNA was extracted and reverse 
transcribed prior to PCR amplification with primers specific to GAPDH, total APP or 
APP-KPI mRNA. For all primer sets, there was a single PCR product at the predicted 
size. 
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Appendix 7- SATB1 vehicle gene ontology. 
 
Appendix 8- SATB1 Aβ gene ontology. 
 
Appendix 9- SATB1 vehicle and Aβ gene ontology. 
 
Appendix 10- 82-kDa ChAT and SATB1 Aβ gene ontology. 
 
Appendix 11- 82-kDa ChAT and SATB1 vehicle and Aβ gene ontology. 
 
 
Appendix 7 can be found in online supplemental information. 
Appendix 8 can be found in online supplemental information. 
Appendix 9 can be found in online supplemental information. 
Appendix 10 can be found in online supplemental information. 
Appendix 11 can be found in online supplemental information. 
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